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 Quality of Life in Latino and Non-Latino Youth aged 8-18 Years with Sickle Cell Disease: A Mixed 
Methods Study 
Jennel C. Osborne 
While sickle cell disease (SCD) primarily affects those of African heritage, Latinos, the second most 
commonly affected group, are often not included in studies of youth with SCD. The purpose of this mixed 
methods study was to complete the linguistic translation validation of the PedsQL SCD Module, a recently 
validated disease specific quality of life (QOL) instrument, for use in Spanish speaking parents and youth 
with SCD (Aim 1). Using this instrument, QOL of Latino and African American youth with SCD who 
participated in an NIH funded study to improve adherence to hydroxyurea therapy (R21 NR013745) were 
compared (Aim 2) and factors associated with QOL examined (Aim 3). For Aim 1, 10 Latino youth with 
SCD (n = 5 age, 8-12 years; n = 5 age, 13-18 years) and their parents completed a demographic survey, 
Spanish version of PedsQL SCD Module and an audio-taped cognitive interview. Across age groups, all 
reported that the translated PedsQL Sickle Cell Disease Module was easy to understand and had minimal 
suggestions for further improvement. For Aims 2 and 3, secondary baseline data from 28 youth (mean 
age 13.6  2.4 years) with sickle cell disease and their parents who participated in the HABIT feasibility 
trial were analyzed using descriptive statistics, Wilcoxon Signed Rank and Mann-Whitney test, and linear 
regression modeling. Latino youth reported higher QOL scores than non-Latino youth for all QOL 
measures except for the Worry II subscale of the disease-specific QOL measure while Latino parents 
reported higher QOL scores than non-Latino parents for all subscales except for three: the disease-
specific Worry I, Worry II, and Communication I subscales. Poorer disease specific QOL was predicted by 
greater youth-parent discordance regarding sickle cell disease responsibility for parents (β = -3.07, p = 
0.04) but not youth. Poorer disease-specific QOL was predicted by greater number of both emergency 
room visits during the prior year for both youth (β = -2.89, p = 0.005 [self-report]; β = -5.07, p = 0.002 
[electronic medical records]) and parents (β = -3.41, p = 0.002 [self-report]; β = -6.93, p = <0.001 
[electronic medical records]) and hospitalizations during the prior year (youth β = -5.72, p = <0.001 [self-
report]; β = -7.56, p = 0.03 [electronic medical records]; parents β = -6.48, p = <0.001 [self-report];  
 
 
β = -9.16, p = 0.02 [electronic medical record]). Based on these findings, greater youth-parent 
discordance regarding sickle cell family responsibility and greater utilization of emergency rooms and/or 
hospitals were associated with poorer disease-specific QOL. 
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Chapter I: Introduction 
Background 
Sickle cell disease is one of the most prevalent genetic disorders in the United States (National 
Human Genome Research Institute, 2014). It affects approximately 90,000 to 100,000 Americans of 
African, Spanish, Saudi Arabian, Indian, and Mediterranean descent; worldwide, sickle cell disease 
affects millions of people (W. Wang et al., 2013), with about 300,000 infants born each year (Strouse, 
2016). In the U.S., children of African descent experience the highest prevalence of sickle cell disease 
(Dale, Cochran, Roy, Jernigan, & Buchanan, 2011; Fisak, Belkin, von Lehe, & Bansal, 2012; Newland, 
2008) with a prevalence of 1 in 365 (Hassell, 2010), while children of Latino descent experience the 
second highest prevalence of sickle cell disease with a prevalence of 1 in 16,000 (Hassell, 2010).  
Sickle cell disease occurs as a result of a β-globin gene variation known as hemoglobin S (Hb S) 
or sickle hemoglobin (Ashley-Koch, Yang, & Olney, 2000). Various forms of sickle cell disease exist. The 
most common forms of sickle cell disease are hemoglobin SS (a person has 2 copies of hemoglobin S 
gene) and Hemoglobin SC (a person inherits the hemoglobin C gene from one parent and the 
hemoglobin S gene from the other).  
Regardless of the sickle cell disease type (hemoglobin SS, hemoglobin SC, etc.), a person may 
be classified as having either mild or severe sickle cell disease (Panepinto, Pajewski, Foerster, Sabnis, & 
Hoffmann, 2009). In their study of 178 youth and parents: 104 youth with sickle cell disease and 74 youth 
without sickle cell disease, Panepinto et al. (2009) classified youth with a history of sickle cell-related 
stroke and/or acute chest syndrome, 3 or more hospitalizations for vaso-occlusive crisis, and/or recurrent 
priapism in the past 3 years as having severe disease. Youth without any of the above symptoms were 
considered as having mild sickle cell disease. 
Those with sickle cell disease are at risk for acute complications like painful vaso-occlusive crisis 
and priapism, and chronic complications that affect various organs and systems (Darbari & Panepinto, 
2012). While symptom severity differs from person to person, sickle cell disease is characterized by 
episodic pain as a result of oxygen deprivation in tissues and organs that may cause complications like 
organ destruction (Bhatia & Sheth, 2015) and acute chest syndrome, described as having pulmonary 
infiltrate with chest pain, fever, tachypnea, wheezing, or cough, is a leading cause of mortality in adults 
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(Elmariah et al., 2014). Other symptoms may include anemia, which results in shortness of breath, 
fatigue, and developmental delays in youth (Cherry et al., 2012).  
Sickle cell disease pain symptoms may be acute, chronic, or a combination of both (Okpala & 
Tawil, 2002), and may range from mild to severe. Mild pain is usually treated at home with oral analgesics 
(Ballas, Gupta & Adams-Graves, 2012), while severe painful crisis is usually treated in the emergency 
room or hospital (Amid & Odame, 2014; Ballas, Gupta, & Adams-Graves, 2012) with opioids, non-
steroidal anti-inflammatory drugs, and intravenous hydration in addition to other pain relieving therapies 
(Okpala & Tawil, 2002). Substantial analgesic use as a result of chronic pain often results in damage to 
tissues and organs (Ballas, Gupta, & Adams-Graves, 2012; Lehrke et al., 2004). Quality of life in 
individuals with sickle cell disease needs to be measured to inform clinicians who are unfamiliar with 
sickle cell disease-related pain on how sickle cell disease impacts QOL (McClish et al., 2005). 
Sickle Cell Disease Therapy 
There is no single best treatment for sickle cell disease. However, depending on symptom, 
several treatment options are available and can be broadly classified as preventative or therapeutic 
(Lukens, 1981).  
Preventative symptom management. Screenings and vaccinations are used prophylactically to 
manage symptoms of sickle cell disease. Diagnosis is primarily conducted using a special type of blood 
test that tests for sickled hemoglobin (Pack-Mabien & Haynes, 2009), and may be used in newborns and 
adults. Early diagnosis allows for awareness of the diagnosis and the initiation of prophylactic measures 
like vaccinations against pneumococcal bacteria (Quinn, Rogers, & Buchanan, 2004). As a prophylactic 
measure, the CDC recommends pneumococcal polysaccharide (Pneumovax) vaccine (given from 2 years 
of age) and pneumococcal conjugate (Prevnar) vaccine (given from 2 months old to 6 years of age at 
specific time-points) for youth with sickle cell disease (“Pneumococcal Vaccines: CDC Answers Your 
Questions” http://www.immunize.org/catg.d/p2015.pdf, n.d.). Twice daily penicillin is also recommended 
starting in early infancy and continuing throughout age 5 and older, in addition to routine health 
management with a health care provider who is an expert in sickle cell disease management (Gaston, et 
al., 1986). In low-income countries, infection is the most common cause of morbidity and mortality (Amid 
& Odame, 2014). In countries like the U.S. penicillin is used prophylactically to prevent infections like 
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Streptococcus pneumoniae and Haemophilus influenza type b (Quinn, Rogers, McCavit, & Buchanan, 
2010). 
Transfusion therapy is used to prevent stroke in children who have abnormal transcranial Doppler 
ultra-sonographic examinations (Adams & Brambilla, 2005). For over 2 decades red blood cell transfusion 
has been used to prevent stroke in sickle cell disease (Pegelow et al., 1995) by reducing the 
concentration of hemoglobin S (Amid & Odame, 2014). Most transfusions for sickle cell disease are 
simple red blood cell transfusion; red cell exchange transfusion, though effective, is used less frequently 
(Swerdlow, 2006). Chronic red blood cell transfusion (transfused at least monthly) is considered the main 
treatment for the prevention of stroke in children with sickle cell disease (Styles & Vichinsky, 1994; 
Swerdlow, 2006). Red blood cells transfusion can be prescribed as chronic treatment in cases where 
hemoglobin S levels are elevated or as an acute treatment in emergency situations to decrease 
hemolysis and prevent further vaso-occlusion and damage to organs (Swerdlow, 2006). 
 Therapeutic symptom management. Hydrocarbamide (hydroxyurea) and L-glutamine oral 
powder (Endari) are the 2 disease-modifying agents used in the treatment of sickle cell disease. For the 
past 2 decades, hydroxyurea was the only medication that was approved by the U.S. Food and Drug 
Administration (FDA) for therapeutic treatment of sickle cell disease (Rodgers, Dover, Noguchi, 
Schechter, & Nienhuis, 1990). Hydroxyurea is an antineoplastic drug that is used to treat neoplastic 
diseases and other diseases, including sickle cell disease. Hydroxyurea has long been considered the 
pharmacologic agent that is capable of enhancing the quality of life (QOL) of persons with sickle cell 
disease (Voskaridou et al., 2010). Hydroxyurea primarily works by increasing fetal hemoglobin levels by 
inducing stress red blood cell production (Green & Barral, 2011), and has been shown to decrease 
morbidity in persons with sickle cell disease by reducing incidences of chest syndrome and vaso-
occlusive crises by almost 50% in adults (Charache et al., 1995; Steinberg et al., 2003). 
Although hydroxyurea has not been approved by the FDA as a disease-modifying agent for sickle 
cell disease in children, it continues to be essential in preventing complications in this population (Estepp 
et al., 2016). Several clinical trials to examine the safety and effectiveness of hydroxyurea in youth with 
sickle cell disease have shown that hydroxyurea increased fetal hemoglobin levels in this population 
(Scott, Hillery, Brown, Misiewicz, & Labotka, 1996; Ware et al., 2002; Ware et al., 2016). Ware et al. 
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(2002) for example, reported that in their study of 53 youth with sickle cell disease, hydroxyurea 
decreased symptoms in all participants, with increased percentages of fetal hemoglobin levels ranging 
from 0.1% to 26.4%. 
In July 2017, the FDA approved Endari for patients with sickle cell disease aged 5 years and 
older (“ENDARI- glutamine powder, for solution,” n.d.). Endari works by reducing acute complications of 
sickle cell disease. To date, 2 placebo-controlled trials (phase 2 study, n = 70 and phase 3 study, n = 
230) were conducted in pediatric and adult patients with sickle cell anemia or sickle β
0
-thalassemia. Both 
studies established the safety and effectiveness of Endari in pediatric patients aged 5 or older and in 
adult patients. Endari holds promise to reduce complications of sickle cell disease and should therefore 
be explored in additional studies. 
 Hematopoietic stem cell transplant (HSCT) involving bone marrow donated from a healthy donor 
is currently the only cure for some patients with sickle cell disease (Bhatia & Sheth, 2015). Even though 
HSCT has proven to be the only cure, this procedure is mostly limited to patients who live in high-income 
countries, which excludes the majority of sickle cell disease patients worldwide (Amid & Odame, 2014). 
Additionally, hematopoietic stem cell transplantation is not used widely because of donor availability, cost, 
and potentially life-threatening complications (Al-Anazi, 2015). 
Quality of Life Measurement   
Throughout history and up until the 1950s, mortality rate was used to determine the health of the 
nation (Linder, 1966). Social indicators and societal resources like the gross national product, infant 
mortality, and social mobility, were seen as QOL indicators (Power, Bullinger, & Harper, 1999). In the 
1960s a new curiosity in a person’s perspective of QOL based on their emotional well-being, physical 
state, and social functioning began to take root (Power et al., 1999). In 1995, the World Health 
Organization QOL Group defined QOL as a person’s perception of the interaction between their physical 
health, psychological state, independence level, social relationships, environment and their cultural and 
value systems, in relation to their goals, expectations, concerns, and standards. Traditionally, the parent’s 
perspective of the child’s QOL (proxy-report) had been used to assess the child’s perception of QOL. 
Compared to proxy-report, QOL measurements obtained from self-report are more valuable as they 
provide a subjective report of a person’s perspective of disease effect and treatment (McClellan, Schatz, 
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Sanchez, & Roberts, 2008). Physical, mental, and social development in youth are inherently different 
from that of an adult’s, therefore even though overall QOL definitions apply to youth and adults alike, 
using a QOL instrument that is not tailored to the youth’s experiences, activities, and contexts and are not 
directly relevant to the youth’s age, would be incorrect. Children and adolescents may have different 
concerns in relation to health and QOL. The daily activities of youth, such as school functioning and play 
activities, need to be included in questionnaires in order to capture an accurate picture of the youths’ 
perception of his/her QOL (Eiser & Morse, 2001). Additionally, the language of the questionnaire needs to 
be adapted so that is comprehensible to the appropriate age group being studied (Eiser & Morse, 2001). 
When the youth is too young or is physically and/or mentally unable to provide self-report, a parent proxy-
report may be completed instead (Varni, Limbers, & Burwinkle, 2007). Assessing QOL either by youth 
self-report or by parent proxy-report or primary caregiver-report has become an integral part of pediatric 
research and in the trajectory of treatment by assessing disease burden in youth along with their 
parents/caregivers (Eiser & Morse, 2001).  
Quality of life instruments. Quality of life is measured with questionnaires that are either 
generic or disease-specific. Disease-specific QOL instruments were designed to measure the effect of 
specific disorders and are valid measures of specific diseases or conditions (Guyatt, Deyo, Charlson, 
Levine, & Mitchell, 1989; Clark & Eiser, 2004). Several disease-specific instruments have been validated 
and used as outcome measures of QOL in youth with various diseases/disorders such as cancer (Yeh & 
Hung, 2003) and diabetes (Ingersoll & Marrero, 1991). Until the development of the Pediatric QOL Sickle 
Cell Disease Module in 2012, disease-specific QOL appraisal was not possible for children living with 
sickle cell disease.  
Generic QOL questionnaires for the pediatric population usually include domains that measure 
emotional, physical, social, and school functioning and are not specific to a disease type (Varni, Seid, & 
Kurtin, 2001). Generic QOL instruments like the Pediatric Quality of Life (PedsQL) Generic Core Scales 
(Varni, Seid, & Rode, 1999), may not capture a person’s concerns regarding a particular disease due to 
the broad phrasing of questions (Meltzer, 2001; Merikallio, Mustalahti, Remes, Valovirta, & Kaila, 2005).  
Need for linguistically validated instruments in the language of the population being 
studied. Most questionnaires used in clinical trials/settings are developed in English-speaking countries 
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(Wild et al., 2009). Since QOL instruments are being increasingly used across different cultures in diverse 
settings, assessment measures have to be validated in the respective languages and cultures of the 
population being researched (Bullinger & Von Mackensen, 2008; Wild et al., 2005; Wild et al., 2009). To 
achieve this, original instruments have to be translated and validated to produce a new language version 
that is conceptually equivalent with the original instrument, is applicable, clear, and easy to understand by 
the target culture (Wild et al., 2009).  
Culture and quality of life. Quality of life perception is in part due to cultural influences. Culture 
is defined as a system of meanings that influences a particular population’s way of living and are 
transferred from generation to generation (Rohner, 1984). Culture is an important, multi-dimensional 
concept in QOL that includes: (1) ethnicity, defined as the foundation of a person’s culture that 
determines how a person behaves and how he/she views him/herself and the connection to ancestors 
(Kagawa-Singer, 2000); (2) interconnectedness, defined as the quality and demands of family life and 
social relationships, attitudes/beliefs, and spirituality i.e., religious beliefs and practices (Ashing-Giwa, 
2005; Bullinger & Von Mackensen, 2008; Maramaldi, Berkman, & Barusch, 2005; Wong, Lee, Ang, Oei, & 
Ng, 2009); and (3) acculturation, defined as the phenomena that occurs when groups of individuals with 
differing cultures repeatedly intermingle with resulting variations in the original pattern of either or both 
groups (Marin & Gamba, 1996; Olmedo, 1979; Redfield, Linton, & Herskovits, 1936). Acculturation can 
occur over a long period of time (Burnam, Telles, Karno, Hough, & Escobar, 1987; Marin & Gamba, 1996; 
Olmedo, 1979) with no universally agreed upon length of time when a person has to become acculturated 
to a specific culture (Burnam et al., 1987; Laroche, Kim, & Hui, 1997). Some Latinos for example, adapt 
sufficiently to North American culture while others experience difficulty adjusting, which often leads to 
difficulty managing social, physical, or emotional problems (Cuellar, Arnold, & Maldonado, 1995; Neff & 
Hoppe, 1993; Perez-Stable, Napoles-Springer, & Miramontes, 1997).  
Perception of QOL was shown to be different across cultural groups (Ashing-Giwa, Tejero, Kim, 
Padilla, & Hellemann, 2007; Fu et al., 2007; Scott et al., 2008). In their cross-cultural study of African-, 
Asian-, European-, and Latina-American survivors of breast cancer, Ashing-Giwa et al. (2007) reported 
that perception of QOL was lower in Latino participants compared to non-Latino participants. Scott et al. 
(2008) likewise reported that in their study of 11 cultures worldwide, participants from Latin America 
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reported almost the lowest QOL: only participants from South Asia reported QOL that was lower than 
those from Latin America. Based on this knowledge, this researcher decided to include cultural aspects in 
the examination of QOL in this dissertation. 
Conceptual Model 
This dissertation is guided by Ashing-Giwa’s Conceptual Model of Health-Related QOL (Ashing-
Giwa, 2005; Ashing-Giwa & Lim, 2011; Graves et al., 2012). This conceptual model (Figure 1) was 
chosen because it most accurately reflects the domains that play important roles in QOL. Ashing-Giwa 
and Lim’s conceptual model comprises 2 contextual levels: systemic-level context, which includes cultural 
and socio-ecological factors, and individual-level context which contains general health status.  
Systemic-level contexts such as demographic information, health care satisfaction, and socio-
ecological factors that pertain to social support, life burden, and socio-economic status, comprise 
variables that are expected to assert a broad yet weaker impact on QOL (Ashing-Giwa & Lim, 2011). Life 
burden is one of the key aspects of QOL that consist of familial (e.g. having children, disease, etc.) 
functional (education, housing, etc.) and neighborhood (environment, transportation, etc.) stresses. Life 
burden for youth with sickle cell disease may include familial stressors like having another family member 
in the home with sickle cell disease (Ashing-Giwa & Lim, 2011). Traditionally, the effects of life burden of 
sickle cell disease on QOL were measured by the number of hospitalizations and vaso-occlusive crises or 
deaths (Charache et al. 1995; Platt et al. 1994). More recently, the focus has been on understanding the 
impact of life burden of sickle cell disease on the QOL of youth and their families in order to better assist 
in the decision-making process regarding the most effective ways of preventing or treating sickle cell 
disease complications (Panepinto, 2008; Panepinto, Hoffmann, & Pajewski, 2009).  
 Individual-level contexts include variables that are expected to have a stronger influence and 
directly predict QOL, such as medical factors, general health status, and psychological well-being 
(Ashing-Giwa, 2005; Ashing-Giwa & Lim, 2011). General health status may be measured using 
components such as the physical component summary subscale from an established instrument (RAND 
12-item Health Survey), and 1 item measuring the number of co-morbidities (Ashing-Giwa & Lim, 2011). 
For this dissertation research, Ashing-Giwa’s Conceptual Model of Health-Related QOL was adapted for 
use in youth with sickle cell disease to explore the relationship between socio-ecological factors (life 
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burden) and general health status (poorer health) and disease-specific QOL in Latino and non-Latino 
youth with sickle cell disease and their parents. 
Significance 
Prior to the development of the PedsQL Sickle Cell Disease Module, researchers used self-
concept instruments like the Piers-Harris self-concept scale to measure QOL in African American children 
aged 7-18 years with sickle cell disease (Hurtig & White, 1985; Kumar, Powers, & Allen, 1976). Within the 
last 5 years, a disease-specific QOL measurement for youth with sickle cell disease has been developed 
(Panepinto et al., 2013). Currently, measurement of disease-specific QOL of youth with sickle cell disease 
is limited to those who are comfortable completing English language questionnaires. Sickle cell disease 
QOL research needs to include the Latino population, which is the second highest population diagnosed 
with sickle cell disease in the U.S. Families of many youth with sickle cell disease living in New York City 
have emigrated from Caribbean Spanish-speaking countries. From 2000 to 2008, Latino newborns 
accounted for almost 12% of newborns born with sickle cell disease in New York State (Y. Wang et al., 
2013). Some Latinos living in the U.S. have poor English proficiency and as result prefer to read and view 
information in their native language (De Jesus & Xiao, 2012). In a recent survey of Latino parents and 
adolescents, 59% of parents and 8% of youth were more comfortable with reading health information in 
Spanish (Smaldone et al., 2015). Therefore, Spanish language survey instruments that have been 
linguistically validated using a rigorous methodology are needed. 
Racial and/or ethnic disparities in QOL of youth have received minimal interest in research 
(Nelson, 2002). Ethnicity and culture may be associated with how a person views his/her QOL (Aziz & 
Rowland, 2002; Ashing-Giwa, 2005). Because Latinos are culturally and ethnically different from African 
Americans, research conducted in African American samples may not be generalizable to Latinos. 
Research on QOL in sickle cell disease pediatric population must include Latinos given that Latinos are 
the fasting growing population in the U.S., the largest ethnic or race minority in the U.S. (Centers for 
Disease Control and Prevention, 2013), and the second largest population diagnosed with sickle cell 
disease in the U.S. (Huttle, Maestro, Lantigua, & Green, 2015; Y. Wang et al., 2013). By 2050 it is 
estimated that Latinos will constitute 30% of the total U.S. population (Centers for Disease Control and 
Prevention, 2013); therefore, as the number of Latinos in the U.S. increases, the incidence of sickle cell 
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disease will also increase. This exploratory mixed methods study examined QOL in Latino and non-Latino 
youth aged 8-18 years with sickle cell disease and their parents.  
Contribution to Future Knowledge 
Research has shown that health disparities between diverse cultures exist in our society. A 
linguistically validated QOL instrument in this growing sickle cell disease population would enable better 
understand QOL in Latino youth with sickle cell disease and the impact of present and future therapies on 
QOL in this population. 
Aims and Hypotheses 
Specific Aim 1: To complete the linguistic validation process of the Spanish version of the PedsQL 
Sickle Cell Disease Module for parents and youth aged 8-12 and 13-18 years. 
Specific Aim 2: To compare perception of disease-specific and generic QOL in a sample of Latino and 
non-Latino youth with sickle cell disease aged 10-18 years and their parents who participated in a NIH 
funded study to improve adherence to hydroxyurea therapy. 
Hypothesis 2.1: Youth perception of disease-specific and generic QOL will be higher compared to 
parent proxy perception. 
Hypothesis 2.2: Perception of disease-specific and generic QOL in Latino youth and parents will 
be lower compared to non-Latino youth and parents. 
Specific Aim 3: To explore the relationship between disease-specific QOL as it relates to sickle cell 
disease life burden and poorer health in Latino and non-Latino youth with sickle cell disease aged 10-18 
years and their parents.  
Hypothesis 3.1: Youth with sickle cell disease and their parents with higher sickle cell disease life 
burden will have lower disease-specific QOL compared to those with lower sickle cell disease life burden. 
Hypothesis 3.2: Youth with poorer health and their parents will have lower disease-specific QOL 






Figure 1. Conceptual model of health-related QOL (Ashing-Giwa & Lim, 2011). Variables within each 
systemic-level context and individual-level context can be correlated with each other (Ashing-Giwa & Lim 





Chapter II: Literature Review  
Overview  
This chapter presents the methods and findings of 2 integrative literature reviews: (1) disease-
specific QOL instruments in youth, the primary area of interest in this dissertation research, and (2) 
cultural factors associated with QOL to better comprehend the role of culture in perception of QOL. Both 
integrative literature reviews were guided by Cooper’s (1982) and Whittemore and Knafl’s (2005) updated 
integrative review methodology.  
Integrative Review Method 
The integrative review method is the most inclusive type of research review that facilitates the 
inclusion of experimental and non-experimental research simultaneously to more fully understand a 
phenomenon or healthcare problem of concern (Whittemore and Knafl, 2005). The integrative review 
method has 5 stages: (1) Problem identification and purpose of review, (2) Literature search, (3) Data 
evaluation and quality appraisal, (4) Data analysis employing data reduction where studies are divided 
into subgroups according to study design to facilitate analysis; data display using graphs, tables, and 
flowcharts; data comparison to identify associations between variables, conclusion drawing and 
verification of results, and (5) Presentation of findings that captures the depth and breadth of the topic 
including limitations.  
Disease-specific Quality of Life Instruments in Youth 
Problem Identification and Purpose of Review 
Literature related to QOL measurement in youth suggest that QOL may be measured using 
generic and/or disease-specific QOL instruments by youth self-report and/or parent proxy-report. 
Additionally, it is important to understand QOL perspectives of normal/healthy youth compared to those 
with chronic illnesses, as it may improve understanding regarding how the burden of having a chronic 
illness affects youths’ daily activities. For youth with chronic illnesses, measurement and comparison of 
self-reported symptom-related perceptions of QOL may help to illuminate which chronic illnesses youth 
perceive as having the most disease burden.  
Currently, there are a variety of disease-specific QOL instruments available for youth self-
reported and parent proxy-reported QOL that are reliable and valid (Panepinto et al., 2013; Varni et al., 
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2014). However, the following areas pertaining to QOL in youth were not readily available and needed to 
be reviewed to better understand how disease-specific QOL is measured in youth with various diseases: 
(1) comparison of disease-specific QOL scores in youth, (2) diseases most frequently measured in youth, 
and (3) comparison of QOL scores by self-report and parent proxy-report. Therefore, the purpose of this 
integrative review was to examine literature pertaining to disease-specific QOL instruments in youth as 
relating to types of diseases measured and QOL scores. 
Literature Search 
A literature search using Scopus, Web of Science, PubMed, and PsycINFO databases was 
carried out. Observational studies of disease-specific QOL instruments in youth were examined for 
inclusion. Search terms used were: “disease specific quality of life AND children” and “quality of life”. 
During search, records were excluded if they were: non-English, review, non-pediatric, report or 
conference papers, non-human, or qualitative, Citations were limited to full text entries between the 
publication dates 1942 to 2017. Additional records were excluded after screening titles, abstracts and full 
text articles if necessary. Studies were read and were included if: (1) youth were 0-18 years old, (2) study 
used established QOL instrument(s) and/or newly developed instrument(s) completed by youth and/or 
parent/guardian/caregiver, (3) the instrument was disease-specific and outcome measured was QOL, (4) 
total QOL scores and standard deviation were reported, (5) the article was published in English, and (6) 
psychometric properties of the instrument were reported. Studies were excluded if: (1) study participants 
were older than 18 years, (2) studies used only generic QOL instruments, (3) instrument was not 
pediatric-specific, (4) study was a review of literature, (5) study was qualitative, (6) the article was 
published in a language other than English, (7) QOL was not the outcome of interest, or (8) total QOL 
scores and/or standard deviation not reported. 
Data Evaluation and Quality Appraisal 
The quality of all articles was reviewed by1 reviewer using the Mixed Methods Appraisal Tool 
(MMAT) – Version 2011 (Pluye et al., 2011). MMAT is a comprehensive instrument for appraising 
methodological quality of 5 design methods: (1) qualitative, (2) quantitative randomized controlled (trials), 
(3) quantitative non-randomized, (4) quantitative descriptive and (5) mixed methods. Qualitative and 
quantitative sections each have 4 questions to appraise study quality. The mixed methods section has 3 
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additional questions conjunction with the qualitative and appropriate quantitative section. Two screening 
questions common to all study designs must be answered prior to moving on to completion of the design-
specific criteria. If the response to either or both screening questions is “No” or “Can’t Tell” further 
appraisal of the study was is warranted. Based on the MMAT criteria, a survey response rate of 60% or 
greater is acceptable for non-randomized controlled trials, cohort, case-controlled, and cross sectional 
studies; complete outcome data ≥ 80% is acceptable for non-randomized controlled trials, cohort, case-
controlled, and cross sectional studies. Following study appraisal, a quality score is calculated by dividing 
the number of criteria met by the total number of criteria and then multiplying by 100.  
A random sample of 20% of the studies was appraised for quality by a second reviewer and inter-
rater reliability was assessed. Guided by the MMAT, strengths and weaknesses of studies were 
evaluated and presented in narrative form. Methodological quality was appraised and a quality score 
computed for each study; these are presented in narrative and graphical forms.  
Data Analysis 
Data were extracted from each study including study aim, instrument description, author’s name 
and year of publication, study design, intended audience, disease/disorder, and Latino participant sample 
representation for each study. Data were synthesized into tables that present psychometric properties of 
disease-specific QOL instruments by disease state. 
Presentation of Findings 
In this section, results of literature search of disease-specific QOL instruments are evaluated and 
presented. Responses to MMAT were evaluated, appraised, and synthesized into graphs. The reliability 
and validity of instruments are synthesized into tables. Because perception of QOL may differ between 
youth and parent, the difference between perception of QOL in youth and parent was examined and 
presented. The syntheses of subscales across instruments are presented. Additionally, studies were 
examined in order to address whether Latinos were adequately represented particularly for diseases 
where Latinos are disproportionately affected. 
Literature Search. Figure 2 provides details of the literature search. The initial search using 
search term “disease specific quality of life AND children” and “quality of life” resulted in identification of 
1876 records. Additional screening and cross-checking for duplicity resulted in removal of 97 records, 
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with 1779 records remaining. Additionally, 1,472 additional records were excluded as a result of 
screening titles, abstracts, and full text articles if necessary. Inclusion/exclusion criteria were applied 
leaving 307 full-text articles to be assessed for eligibility. An additional 268 articles were excluded after 
applying inclusion and exclusion criteria. A total of 33 cross-sectional and 6 cohort studies were included 
for review. Studies ranged in years of publication from 2003 (Otley et al., 2003) to 2017 (Mizuno, Ohya, 
Nagao, DunnGalvin, & Fujisawa, 2017).  
Data evaluation and quality appraisal. All studies received satisfactory responses to both 
MMAT screening questions. Figure 3 displays results of MMAT appraisal. A major strength is that all 
studies used appropriate instrument(s) that possessed a clear origin and validity, and clearly defined 
independent and dependent variables (criterion 3.2). For example, Varni and colleagues (2004) 
investigated the reliability, validity, and initial responsiveness of the PedsQL 3.0 Asthma Module and 
compared it to the PedsQL 4.0 Generic Core Scales and the Pediatric Asthma QOL Questionnaire 
(PAQOL) in a sample of 529 children aged 2-16 years with asthma and their parents and 730 healthy 
children aged 2–18 years (Varni, Burwinkle, Rapoff, Kamps, & Olsen, 2004) hypothesized that asthma-
specific symptoms/problems would correlate with lower Generic Core Total Scale Scores and therefore 
lower overall QOL perception. They found a statistically significant difference between healthy children 
(higher QOL) and children with asthma (lower QOL). Another strength noted was that the majority of 
authors included a representative sample of the population of interest in their study (criterion 3.1).  
Another of the strengths noted was that the majority of authors (34/39) reported either complete 
outcome data (where almost all the participants contributed to almost all measures) or survey response 
rate (Abdovic et al., 2013; Allan, Flett, & Dean, 2008; Botello-Harbaum, Nansel, Haynie, Iannotti, Simons-
Morton, 2008; Bradley et al., 2006; Chang & Yeh, 2005; Chow et al. 2014; Davis et al., 2010; DunnGalvin 
et al., 2010; Franciosi et al., 2013; Gray, Denson, Baldassano, Hommel, 2011; Hartman et al., 2007; 
Hopkins et al., 2010; Hu et al., 2013; Iannaccone et al., 2009; Ingerski, Laffel, Drotar, Repaske, & Hood., 
2010; Jaser et al., 2011; Kalyva, Malakonaki, Eiser, & Mamoulakis, 2011; Knibb et al., 2013; Kocova, 
Dvorackova, Vondracek, & Haberlova, 2014; MacKenzie, Roberts, Van Laar, & Dean, 2012; Marino et al., 
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Figure 2. Flow Diagram of Literature Search of Disease-specific QOL Instruments. Results of literature 
search and selection process for disease-specific instruments. Format for Figure 2 adapted from: 
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for 
Systematic Review Analyses: The PRISMA Statement. PLos Med 6(6): 
e1000097.doi:10.1371/journal.pmed 1000097  
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Otley et al., 2003; Panepinto et al., 2013; Petsios et al. 2011; Pollak, Mühlan, Von Mackensen, & 
Bullinger, 2006; Valenzuela et al., 2006; van Doorn, Winkler, Zwinderman, Mearing, & Koopman, 2008; 
Varni et al., 2004; Weissberg-Benchell et al., 2010; Varni et al., 2014; Young et al., 2013; Yuksel, Yilmaz, 
Kirmaz, & Eser,, 2009). Five authors did not report complete outcome data (Klaassen et al., 2013; 
Moorthy et al., 2007; Zashikhina & Hagglof, 2014). 
Seven authors mailed questionnaires to participants (Hartman et al., 2007; Knibb et al., 2013;   
Mackenzie et al., 2012; van Doorn et al., 2008; Weissberg-Benchell et al., 2010; Young et al., 2013; 
Zashikhina & Hagglof, 2014); of these, survey response rates were reported in all but1 study (Young et 
al., 2013). Response rates were greater than 60% for all studies except MacKenzie et al. (2012) and 
Weissberg-Benchell et al. (2010) (44.5% and 39% respectively). 
A weakness noted was less than half of authors reported on the comparability of study groups 
and/or controlled for differences between groups (criterion 3.3). Bradley et al.’s (2006) study of boys with 
hemophilia was an exception: the researchers compared but did not control for the characteristics of 
Canadian and European boys with hemophilia, such as the severity and type of hemophilia, mean age in 
years, treatment, and QOL, using the CHO-KLAT (Canadian dataset) and the Haemo-QoL (European 
dataset) QOL instruments. Figure 4 summarizes the quality scores of all studies. The majority of studies 
met at least 2 of the 4 criteria and scored ≥ 50% in overall quality.  
Data Analyses. The majority of researchers used established disease-specific instruments that 
measure youth and/or parent perception of QOL for a wide range of chronic illnesses affecting children 
such as asthma (Petsios et al., 2011; Varni et al., 2004; Zashikhina & Hagglof, 2014), Type I diabetes 
(Botello-Harbaum et al., 2008; Jaser et al., 2011; Ingerski et al., 2010; Kalyva et al., 2011; Valenzuela et 
al., 2006; Zashikhina & Hagglof, 2014), Type II diabetes (Allan, et al., 2008), epilepsy (Zashikhina & 
Hagglof, 2014); cancer (Chang & Yeh, 2005), chronic cough as a result of protracted bacterial bronchitis, 
asthma, or bronchiectasis (Newcombe et al., 2011), Duchenne Muscular Dystrophy (Davis et al., 2010), 
eosinophilic esophagitis (Franciosi et al., 2013), food allergy (Knibb et al., 2013; Mizuno et al., 2017), 
gastrointestinal symptoms (Varni et al., 2014), heart disease (Marino et al., 2011), hemophilia (Bradley et 
al., 2006; McCusker et al., 2015), Hirschsprung Disease or anorectal malformations (Hartman et al., 
17 
 
2007), inflammatory bowel disease (Abdovic et al., 2013; Gray et al., 2011; Otley et al., 2003), influenza 
(Chow et al., 2014) and spinal muscular atrophy (Iannaccone et al., 2009; Kocova et al., 2014).  
Eight researchers developed new instruments to measure disease-specific QOL for youth with cerebral 
palsy (Narayanan et al., 2006), food allergy (DunnGalvin et al., 2010; MacKenzie et al., 2012), hemophilia 
(Pollak et al., 2006), influenza (Chow et al., 2014), organ transplantation (Weissberg-Benchell et al., 
2010), systemic lupus erythematosus (Moorthy et al., 2007), and sickle cell disease (Panepinto et al., 
2013). 
 
Figure 3 Methodological Quality Appraisal Assessments of All Studies  
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In other studies, researchers adapted an established instrument and then examined its 
psychometric properties. van Doorn et al. (2008), for example, reduced the 25-item celiac disease 
instrument (DUX-25) to a shorter 12-item CDDUX questionnaire. Hopkins et al. (2010) modified and 
abbreviated the 16-item Tonsil and Adenoid Health Status Instrument to the 14-item Paediatric Throat 
Disorders Outcome Test for youth with tonsil and adenoid disease in the U.K.  
Linguistic validation in studies. In 5 studies researchers linguistically and culturally adapted 
established instruments for use in another culture or population using forward and backward translations 
and cognitive debriefing/face-to-face interviews, and then examined the psychometric properties of the 
adapted instruments (Hu et al., 2013; Klaassen et al., 2013; McCusker et al., 2015; Mizuno et al., 2017; 
Yuksel et al., 2009). Hu et al. (2013) linguistically translated the PedsQL 3.0 Neuromuscular Module from 
English to Chinese using a process of forward and backward translation, and cognitive debriefing with 6 
Chinese youth with Duchenne muscular dystrophy and their parents. Klaassen et al. (2013) linguistically, 
culturally and clinically translated a North American English parent and youth version of the Kids ITP 
Tools (KIT) for a sample of 127 families with youth ages 2-18 years with immune thrombocytopenia and 
their parents across 3 languages (French, German, and Spanish) and adapted to new cultures in France, 
Germany, UK, and Uruguay. Using a sample of144 boys with hemophilia aged 4-18 years, McCusker et 
al. (2015) adapted the North American English CHO-KLAT version for use in five countries: France, 
Germany, the Netherlands, Spain and the United Kingdom (UK). Mizuno et al. (2017) examined the 
validity and reliability of the Japanese version of food allergy QOL questionnaire – parent form using 
parents of youth with food allergy (n = 127) and parents of healthy youth (n = 48) aged 0-12 years. Yuksel 
et al. (2009) adapted the 23-item Pediatric Asthma QOL Questionnaire (PAQLQ) from English into 
Turkish. The Turkish language version resulted in the same number of items, with Cronbach α scores 
ranging from 0.80 (Activity) - 0.90 (Symptoms) and significant correlations between PAQLQ and KINDL 
(Kinderlebensqualita¨tsfragebogen), a short, methodologically suitable, psychometrically sound measure 
of QOL in youth (subscales were Physical r = 0.33, Psychological r = 0.45, and Well-Being r = 0.31).  
Questionnaire language. Authors of 18 studies specified using questionnaires and/or survey 
language according to participants’ preference (Abdovic et al., 2013; Bradley et al., 2006; Chang & Yeh, 
2005; Hu et al., 2013; Iannaccone et al., 2009; Kalyva et al., 2011; Klaassen et al., 2013; Kocova et al., 
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2014; McCusker et al., 2015; Mizuno et al., 2017; Petsios et al., 2011; Pollak et al. 2006; van Doorn et al., 
2008; Varni et al., 2004, Yuksel et al., 2009; Zashikhina & Hagglof, 2014). For example, in their study of 
American youth (n = 404) with asthma and their parents (n = 526), Varni et al. (2004) reported that the 
PedsQL 4.0 Generic Core Scales was administered in 5 languages - English, Spanish, Vietnamese, 
Chinese, and Korean. Varni et al. (2004) investigated the reliability, validity, and initial responsiveness of 
PedsQL Asthma Module and Generic Core Scales.  
In thirteen studies conducted in North America completion of survey instruments was restricted to 
English language (Botello-Harbaum et al., 2008; Davis et al., 2010; Franciosi et al., 2013; Gray et al., 
2011; Ingerski et al., 2010; Jaser et al., 2011; Marino et al., 2011; Moorthy et al., 2007; Otley et al., 2003; 
Panepinto et al., 2013; Valenzuela et al., 2006; Varni et al., 2014; Weissberg-Benchell et al., 2010). 
Language option for survey completion was not reported in 6 studies conducted in Canada (Allan et al., 
2008; Bradley et al., 2006; Iannaccone et al., 2009; Narayanan et al., 2006; Otley et al., 2003; Young et 
al., 2013) and 12 studies in Europe (Abdovic et al. 2013; DunnGalvin et al., 2010; Hartman et al., 2007; 
Hopkins et al., 2010; Kalyva et al. 2011; Knibb et al., 2013; Kocova et al. 2014; Mackenzie et al., 2012; 
Petsios et al., 2011; van Doorn et al., 2008;  Yuksel et al., 2009; Zashikhina & Hagglof, 2014).  
All but 4 researchers (Klaassen et al., 2013; McCusker et al., 2015; Narayanan et al. 2013; 
Young et al., 2013) examined Cronbach’s alpha as a measure of instrument reliability. Cronbach’s alpha 
ranged from 0.70 for the Pediatric Cardiac QOL Inventory (Marino et al., 2011) and the Paediatric Asthma 
QOL Questionnaire (Zashikhina & Hagglof, 2014) to 0.97 for PedsQL Gastro Intestinal Module (Varni et 
al., 2014) and the PedsQL Sickle Cell Disease Module (Panepinto et al., 2013). In lieu of Cronbach’s 
alpha, test re-test reliability, youth-parent concordance (Klaassen et al., 2013; Young et al., 2013), and 
intra-class correlation (ICC) with its 95% confidence interval (CI) (Narayanan et al., 2013) were measured 
as a measure of instrument reliability.  
Construct validity was reported for each instrument. According to Pedhazur and Schmelkin 
(2013), initial information on the construct validity of an instrument is achieved by computing the 
intercorrelations among instrument scales. Panepinto and colleagues, (2013), for example, computed 
intercorrelations between the newly developed PedsQL Sickle Cell Disease Module Scales and Total 
Scale Score with the established PedsQL 4.0 Generic Core Scales and summary scores in order to 
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determine construct validity of the PedsQL Sickle Cell Disease Module. The majority of intercorrelations 
for both parents and youth were moderate to large which supported construct validity of the sickle cell 
disease scales and total scale Score. The instrument is developmentally appropriate and available for 
youth self-report for ages 5-7, 8-12, and 13-18 years, and parent proxy-report for ages 2-4, 5-7, 8-12, and 
13-18 years.   
Quality of life measurement over time. Longitudinal data were collected over 2 or more time 
points for 6 studies. Data of youth with Type I diabetes were collected at baseline and 1 month (Botello-
Harbaum et al., 2008). Botello-Harbaum et al. (2008) did not report whether QOL improved over time. 
DunnGalvin et al. (2010) collected data of youth with food allergy at baseline, months 2 and 6; they 
reported that QOL improved over time. Hartman et al. (2007), collected data of youth with anorectal 
malformations or Hirschsprung Disease at baseline and 3 years. Hartman and colleagues reported that 
there were improvements in disease-specific functioning and mental QOL for adolescents and children, 
but only adolescents improved over time in physical QOL. Hopkins et al. (2010), collected data of youth 
with tonsil and adenoid disease at baseline and between 2-6 months, reported improvement in QOL over 
time. Newcombe et al. (2011), collected data of youth with chronic cough at baseline and between 2-3 
weeks reported that scores for 29 of 34 youth showed improvement over time. Young et al. (2013), 
collected data of boys with hemophilia at baseline and 2 weeks later, but did not report whether QOL 
improved over time. Table 1 provides the psychometric properties by disease state. 
Youth versus parent disease-specific quality of life rating. The majority of studies measured 
both youth and/or parent/caregiver perception of QOL. Youth reported higher QOL scores compared to 
ratings of their parent/caregiver in approximately half (10/21) of the studies. For example, youth with Type 
II diabetes who participated in the Allan et al. (2008) study reported higher scores (indicating better QOL) 
for the Symptoms and Treatment I subscale compared to their parent suggesting that parents 
overestimated the impact of diabetes symptoms and treatment on their youth. Youth with Duchenne 
muscular dystrophy who participated in the Davis et al. (2010) study reported higher total QOL scores 
73.8 ± 13.2 compared to parents 59.6 ± 15.5. In 5 studies youth and parents reported similar QOL ratings 
(Bradley et al., 2006-hemophilia; Chang & Yeh, 2005; Hu et al., 2013; Valenzuela et al., 2006-diabetes; 
Weissberg-Benchell et al., 2010-organ transplantation). 
 Table 1 Psychometric Properties of Disease-specific Quality of Life Instruments by Disease State 
  Psychometric Properties 
Author, Year Instrument, # of items and subscales;  




Petsios et al. 
(2011) 
DISABKIDS Asthma Module – 11 items, 2 
subscales; Score range: 0 (worst) - 100 
(best); 4-7, 8-14 years 
Impact domain α = 0.83 
Worry domain α = 0.84 
  
Construct: Correlation between parent and youth 
scores showed lower values in children with 
uncontrolled asthma (actual values not reported) 
Varni et al. 
(2004) 
Pediatric QOL Inventory (PedsQL) 3.0 
Asthma Module 
28 items, 4 subscales;  
Score range: 0 (worst) – 100 (best);  
4 versions: 2-4, 5-7, 8-12, 13-18 years 
Youth α = 0.85 
Parent α = 0.91 
Construct: Correlations between PedsQL Asthma 
Module and PedsQL 4.0 Generic Core Scales were: 
Asthma Symptoms r = 0.55 (youth); r = 0.62 (parent) 
Treatment Problems r = 0.50 (youth); r = 0.59 (parent)  
Worry r = 0.53 (youth); r = 0.49 (parent)  
Communication r = 0.39 (youth); r = 0.36 (parent)  
Yuksel et al. 
(2009) 
Pediatric Asthma QOL Questionnaire 
(PAQLQ) – 23 items, 3 subscales;  
Score range: 1 (worst) – 7 (best)  
7-16 years 
All subscales α > 0.75 
 
 
Construct: Correlation between total PAQLQ and 
KINDL Physical and Psychological Well-Being 
domains were significant (r=0.33, 0.45 & 0.31) 
PAQLQ overall score and domain scores were higher 




Paediatric asthma QOL questionnaire 
(PAQLQ) – 23 items, 3 subscales; Score 
range: 1 (worst) - 7 (best)  
13-16 years  
All subscales α ≥ 0.70 Construct: Moderate correlations between symptom, 
activity, and emotion subscales and medication use 
and morning peak flow rates (actual values not 
reported) 
Cancer 
Chang and Yeh 
(2005) 
Quality of Life for Children with Cancer 
(QOLCC) – 34 items, 5 subscales; 
Scale range not reported but higher scores 
reflect lower QOL 
7-12, 13-18 years  
7-12 years total α = 
0.88 Parent of 7-12 
year olds total α =0.91 
13-18 years total α = 
0.89 Parent of 13-18 




Construct: Inter-correlations between patient report 





   Psychometric Properties 
Author, Year Instrument, # of items and subscales;  




van Doorn et al. 
(2008) 
Celiac Disease DUX (CDDUX) – 12 items, 3 
subscales; Score range: 0 (worst) - 100 
(best); 3 versions: 8-11, 12-15, 16-18 years 
Youth and parent α = 
0.88 
Construct: Youth and parent correlation of CDDUX 




Caregiver Priorities and Child Health Index of 
Life with Disabilities (CPCHILD) – 36 items, 6 
subscales; Score range: 0 (best) to 100 
(worst); Caregiver proxy-report for 5-18 year 
olds 
Caregiver total ICC = 
0.97  
Subscale ICC ranged 
from 0.88-0.96 
 
Construct: Mean (SD) CPCHILD scores showed youth 
with poorer function had worse QOL scores (actual 
values not reported) 





Parent Cough-Specific Quality-of-Life 
questionnaire (PC-QOL) – 27 item, 5 
subscales; Score range: 1-7 score range;  
Parent proxy-report for 14-18 years 
Parent total scale and 
subscales α ≥ 0.84 
 
 
Construct: Significant correlations were 
found between subscales of the PC-QOL 
questionnaire and the scales of the Short Form12 
version 2 (SF-12v2) and PedsQL4.0 scores (actual 
values not reported) 
Diabetes Type I 
Botello-
Harbaum et al. 
(2008) 
Diabetes QOL scale (DQOL)  
– 51 items, 3 subscales;  
Scale range: Higher scores indicate better 
QOL; 11-16 years 
Youth baseline total 
scale α = 0.75 
 
Construct: No significant association among overall 
QOL, diabetes-related QOL and DQOL (actual values 
not reported) 
Ingerski et al. 
(2010) 
PedsQL Type 1 diabetes module – 28 items; 
5 subscales;  Score range: 0 (worst) - 100 
(best); 4 versions: 2-4, 5-7, 8-12, 13-18 years 
Youth total scale α = 
0.74 
Construct: Treatment Barriers, Treatment Adherence, 
and Worry subscales positively correlated with 
PedsQL Generic Total Score (actual values not 
reported) 
Jaser et al. 
(2011) 
PedsQL Diabetes Module – 11 items; 1 
subscale; Score range: 0 (worst) – 100 (best)  
4 versions: 2-4, 5-7, 8-12, 13-18 years 
Youth total scale α = 
0.75 
Construct: Use of primary control coping strategies 
was associated with better diabetes-related QOL (r = 
0.40) and better total QOL (r = 0.48) in youth 
Kalyva et al. 
(2011) 
PedsQL 3.0 Diabetes Module – 28 items, 5 
subscales; Score range: 0 (worst) – 100 
(best); 4 versions: 2-4, 5-7, 8-12, 13-18 years 
Youth total scale α = 
0.81 
Construct: Treatment Barriers, Treatment Adherence, 
Worry subscales positively correlated with PedsQL 




   Psychometric Properties 
Author, Year Instrument, # of items and subscales;  




PedsQL Type 1 Diabetes Module – 28 items, 
5 subscales;  Score range: 0 (worst) – 100 
(best); 4 versions: 2-4, 5-7, 8-12, 13-18 years 
Youth and parent total 
scale was α = 0.84 
Construct: Treatment Barriers, Treatment Adherence, 
and Worry subscales positively correlated with 




Diabetes QOL questionnaire for youths 
(DQOLY) – 52 items, 4 subscales;  
Score range: 0 (best) - 100 (worst)  
13-16 years 
Youth total scale α = 
0.88 
Construct:  In all subscales except for the Life 
Satisfaction subscale, lower score indicated higher 
QOL (actual values not reported) 
Diabetes Type II 
Allan et al. 
(2008) 
PedsQL 3.0 Diabetes Module – 28 items, 5 
subscales; Score range: 0 (worst) - 100 
(best); 4 versions: 2-4, 5-7, 8-12, 13-18 years 
Youth total scale α = 
0.79  Parent total 
scale α = 0.89 
Construct: Treatment Barriers, Treatment Adherence, 
and Worry subscales positively correlated with 
PedsQL Generic Total Score (actual values not 
reported) 
Duchenne Muscular Dystrophy 
Davis et al. 
(2010) 
PedsQL 3.0 Neuromuscular Module (NMM) – 
25 items, 3 scales; Score range: 0 (worst) - 
100 (best); 4 versions: 2-4, 5-7, 8-12, 13-18 
years 
Youth total α = 0.85 
Parent total α = 0.87 
Youth test-retest ICC 
= 0.59  
Parent test-retest ICC 
= 0.75 
Construct:  Correlation between total PedsQL Generic 
Core Scale and total PedsQL 3.0 NMM was r = 0.65 
(youth) and r = 0.71 (parent) 
Hu et al. (2013) PedsQL 3.0 Neuromuscular Module (NNM) - 
25 items, 3 scales; Score range: 0 (worst) - 




Youth total α = 0.81 
Parent total α = 0.86 
Youth total test-retest 
ICC = 0.66  
Parent total test-retest 
ICC = 0.88 
Construct: Correlation between PedsQL Generic Core 
Scale and PedsQL 3.0 NMM was r = 0.67 (youth) and 
r = 0.60 (parent) 
Eosinophilic esophagitis 
Franciosi et al. 
(2013) 
PedsQL Eosinophilic Esophagitis (EoE) 
Module - 33 items, 7 subscales; Score range: 
0 (worst) - 100 (best); 4 versions: 2-4, 5-7, 8-
12, 13-18 years 
All youth and parent 
scales α > 0.70 
Youth test-retest ICC 
= 0.88  
Parent test-retest ICC 
= 0.82 
Construct: Correlation between PedsQL Generic Core 






   Psychometric Properties 
Author, Year Instrument, # of items and subscales;  





Quality of life in epilepsy inventory for 
adolescents (QOLIE-AD-48) – 48 items, 8 
subscales; Score range: 0 (worst) - 100 
(best); 13-16 years 
Youth total scale α = 
0.74 
Construct: Correlation between youth and parent 




Food Allergy QOL Questionnaire – Parent 
Form (FAQLQ-PF): 
14 items (0-3 years), 
26 items (4-6 years) 
30 items (7-12 years); 3 subscales;  
Score range: 0 (best) - 6 (worst)  
Parents of youth 0-12 years 
Parent scale α ranged 






Construct: Correlation between total FAQLQ and Food 
Allergy Independent Measure r = 0.70 (2 months) and 
r = 0.65 (6 months) 
ICC total scale = 0.90 
Knibb et al. 
(2013) 
Paediatric Food Allergy QOL Questionnaire 
(PFA-QL) -25 items; Score range: 25 (best) - 
100 (worst); 6-16 years 
Youth α = 0.77 
PFA-QL test-retest 
ICC = 0.77 
Construct: Correlation between PedsQL Generic Core 
Scales and PFA-QL was  
r = -0.31 
Mackenzie et 
al. (2012) 
You and Your Food Allergy – 34 items, 5 
subscales; Higher scores indicate better 
QOL; 13-18 years 
Youth total scale α = 
0.92 
Youth total scale test-
retest ICC = 0.87 
Construct: Correlation between PedsQL Generic Core 
Scales and You and Your Food Allergy was r = 0.504 
Mizuno et al. 
(2017) 
Food Allergy QoL Questionnaire – Parent 
Form-Japanese (FAQLQ-PF-J) – 30 items, 3 
domains; 0 (best) – 6 (worse); 
0-12 years 
Parents: 
α = 0.77 
ICC > 0.7 
Construct: Correlation between FAQLQ-PF-J and the 
Food Allergy Independent Measure (FAIM) total score 
was r = 0.56; subscale scales ranged from r = 0.39 - 
0.64  
Gastrointestinal Disorders 
Varni et al. 
(2014) 
PedsQL Gastrointestinal Symptoms Module 
(GI Module) -74 items, 14 subscales;  
Score range: 0 (worst) - 100 (best);  
4 versions: 2-4, 5-7, 8-12, 13-18 years 
Youth and parent total 
scale α = 0.97  
Construct: Correlation between PedsQL GI Module 
and PedsQL Generic Core Scales ranged from r = 









   Psychometric Properties 
Author, Year Instrument, # of items and subscales;  
Scale range; Age range of youth sample 
Reliability Validity 
Heart Disease 
Marino et al. 
(2011) 
Pediatric cardiac QOL inventory (PCQLI) – 
23 items (child), 29 items (adolescent)  2 
subscales: disease impact and psychosocial 
impact; Score range: 0 (worst) – 100 (best); 
8-18 years 





Construct: Correlations were similar between all items 
of the PCQLI (actual values not reported) 
Hemophilia 
Bradley et al. 
(2006) 
Canadian Haemophilia Outcomes – Kids’ 
Life Assessment Tool (CHO-KLAT) - 35 
items; Score range: 0 (worst) to 100 (best) 4-
7, 8-18 years 
 
Haemo-QoL – 16 items, 8 subscales (4-7 
year olds)  and 35 items, 9 domains (8-18 
year olds); Score range: 0 (best) to 100 
(worst); 4-7, 8-16 years 





Total scale α ranged 
from 0.81–0.91 
Construct: Correlation between CHO-KLAT and 




Construct: Correlation between the Haemo-QoL and 
PedsQL was r = -0.76 (youth) and r = -0.63 (parent) 
McCusker et al. 
(2015) 
CHO-KLAT- 35 items; 0 (worse) – 100 (best); 
4-18 years 
Test–retest: child self-
report = 0.67 
ICC > 0.7 
Construct: Correlations between CHO-KLAT summary 
scores and PedsQL (r = 0.52); between CHO-KLAT 
and Haemo-QoL (r = 0.73) 
Pollak et al. 
(2006) 
Haemo-QoL Index – 8 items;  
Score range: 0 (best) to 100 (worst)  
3 versions: 4-7, 8-12, 13-16 years 
Youth α = 0.70  
Parent α = 0.78 
Youth test-retest ICC 
= 0.76 
Parent test–retest ICC 
= 0.27 
Construct: Correlations between Haemo-QOL, KINDL-
R, Child Health Questionnaire General Health Index, 
and a third scale (the Fragebogen zur 
Lebenszufriedenheit) were moderate to high (actual 
values not reported) 
Young et al. 
(2013) 
CHO-KLAT – 35 items; 
Score range: 0 (worst) to 100 (best);  
Parent proxy-report for 4-7 and youth self-
report and parent proxy-report for 8-17 years 
Youth test-retest ICC 
= 0.63 
Parent test-retest ICC 
= 0.79 
Youth-parent 
concordance = 0.65 
 
 
Construct: Correlation between  PedsQL and CHO-





   Psychometric Properties 
Author, Year Instrument, # of items and subscales;  
Scale range; Age range of youth sample 
Reliability Validity 
Hirschsprung Disease (HD)/Anorectal Malformation (ARM) 
Hartman et al. 
(2007) 
Hirschsprung Disease/Anorectal 
Malformation QOL Questionnaire (HAQL) – 
38 items for child questionnaire and 40 for 
adolescent questionnaire, 9 subscales; 
Score range: 0 (worst) – 100 (best); 8-11, 12-
16 years 
Youth α ranged from 





Discriminant validity: good between age 8-11 and 17+ 
participants  
Convergent validity: correlation <40 between HAQL 
and TNO-AZL Questionnaires for Children's Health-
Related QOL (TACQOL) (actual values not reported) 
Inflammatory Bowel Disease 
Abdovic et al. 
(2013) 
IMPACT-III Questionnaire – 35 items, 6 
subscales; Score range: 35 (worst) - 175 
(best); 9-18 years 
Youth total score α = 
0.92 
Construct: Correlation between total IMPACT-III and 
PedsQL was r = 0.738 
Gray et al. 
(2011) 
IMPACT-III questionnaire – 35 items, 6 
subscales; Score range: 33 (worst) - 175 
(best); 13-17 years 
Youth total score α = 
0.94 
Construct: Intercorrelations for Disease Activity, 
Behavioral Dysfunction, and QOL ranged between r = 
-0.67 and r = 0.54 
Otley et al. 
(2003) 
IMPACT – 35 items, 6 subscales;  
Score range: 0 (worst) to 231 (best)  
9-18 years 
Youth total score  
α = 0.96 
Youth total score  
 ICC = 0.90 
Construct:  IMPACT questionnaire was shown to 
measure QOL in pediatric IBD (actual values not 
reported) 
Immune Thrombocytopenia 
Klaassen et al. 
(2013) 
Kids’ Immune Thrombocytopenia Tools (KIT) 
– 26 items; 0 Score range:  (worst) - 100 
(best); 2-18 years 
Youth-parent 
concordance ICC = 
0.52 
Youth test-retest ICC 
= 0.71 
Parent test-retest ICC 
= 0.76 
Construct: Correlation between KIT and PedsQL r = 
0.54 
Correlation between KIT and KINDL r = 0.48 
Influenza  
Chow et al. 
(2014) 
Care-ILI-QoL (Influenza-like illnesses) – 16 
items, 4 subscales; 1 (worse) – 7 (best); 
parent proxy; 6-48 months 
Parent subscales: 
Daily Activities α = 
0.90;  
Perceived Support α = 
0.92;  
Social Life α = 0.78;  
Emotions α = 0.72 
Correlations between Care-ILI-QoL total scores and 
Mental Component Summary of Short Form-12v2 




   Psychometric Properties 
Author, Year Instrument, # of items and subscales;  




Moorthy et al. 
(2007) 
Simple Measure of the Impact of Lupus 
Erythematosus in Youngsters (SMILEY) – 26 
items, 4 subscales; Score range: 0 (worst) - 
100 (best); 7-18 years 
 
 
Youth and parent total 
α = 0.90 
Youth and parent test-
retest ICC ranged 
from 0.70 -  0.90 
Youth-parent 
concordance ranged  
from 0.6 - 0.7 
Construct: Spearman’s correlation: 
rho = 0.3-0.6 (youth) 
rho = 0.2-0.6 (parent) 
Spearman’s rank correlation of SMILEY and PedsQL 
was rho = 0.6 (youth and parent) 
 
Organ transplantation: Liver, Kidney, Heart and Small Bowel Disorders 
Weissberg-
Benchell et al. 
(2010) 
PedsQL 3.0 Transplant Module – 46 items, 8 
subscales;  
Score range: 0 (worst) – 100 (best);  
4 versions: 2-4, 5-7, 8-12, 13-18 years 
Youth α = 0.93  
Parent α = 0.94 
 
 
Construct: Youth total effect size = 0.75 Parent total 
effect size = 0.74 (for differences between healthy 
youth & youth with solid organ transplants) 
Sickle Cell Disease 
Panepinto et al. 
(2013) 
PedsQL Sickle Cell Disease Module - 43 
items, 9 subscales;  
Score range: 0 (worst) - 100 (best);  
4 versions: 2-4, 5-7, 8-12, 13-18 years 
Youth α = 0.95  
Parent α = 0.97 
Construct:  Inter-correlation between PedsQL Sickle 
Cell Disease Module and PedsQL Generic Core was r 
= 0.70 (youth)  
r = 0.68 (parent) 
Total effect size: r = 0.28 (youth) and r = 0.56  (parent) 
for difference between mild and severe sickle cell 
disease 
Spinal Muscular Atrophy 
Iannaccone et 
al. (2009) 
PedsQL 3.0 Neuromuscular Module – 17 
items (youth) and 25 items (parent), 3 
subscales; Score range: 0 (worst) – 100 
(best); 4 versions: 2-4, 5-7, 8-12, 13-18 years 
Youth α = 0.88 
Parent α = 0.89 
Youth-parent 
concordance ICC = 
0.45 
Youth test-retest ICC 
= 0.81  
Parent test-retest ICC 
= 0.89 
Construct: Correlation between PedsQL 3.0 NMM and 
PedsQL Generic Core Scales was r = 0.79 (youth) and 




   Psychometric Properties 
Author, Year Instrument, # of items and subscales;  
Scale range; Age range of youth sample 
Reliability Validity 
Kocova et al. 
(2014) 
PedsQL 3.0 Neuromuscular Module - 25 
items, 3 subscales; Score range: 0 (worst) - 
100 (best); 4 versions: 2-4, 5-7, 8-12, 13-18 
years 
Youth α = 0.86 
Parent α = 0.90 
Construct: Correlation between PedsQL 3.0 NMM and 
PedsQL Generic Core Scales was r = 0.79 (youth) and 
r = 0.61 (parent) 
Tonsil and Adenoid Disease 
Hopkins et al. 
(2010) 
Paediatric Throat Disorders Outcome Test – 
14 items;  
Score range: 0 (best) - 60 (worst); Parents of 
1-16 year olds 
Parent total α=0.84 
Parent test-retest ICC 
= 0.98 
Construct: Good internal consistency (actual values 
not reported) 






Parents reported higher but not significant QOL ratings than youth in several studies (Franciosi et 
al., 2013; Panepinto et al., 2013; Pollak et al., 2006; Young et al., 2013). Petsios et al. (2011) reported 
that perception of QOL of youth with asthma was significantly lower compared to that of their parents for 
all subscales, except for youth with severe asthma in the 8–14 years group, where perception of Impact 
and Worry were in close agreement. Marino et al. (2011) reported that younger children and adolescents 
with heart disease perceived their QOL differently: younger youth reported their QOL as higher than 
parent-proxy report while adolescents reported their QOL as poorer than parent-proxy report.  
Four instruments were developed to measure perception of youth’s disease-specific QOL from 
the parent/caregiver’s perspective only. The Parent Cough-Specific Quality-of-Life questionnaire 
(Newcombe et al., 2011) is a 27-item questionnaire that assessed the level of frequency of parent’s 
feelings (15 items) and worry (12 items) related to the youth’s cough measured parental perception of 
QOL for youth aged 17.3 to 38.8 months. The Caregiver Priorities and Child Health Index of Life with 
Disabilities (Narayanan et al., 2006) consists of 36 items in 6 domains and measured primary caregiver 
perception of QOL in youth aged 5 to 18 years with cerebral palsy. The 14-item Paediatric Throat 
Disorders Outcome Test is a 14-item instrument designed to measure parental perception of QOL in 
youth aged 1-16 years following tonsil and adenoid surgery in the U.K. (Hopkins et al., 2010). The Food 
Allergy QOL Questionnaire – Parent Form (FAQLQ-PF) is an instrument designed to measure parental 
perception of QOL in youth 0-12 years with food allergy (DunnGalvin et al., 2010). Sample demographics, 
disease-specific QOL and subscale scores are provided in Table 2. 
Disease impact on youth self-reported quality of life. In the majority of studies researchers 
examined the relationship between disease and disease-specific QOL using 1 of the PedsQL instruments 
singularly or in combination with other instruments (Abdovic et al. 2013; Allan et al. 2008; Bradley et al. 
2006; Davis et al. 2010; Franciosi et al. 2013; Hu et al. 2013; Iannaccone et al. 2009; Ingerski et al. 2010; 
Jaser et al. 2011; Kalyva et al. 2011; Knibb et al. 2013; Kocova et al. 2014; Mackenzie et al. 2012; 
Moorthy et al. 2007; Panepinto et al. 2013; Valenzuela et al. 2006; Varni et al. 2004; Varni et al. 2014; 
Weissberg-Benchell et al. 2010; Young et al. 2013). The number of items per disease-specific QOL 
instrument varied considerably, ranging from 8 on the Haemophilia QOL Index, to 74 on the PedsQL 
Gastrointestinal Symptoms Module.  
 Table 2 Sample Demographics, Disease-specific Quality of Life and Subscale Scores of the Included Studies 
Author, Year Sample Demographics: 




Instrument; All scales are 0 
(worst) - 100 (best) unless 
otherwise noted. 
Mean Total QOL score (SD) 
 
Subscale: Score Mean (SD).  
Asthma 
Petsios et al. 
(2011) 




DISABKIDS smiley measure 
(DSM) for 4-7 years 
DISABKIDS Asthma Module for 8-
14 years; 
Youth 4-7 years 67.7(18.4)  
Parent 72.5(11.7)                 
Independence: 78.2(16.5) Youth; 83.9(11.4) Parent 
Physical limitation: 53.3(10.2) Youth; 60.9(12.7) Parent 
Emotion: 74.9(21.5) Youth; 75.1(16.9) Parent 
Exclusion: 86.4(16.9) Youth; 90.2(11.8) Parent 
Inclusion: 67.8(12.0) Youth; 69.2(9.1) Parent 
Medication: 67.1(21.5) Youth; 73.3(20.5) Parent 
General: 57.9(9.85) Youth; 77.1(11.3) Parent 
Impact: 72.6(21.4) Youth; 71.6(19.4) Parent 
Worry: 67.6(19.9) Youth; 68.5(19.1) Parent 
Varni et al. (2004) 529 youth and 516 parents; 
USA: Kansas; 
35.2% Latino 
25.5% White   
8.7% Black  
4.9% Asian/Pacific Islander  
0.9% American Indian or 
Alaskan Native 
0.9% Other  
23.8% Not reported 
Pediatric QOL Inventory (PedsQL) 
3.0 Asthma Module; 
Youth 74.7(15.8)  
Parent 72.4(16.6) 
 
Asthma Symptoms: 64.2(19.2) Youth; 63.3(21.4) Parent 
Treatment Problems: 80.6(14.2) Youth;                       
77.3(17.2) Parent 
Worry: 76.3(21.9) Youth; 77.4(22.4) Parent 
Communication: 73.7(24.9) Youth; 71.4(26.9) Parent 
Yuksel et al. 
(2009) 
122 youth and 122 parents; 
Turkey; 
Turkish  
Pediatric Asthma QOL 
Questionnaire (PAQLQ);  
1 (worst) – 7 (best); 
Youth with ≤1 sibling 5.5(1.2)  
Youth with >1 sibling  
5.9(0.9) 
Activity: ≤1 sibling 5.2(1.2); >1 sibling 5.7(0.9) 
Symptoms: ≤1 sibling 5.2(1.2); >1 sibling 5.9(1.0) 
Emotional: ≤1 sibling 5.5(1.2); >1 sibling 5.9(0.9) 
Zashikhina and 
Hagglof (2014) 














 Author, Year Sample Demographics: 




Instrument; All scales are 0 
(worst) - 100 (best) unless 
otherwise noted. 
Mean Total QOL score (SD) 
 
Subscale: Score Mean (SD).  
Cancer 
Chang and Yeh 
(2005) 
141 youth and 141 parents; 
Taiwan; 
Taiwanese  
Quality of Life for Children with 
Cancer (QOLCC);  
Scale range not reported but 
higher scores represent worse 
QOL; 
Child 7-12 years 0.8(0.4)  
Parent of child 0.8(0.4) 
Adolescent 13-18 years 0.8(0.4)   




Physical: 0.6(0.6) Child; 0.5(0.7) Parent 
Psychological: 0.8(0.6) Child; 0.6(0.6) Parent 
Social: 0.5(0.5) Child; 0.4(0.4) Parent 
Disease/symptom: 0.8(0.6) Child; 0.9(0.5) Parent 
Cognitive: 0.8(0.6) Child; 0.7(0.6) Parent 
Understanding: 1.5(0.8) Child; 1.5(1.0) Parent 
Communication: 0.8(0.7) Child; 0.8(0.6) Parent 
Physical: 0.6(0.6) Youth; 0.3(0.4) Parent 
Psychological: 0.9(0.7) Youth; 0.5(0.4) Parent 
Social: 0.6(0.5) Youth; 0.4(0.4) Parent 
Disease/symptom: 0.9(0.6) Youth; 0.8(0.5) Parent 
Cognitive: 0.9(0.6) Youth; 0.6(0.5) Parent 
Understanding: 0.7(0.7) Youth; 0.6(0.7) Parent 
Communication: 0.8(0.8) Youth;0.7(0.6) Parent 
Celiac Disease 
van Doorn et al. 
(2008) 
510 youth and 501 parents; 
the Netherlands; 
98% Dutch 




Communication: 59(21) Youth; 53(20) Parent 
Having CD: 36(21) Youth; 30(18) Parent 
Diet: 36(16) Youth; 33(18) Parent 
Cerebral Palsy 
Narayanan et al. 
(2006) 
77 youth and 77 parents; 
Canada;  
Canadian  
Caregiver Priorities and Child 
Health Index of Life with 
Disabilities (CPCHILD); 0 (best) to 
100 (worst);  
Non-ambulatory youth caregiver 
24.3(12.3) 









 Author, Year Sample Demographics: 




Instrument; All scales are 0 
(worst) - 100 (best) unless 
otherwise noted. 
Mean Total QOL score (SD) 
 
Subscale: Score Mean (SD).  
Chronic Cough 
Newcombe et al. 
(2011) 




Life questionnaire (PC-QOL);  
1 (worst) – 7 (best); 
Parents at week 2: 5.6(1.3)  
Parents at week 3: 6.1(1.1) 
Psychologic: 5.7(1.4) Week 2; 6.2(1.1) Week 3 
Physical: 5.4(1.4) Week 2; 6.0(1.2) Week 3 
Social: 6.0(1.2) Week 2; 6.1(1.3) Week 3 
Diabetes Type I 
Botello-Harbaum 






Diabetes QOL scale (DQOL); 
Scale range not reported; 
Youth baseline: 4.2(0.5)  
12-month follow-up: 4.1(0.5) 
 
Not reported 
Ingerski et al. 
(2010) 
261 youth and 261 parent; 
USA: Northeast and Midwest 
87.4% White  
12.6% Minority race 
PedsQL Type 1 diabetes module; 
Youth 74.0(12.7) 
Youth 
Treatment 1: 74.5(16.8) 
Treatment 2: 76.7(15.0) 
Worry: 67.0(19.5) 
Jaser et al. 
(2011) 





PedsQL Diabetes Module; 
Youth 71.4(12.4) 
 Not reported 
Kalyva et al. 
(2011) 




PedsQL 3.0 Diabetes Module; 
Youth 61.1(13.4)  
Parent 54.6(12.1) 
Diabetes symptoms: 60.0(13.3)Youth; 53.9(12.0) Parent 
Treatment barriers: 60.0(19.8) Youth; 50.6(17.0) Parent 
Treatment adherence: 64.8(15.8) Youth; 59.5(15.0) 
Parent 
Worry: 61.2(22.8) Youth; 52.8(21.6) Parent 




 Author, Year Sample Demographics: 




Instrument; All scales are 0 
(worst) - 100 (best) unless 
otherwise noted. 
Mean Total QOL score (SD) 
 
Subscale: Score Mean (SD).  
Valenzuela et al. 
(2006) 





PedsQL Type 1 Diabetes Module; 







50 youth and 50 parents; 
Russia;  
Russian  
Diabetes QOL questionnaire for 
youths (DQOLY);  
0 (best) - 100 (worst); 





Overall health (not reported) 
Diabetes Type II 
Allan et al. (2008) 28 youth and 28 parents; 
Canada;  
89.3% of Canadian 
Aboriginal ancestry  
PedsQL 3.0 Diabetes Module; 




Symptoms: 70.9(13.4) Youth; 59.8(17.2) Parent 
Treatment I: 74.2(16.2) Youth; 62.5(22.9) Parent 
Treatment II: 76.4(16.4) Youth; 66.6(23.2) Parent 
Worry: 63.1(25.2) Youth; 58.0(30.0) Parent 
Communication: 63.1(30.4) Youth; 60.4(31.2) Parent 
Duchenne muscular dystrophy (DMD) 
Davis et al. 
(2010) 




4.5% More than one 
6.8% Unknown 
PedsQL 3.0 Neuromuscular 
Module; 
Youth 73.8(13.2)  
Parent 59.6(15.5) 
 
About My Neuromuscular Disease: 72.9(13.2) Youth; 
60.3(15.3) Parent 
Communication: 75.6(23.7) Youth; 62.1(27.8) Parent 
About Our Family Resources: 76.6(19.1) Youth; 
55.8(24.9) Parent 
Hu et al. (2013) 50 youth and 50 parents; 
China; 
Chinese 
PedsQL 3.0 Neuromuscular 
Module; 
Youth 53.6(10.6)  
Parent 52.9(9.3) 
About My Neuromuscular Disease: 71.2(12.1) Youth;  
71.1(11.2) Parent 
Communication: 39.1(22.5) Youth; 37.5(20.4) Parent 










 Author, Year Sample Demographics: 




Instrument; All scales are 0 
(worst) - 100 (best) unless 
otherwise noted. 
Mean Total QOL score (SD) 
 
Subscale: Score Mean (SD).  
Eosinophilic Esophagitis 
Franciosi et al. 
(2013) 
263 youth and 263 parents; 
USA: Colorado, Indiana, 
Ohio, Pennsylvania, Texas; 
88.6% White 
4.2% Latino 
1.9% Black  
1.1% Asian/Pacific Islanders 
4.1% Others or not reported 
PedsQL Eosinophilic Esophagitis; 
Youth 65.2(19.1)  
Parent 67.4(17.6) 
Symptoms I: 66.7(20.1) Youth; 67.8(20.9) Parent 
Symptoms II: 70.9(24.3) Youth; 68.2(23.9) Parent 
Treatment: 55.5(26.8) Youth; 72.5(22.8) Parent 
Worry: 68.1(26.1) Youth; 72.1(23.5) Parent  
Communication: 74.0(25.7) Youth; 67.1(27.2) Parent 
Food and Eating: 60.3(32.4) Youth; 59.8(27.1) Parent 




47 youth and 47 parents; 
Russia;  
Russian  
Quality of life in epilepsy inventory 







Impact: 74.5(8.7);  
Memory/concentration: 69.9(17.8) 
Attitude: 36.9(21.4) 
Physical functioning: 70.5(14.2) 
Stigma: 59.8(20.7) 
Social support: 91.4(8.11) 
School behavior: 91.2(10.5) 
Health perception: 60.4(8.8) 
Food Allergy 





Food Allergy QOL Questionnaire – 
Parent Form (FAQLQ-PF);  
0 (best) - 6 (worst); 
Positive for food allergy:  
Baseline 4.1(1.4) 
At 2 months 3.6(1.4) 
At 6 months 2.9(1.5) 
 
Negative for food allergy:  
Baseline 3.9(1.5) 
At 2 months 3.2(1.5) 
At 6 months 1.6(1.5) 
Allergy positive vs negative  
Baseline:  
Emotional impact:4.2(1.3) vs 4.0(1.5)  
Food anxiety: 4.1(1.4) vs 3.9(1.3)  
Social and dietary limitations: 4.0(1.6) vs 4.0(1.3) 
At 2 months:   
Emotional impact: 3.3(1.3) vs 3.4(1.4) 
Food anxiety: 3.7(1.6) vs  3.0(1.4)  
Social and dietary limitations: 3.6(1.2) vs 3.0(1.2)  
At 6 months:   
Emotional impact: 2.5(1.2) vs 1.8(1.3) 
Food anxiety: 3.2(1.6) vs 1.5(1.3)  




 Author, Year Sample Demographics: 




Instrument; All scales are 0 
(worst) - 100 (best) unless 
otherwise noted. 
Mean Total QOL score (SD) 
 
Subscale: Score Mean (SD).  





Paediatric Food Allergy QOL 
Questionnaire (PFA-QL); 
Youth:  
25 (best) - 100 (worst); 
Baseline 51.1(7.4) 
3 months 50.1(8.8) 
 Not reported 
Mackenzie et al. 
(2012) 
350 youth and 350 parents; 
UK; 
89.7% White British 
10.3% Other 
You and Your Food Allergy; 
Youth:  
Higher scores indicate better QOL; 
Allergic to ≤ 2 foods 71.7(13.1)  
Allergic to > 2 foods 67.5(14.1) 
 Not reported 
 
 
Mizuno et al. 
(2017) 
Parents of youth with: 
Food allergy (n = 127) 
No food allergy (n = 48); 
Japan 
Food Allergy QoL Questionnaire 
(FAQLQ-PF-J); 0 (best) – 6 
(worse) 
Mean total scores: 
All ages = 3.1 (1.3) 
All ages: 
Emotional impact: 3(1.4) 
Food anxiety:  2.8(1.9 
Social dietary limitation: 3.6(1.4) 
Gastro-intestinal Symptoms 
Varni et al. (2014) 689 youth and 689 parents; 
USA: Colorado, Illinois, 
Massachusetts, New Jersey, 




1.9 % Asian/Pacific Islander 




Youth 72.5(16.4)  
Parent 70.3(16.3) 
 
Stomach pain/hurt: 54.6(26.4) Youth; 51.3(26.5) Parent 
Stomach discomfort when eating: 74.0(25.7) Youth; 
66.0(26.8) Parent 
Food/drink limits: 68.6(27.0) Youth; 68.2(29.5) Parent 
Trouble swallowing: 91.1(16.1) Youth; 92.2(15.3) Parent 
Heartburn & reflux: 78.8(20.0) Youth; 80.8(20.8) Parent 
Nausea & vomiting: 79.7(22.5) Youth; 78.3(24.9) Parent 
Gas and bloating: 64.3(24.6) Youth; 62.9(25.3) Parent 
Constipation: 71.1(23.5) Youth; 66.5(26.0) Parent 
Blood in poop: 85.9(23.6 ) Youth; 84.5(24.8) Parent 
Diarrhea: 78.5(22.7) Youth; 77.4(22.6) Parent 
Worry about pooping:78.1(25.4) Youth;75.7(26.0) Parent 
Worry about stomach aches: 60.5(32.8) Youth  
60.0(32.0) Parent 
Medicines: 75.5(21.2) Youth; 78.4(21.6) Parent 




 Author, Year Sample Demographics: 




Instrument; All scales are 0 
(worst) - 100 (best) unless 
otherwise noted. 
Mean Total QOL score (SD) 
 
Subscale: Score Mean (SD).  
Heart Disease 
Marino et al. 
(2011) 
1545 youth and 1545 
parents; USA: Arizona, 
California, Massachusetts, 





Pediatric cardiac QOL inventory 
(PCQLI);  




Adolescent 79.7(15.0)  
Parent 76.8(17.4) 
Disease Impact: 36.9(8.5) Child; 38.2(9.4) Parent 
Psychosocial Impact: 36.9(8.9) Child; 38.1(9.3) Parent 
Disease Impact: 38.4(8.3) Adolescent; 37.3(9.5) Parent 
Psychosocial Impact: 41.3(7.4) Adolescent; 39.5(8.8) 
Parent 
Hemophilia 
Bradley et al. 
(2006) 
353 youth and 353 parents; 
Europe and Canada; 
85.3% European 
14.7% Canadian  
 
 
Canadian Haemophilia Outcomes 
– Kids’ Life Assessment Tool 
(CHO-KLAT);  
Haemo-QoL: 0 (best)-100 (worst); 
Europe 
Haemo-QoL: Youth 4-7 years 
23.6(17.2); Parent 22.4(14.5)  
Youth 8-16 years 22.0(11.3);   
Parent 27.1(14.4)  
Canada 
CHO-KLAT  
Youth 4-18 years  74.6(14.0)  
Parent 74.5(11.6)  
Haemo-QOL: 0 (best) – 100 
(worst): Youth 4-7 years 16.4(11.7)  
Parent 17.4(7.7);  
Youth 8-18 years 17.4(15.4)  
Parent 23.8(13.4)  
 Not reported  
McCusker et al. 
(2015) 
144 youth (validation phase) 
France, Germany, the 
Netherlands, Spain and UK 
CHO-KLAT 
Youth : 77 (11.2) 





 Author, Year Sample Demographics: 




Instrument; All scales are 0 
(worst) - 100 (best) unless 
otherwise noted. 
Mean Total QOL score (SD) 
 
Subscale: Score Mean (SD).  
Pollak et al. 
(2006) 
320 youth and 309 parents; 
France, Germany,  
Italy, the Netherlands,  
Spain and UK; 
French, German, Italian, 
Dutch, Spanish and UK 
Haemo-QOL;  
0 (best)-100 (worst);  




Young et al. 
(2013) 







Hirschsprung Disease/Anorectal Malformation 
Hartman et al. 
(2007) 
250 youth; 
the Netherlands;  
Dutch  
Hirschsprung Disease/Anorectal 
Malformation QOL Questionnaire 
(HAQL);  
Youth with anorectal malformation 
18.5(1.3) 
Youth 8-11 years with 
Hirschsprung disease 18.3(1.3);  
Youth 12-16 years with 
Hirschsprung disease 18.3(1.7) 
Not reported 
Inflammatory Bowel Disease 





IMPACT-III Questionnaire;  
35 (worst) - 175 (best); 
Youth 143.1(17.5) 
 
Bowel Symptoms: 29.4(3.9) 
Systemic Symptoms: 11.9(2.3) 
Social Functioning:: 51.0(6.8) 
Body Image: 12.0(2.0) 
Treatment/Interventions:11.6(2.1) 




 Author, Year Sample Demographics: 




Instrument; All scales are 0 
(worst) - 100 (best) unless 
otherwise noted. 
Mean Total QOL score (SD) 
 
Subscale: Score Mean (SD).  
Gray et al. (2011) 62 youth and 62 parents; 






IMPACT-III Questionnaire;  
35 (worst) - 175 (best) 
Youth 137.2(18.6) 
 
Bowel Symptoms: 29.4(3.9) 
Systemic Symptoms: 11.9(2.3) 
Social Functioning:: 51.0(6.8) 
Body Image: 12.0(2.0) 
Treatment/Interventions:11.6(2.1) 
Emotional Functioning: 27.2(4.9) 
Otley et al. (2003) 147 youth and 147 parents; 
Canada; 
Canadian  
IMPACT-III Questionnaire;  
0 (worst) - 231 (best) 
180(32) Quiescent disease activity 
146(31) Mild disease activity  
133(34) Moderate/severe disease 
activity  
 Not reported 
Influenza  
Chow et al. 
(2014) 
Parents of 125 youth; 
Australia; 
Australian   
 
Care-ILI-QoL (Influenza-like 
illnesses); 1 (worse) – 7 (best); 
Mean total = 3.87(0.93) 
Social life =  3.24(.84) 
Daily activity = 3.36(1.41) 
Emotions = 4.0 (1.30) 
Perceived support = 4.86 (1.47) 
Immune thrombocytopenia 
Klaassen et al. 
(2013) 
81 youth and 127 parents 
French, German, UK and 
Uruguay; 
26% French  
17% German 
33% UK  
24% Uruguayan 
Kids’ Immune Thrombocytopenia 
Tools (KIT); 





 Not reported 
Lupus Erythematosus 
Moorthy et al. 
(2007) 
86 youth and 86 parents; 
USA: Illinois, New Jersey, 
New York, and Ohio; 
36% African American 
28% Mexican/Latino  
17% Asian 
17% White 
Simple Measure of the Impact of 
Lupus Erythematosus in 
Youngsters (SMILEY); 




Effect on self: 65(17) Youth; 59(17) Parent 
Limitations: 63(17) Youth; 60(18) Parent 
Social: 81(17) Youth; 74(17) Parent 




 Author, Year Sample Demographics: 




Instrument; All scales are 0 
(worst) - 100 (best) unless 
otherwise noted. 
Mean Total QOL score (SD) 
 
Subscale: Score Mean (SD).  
Organ Transplantation 
Weissberg-
Benchell et al. 
(2010) 
199 youth and 247 parents; 
USA: Alabama, California, 
Illinois, Michigan, Nebraska, 




3.5% Asian/Pacific Islander 
5.0% Other/not reported 
PedsQL 3.0 Transplant Module; 








Youth vs Parent: 
About My Medicines I: 83.1(15.0) vs 84.8(16.0)  
About My Medicines II: 86.6(16.2) vs 83.7(17.7) 
My Transplant and Others: 74.0(19.8) vs 76.9(19.8) 
Pain and Hurt: 71.1(23.4) vs 75.6(21.0) 
Worry: 79.4(21.8) vs 78.1(23.3)  
Treatment Anxiety: 74.8(27.2) vs 71.6(27.5)  
How I Look: 76.3(26.8) vs 78.8(24.4)  
Communication: 76.8(23.5) vs 77.6(26.6) 
Sickle Cell Disease  
Panepinto et al. 
(2013)  
321 youth and 313 parents; 
USA: Alabama, California, 













Pain and Hurt: 66.7(20.9) Youth; 67.7(23.6) Parent 
Pain Impact: 54.0(24.8) Youth; 55.4(29.9) Parent 
Pain Management: 54.9(29.9) Youth; 61.3(31.7) Parent 
Worry  I: 63.5(26.2) Youth; 60.2(31.7) Parent 
Worry  II: 73.4(29.7) Youth; 69.3(33.1) Parent 
Emotions: 62.0(33.1) Youth; 64.7(32.7) Parent 
Treatment: 64.3(21.9) Youth; 69.0(23.2) Parent 
Communication I: 73.8(24.9) Youth; 76.8(25.0) Parent 
Communication II: 57.2(30.5) Youth; 65.8(30.2) Parent 
Spinal Muscular Atrophy 
Iannaccone et al. 
(2009) 
125 youth and 174 parents; 
Canada and USA- DC, Ohio, 
Massachusetts, Minnesota, 
Missouri, New York, Oregon, 




8.0% Not reported 





Youth vs parent 
About My Neuromuscular Disease: 66.0(16.5) Youth;  
58.8(17.7) Parent 
Communication: 70.8(23.6) Youth; 67.0(31.1) Parent 





 Author, Year Sample Demographics: 




Instrument; All scales are 0 
(worst) - 100 (best) unless 
otherwise noted. 
Mean Total QOL score (SD) 
 
Subscale: Score Mean (SD).  
Kocova et al. 
(2014) 




PedsQL 3.0 Neuromuscular 
Module; 
Youth 58.3(14.6)  
Parent 52.1(16.4) 
 
About My Neuromuscular Disease: 57.2(14.5) Youth;   
53.4(17.0) Parent 
Communication: 72.0(20.3) Youth; 62.4(29.9) Parent 
About Our Family Resources: 56.8(22.7)Youth; 
41.4(21.6) Parent 
Tonsil and Adenoid Disease 





Paediatric Throat Disorders 











In our sample of studies, perception of QOL varied among healthy and ill youth and their parents. 
For example, in a sample of chronically ill (n = 367), acutely ill (n = 148), and healthy youth (n = 401) 
aged 2-18 years and their parents, Varni et al. (2001) hypothesized that healthy youth and their parents 
would perceive youth’s QOL as better than acutely or chronically ill youth. Varni and colleagues reported 
mean total scores for chronically ill youth (77.2 ± 15.5), for acutely ill youth (78.7 ± 14.0) and for healthy 
youth (83.0 ± 14.8). Their hypothesis was confirmed for parent proxy-report also: for chronically ill (74.2 ± 
18.4), for acutely ill (80.4 ± 15.3), and for healthy youth (87.6 ± 12.3). 
Latino representation in quality of life assessment. Races and/or ethnicities may be 
disproportionately affected by disease. For example, in 2015, the prevalence of asthma was highest 
among Black/African America youth (18.7%) compared to Whites (11.7%) and Latinos (12.6%) (Centers 
for Disease Control and Prevention, 2017). The percent of Latino youth in the U.S. is on the rise and has 
increased from 15% in 1996 to 24% in 2013 (Murphey, Guzman, & Torres, 2014). As the numbers of 
Latinos increase, they have unevenly dispersed across the U.S., mainly settling in Arizona, California, 
Colorado, Florida, Illinois, New Jersey, New York, and Texas (Pew Research Center, 2013). 
 In order to determine if Latinos were adequately represented in studies that examined disease-
specific QOL, study sample composition was extracted for 14 studies that were conducted in the U.S. 
(Botello-Harbaum et al., 2008; Davis et al., 2010; Franciosi et al., 2013; Gray et al., 2011; Iannaccone et 
al., 2009; Ingerski et al., 2010; Jaser et al. 2011; Marino et al., 2011; Moorthy et al., 2007; Panepinto et 
al., 2013; Valenzuela et al., 2006; Varni et al., 2004; Varni et al., 2014; Weissberg-Benchell et al., 2010). 
Botello-Harbaum et al. (2008), Davis et al. (2010), and Ingerski et al. (2010) did not report the percent of 
Latinos in their study. For researchers who reported Latino representation, the percentage ranged from 
0.6% (Panepinto et al., 2013) to 39% (Valenzuela et al., 2006).   
Latino representation was high in 3 studies. In their study of disease-specific QOL in 86 youth 
with systemic lupus erythematosus, Moorthy et al. (2007) conducted their study in 4 states located in the 
east coast and mid-west U.S. and included 28% Latinos. Participants were required to understand 
English to be included in this study. Valenzuela et al. (2006) included 39% Latinos in their study of 160 
youth with Type I diabetes and their parent. This study was conducted in Florida and participants were 
required to be fluent in English in order to be included. Varni et al.’s (2004) study of 404 youth with 
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asthma and 699 healthy youth was conducted in Kansas. This study included 35% Latinos and was 
conducted in participants’ preferred language choice. 
Latinos were under-represented (Latinos were less than 16% in study) in 9 of the studies that 
were conducted in U.S. states that have a high population of Latinos. Two examples follow: Panepinto 
and colleagues’ study of 321 youth with sickle cell disease and their parents conducted in Alabama, 
California, Texas, and Wisconsin included only 2 Latino participants. Franciosi et al. (2013) conducted 
their study of 263 youth with eosinophilic esophagitis and their parents across 6 clinical sites in Colorado, 
Indiana, Ohio, Philadelphia, and Texas. Even though states like Colorado and Texas have a larger 
number of Latinos (Pew Research Center, 2013), this study only included 4% Latinos. 
Summary of Disease-specific Quality of Life Review 
In summary, studies researching QOL in youth with 21 diseases and their parent/caregiver were 
included in this review. Analysis of studies revealed several main findings. Disease-specific QOL 
instruments were often used in conjunction with generic instruments to assess QOL of youth with different 
types of illness. The majority of authors used established or existing disease-specific QOL instruments to 
measure QOL in youth and/or parent/caregiver. All authors reported reliability and validity of disease-
specific QOL instruments. Subscales of disease-specific QOL instruments measured features of the 
disease of interest. Symptoms, treatment, communication, emotion, impact, and social subscales were 
most frequently found in disease-specific QOL instruments. Other subscales often found were physical 
functioning, medicines, psychological impact, food, disease impact, and pain. The PedsQL Sickle Cell 
Disease Module, for example, include subscales that measured pain and hurt, pain impact, pain 
management, worry, emotions, treatment, and communication, while the IMPACT III included subscales 
such as bowel symptoms, body image, and treatment/interventions and measured QOL in youth with 
inflammatory bowel disease.  
Youth-parent perspective of QOL often differed, and QOL scores varied according to disease 
studied. Perception of QOL was generally lower for youth with chronic illness across disease types. The 
lowest-rated QOL was 18.5(1.3) by youth with Hirschsprung Disease/Anorectal Malformation. The 
highest-rated QOL was 79(14.4) by parents of youth who received organ transplantation. Based on these 
QOL scores, youth viewed themselves as most negatively affected by symptoms of Hirschsprung 
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Disease/Anorectal Malformation and therefore perceived their QOL poorly, whereas youth who received 
organ transplantation did not view themselves as being as negatively affected by having received a 
transplanted organ and perceived their QOL as better. 
Cultural Factors Associated with Quality of Life 
Problem Identification and Purpose of Review  
In the literature review of disease-specific QOL in youth, Latinos were often underrepresented, 
and QOL was often not reported based on ethnicity. Of the 14 studies conducted in the U.S., while 11 
included a representative sample of Latinos (Franciosi et al., 2013; Gray et al., 2011; Iannaccone et al., 
2009; Jaser et al., 2011; Marino et al., 2011; Moorthy et al., 2007; Panepinto et al., 2013; Valenzuela et 
al., 2006; Varni et al., 2004; Varni et al., 2014; Weissberg-Benchell et al., 2010), no study stratified QOL 
perception by race/ethnicity. Latinos accounted for 24% of the U.S. population in 2013 (Murphey et al., 
2014) and are expected to increase to 36.4% by 2050 (Murphey et al., 2014). Considering that the U.S. 
population is becoming increasingly culturally diverse, it is necessary that researchers consider how 
culture and ethnicity impact a person’s QOL (Kagawa-Singer, 2010). It is therefore important that when 
measuring QOL, differences in cultural perceptions of illness, health, and other health-related events be 
included in measurements (Gonzalez-Calvo, Gonzalez, & Lorig, 1997; Herdman, Fox-Rushby, & Badia, 
1998). Examining QOL as perceived by different cultures may assist researchers to better understand the 
construct as perceived by a particular culture (Kagawa-Singer, 2010). 
Culture is based on beliefs and values and stipulates how a group of people live (Kagawa-Singer, 
2000), and provides a social connection with the world (Lopez-Class et al., 2011). Culture provides 
identification with and attachment to family, such as the value of familism (the reduction of the personal 
interests of an individual and an increased interest on the values and demands of the family) among 
Latinos (Urizar & Sears, 2006). In a study of 598 families of Mexican origin, researchers found that 
familism values in adolescent and their parents interacted protectively with deviant peer affiliations such 
as getting drunk/high and/or starting fights (German, Gonzales, & Dumka, 2009). 
People connect with each other through language and communication. In several studies, 
immigrants considered their language barrier an obstacle to good health and reported difficulty 
communicating with clinicians as contributing to health disparities (Carpenter, Schoster, Shreffler, & 
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Callahan, 2011; Jacobs, Karavolos, Rathouz, Ferris, & Powell, 2005; Stevens, Vane, & Cousineau, 
2011). Jacobs et al. (2005) used secondary data from a longitudinal study of a multiethnic sample of 
women to examine whether the ability to speak English was associated with their agreement to have 
breast and cervical cancer screenings. Findings of this study demonstrated that Hispanic, Chinese, and 
Japanese women who spoke English received more frequent Papanicolaou tests, mammograms, and 
clinical breast examinations than those who reported either not reading or speaking English at all or 
reading or speaking their native language more fluently than English. In their study, Carpenter et al. 
(2011) conducted a cross-sectional study to determine whether racial disparities in health status, QOL, 
and activity limitations exist for Latino, Black, and White adults living with arthritis who have similar access 
to a primary care physician. Participants rated having a clinician who spoke the same language as the 
participant as more important than having access to a clinician. Considering that studies have shown that 
the meaning and structure of QOL differs greatly depending on the culture being studied, the purpose of 
this literature review is to examine existing research related to cultural factors that are associated with 
QOL.  
Literature Search 
A specific focus on culture and QOL facilitated this literature search. Search term “culture AND 
quality of life” was used in title search. No restriction was placed on year of article’s publication. Searches 
were conducted in Cumulative Index to Nursing and Allied Health Literature (CINAHL), Medline, and Web 
of Science databases. Records were excluded if they: (1) examined organizational culture (how people 
who are part of an organization behave and the meaning that people attach to that behavior), (2) study 
was a review of literature, (3) were published in a language other than English, or (4) did not examine  
culture and QOL/report QOL scores.  
Data Evaluation and Quality Appraisal 
The Mixed Methods Appraisal Tool (MMAT) (Pluye et al., 2011) was used to evaluate and 
appraise methodological quality of studies. A description of the MMAT is provided on page 13.  
Data Analyses 
Data analysis was performed using a systematic analytic approach. Data were examined and 
quality scores and methodological quality of studies were extracted and presented in graph and narrative 
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form. Data such as the types of disease/disorder researched, country where study was conducted, and 
religiosity/spirituality, ethnicities, familism, fatalism, disease stigma/shame, patient-provider relationship, 
and gender were extracted from each study.  
Presentation of Findings 
This final section presents results of literature search of cultural factors associated with QOL. 
Here, studies evaluated and appraised with the MMAT are evaluated, appraised, synthesized, and 
presented in graphs. Data concerning the type of study, author, and year, the percentage of Latinos in 
each study, the concepts found to be positively, negatively, or not associated with QOL were synthesized 
and are presented in Table 3. 
Literature search. Figure 5 provides details of the literature search. The search resulted in 2376 
records. Eighteen records were excluded after cross-checking databases for duplicates, which resulted in 
2358 records remaining. Titles and abstracts were screened, resulting in the removal of 2213 records 
(2197 records were not related to culture and QOL and 16 records were related to organizational culture), 
leaving 145 articles for full-text review. Ninety seven articles that were literature reviews and 7 articles 
that did not report QOL scores were further excluded as they did not meet this study’s purpose. Forty one 
articles remained and were included in this integrative review: 34 quantitative, 6 qualitative, and 1 mixed 
methods design. Studies ranged in years of publication from 1998 (Bernhard et al., 1998; Juarez, Ferrell, 
& Borneman, 1998) to 2016 (Alaloul, AbuRuz, Moser, Hall & Al-Sadi, 2016; Cruz-Oliver & Sanchez-Reilly, 
2016; Kalyva, Abdul-Rasoul, Kehl, Barkai & Lukacs, 2016). Fourteen studies measured QOL in healthy 
individuals of various races/ethnicities; the majority of participants were female (Aznar & Castañón, 2005; 
Bhandari, 2012; Cruz-Oliver & Sanchez-Reilly, 2016; Fu, Anderson, Courtney, Hu, 2007; Kim & Sok, 
2010; Leung, Wu, Lue, & Tang, 2004; Lieber, Chin, Nihira, & Mink, 2001; Molzahn, Kalfoss, Makaroff, & 
Skevington, 2011; Olmedo-Alguacil et al., 2016; Power et al., 1999; Skevington, 2010; Utsey et al., 2007; 
Urzua, Miranda-Castillo, Caqueo-Urizar, & Mascayano,  2013; Verhagen, Ros, Steunenberg & de Wit, 
2014). Latinos were a focus of interest in 11 studies (Ashing-Giwa et al., 2007; Aznar & Castañón, 2005; 
Brice et al., 2011; Brown, McCauley, Levin, Contant, & Boake, 2004; Cruz-Oliver & Sanchez-Reilly, 2016; 
Graves et al., 2012; Lim, Gonzalez, Wang-Letzkus, & Ashing-Giwa, 2009; Tatis et al., 2005; Urizar & 




Records identified through 
database searching  












identified through hand 
search  
(n = 1) 
Records after 18 duplicates removed  
(n = 2358) 
Titles and abstracts 
screened  
(n = 2358) 
Records excluded  
(n = 2213) 
Reasons for exclusion: 
Research not related to 
culture and QOL (n = 
2197) 
Organizational culture 
and QOL (n = 16) 
Full-text articles 
assessed for eligibility  
(n = 145) 
Figure 5. Flow  Diagram of Literature Search of Cultural Factors Associated with QOL. Literature 
search and selection process.  Format for Figure 5 adapted from Moher D, Liberati A, Tetzlaff J, 
Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Review Analyses: 
The PRISMA Statement. PLos Med 6(6): e1000097.doi:10.1371/journal.pmed 1000097 
Full-text articles 
excluded from review  
(n = 104) 
 
Reason for exclusion:  
QOL scores not 
reported (n = 7) 
Review of literature 
articles (n = 97) 
Studies included in 
integrative review:    
(n = 41) 
Quantitative (n = 34) 
Qualitative (n = 6) 






To determine inter-rater reliability, 39% of studies (2 cohort and 12 cross sectional studies) were 
randomly selected for appraisal by a second reviewer. Inter-rater reliability was assessed at 96% for 
cohort studies and 97% for cross sectional studies. Where appraisal differed, discrepancies were 
resolved by discussion until consensus was achieved. 
Data evaluation and quality appraisal. All studies received satisfactory responses to both 
MMAT screening questions. Thirty four studies used quantitative non-randomized designs. Of these, 30 
were cross sectional (Alaloul et al., 2016; Ashing-Giwa et al., 2007; Aznar & Castañón, 2005; Bhandari, 
2012; Brown et al., 2004; Fielding et al., 2013; Forjaz & Guarnaccia, 2001; Fu et al., 2007; Graves et al., 
2012; Huang et al., 2010; Jafari et al., 2013; Kalyva, Abdul-Rasoul, Kehl, Barkai and Lukacs, 2016; Kang, 
2009; Kim & Sok, 2010; Lim et al., 2009; Molzahn et al., 2011; Myaskovsky et al., 2011; Olmedo-Alguacil 
et al., 2016; Owolabi, 2011; Pfennings et al., 1999; Pluta-Fuerst et al., 2011; Power et al., 1999; Scott et 
al., 2008; Skevington, 2010; Soulsby, Masterman, Kelly, & Thomas, 2010; Urizar & Sears, 2006; Urzua et 
al., 2013; Utsey et al., 2007; Verhagen et al., 2014; Wildes et al., 2009), 1 was quasi-experimental (Tatis, 
Remache, & DiMango, 2005), 1 was case control (Faresjö et al. 2006), and 2 were cohort studies (Brice 
et al. 2011; Bernhard et al. 1998). One study used mixed method design (Lieber et al. 2001). Six studies 
were of qualitative design (Ashing-Giwa et al., 2004; Choe, Padilla, Chae, & Kim, 2001; Cruz-Oliver & 
Sanchez-Reilly, 2016; Juarez et al., 1998; Leung et al., 2004; Lopez-Class et al., 2011).  
A variety of ethnicities were represented in the review. Sample size varied depending on the type 
of study design. Of the quantitative studies, sample size ranged from 68 (Jafari et al., 2013) to 21,743 
(Scott et al., 2008). Qualitative study sample sizes were smaller and ranged from 17 (Juarez et al., 1998) 
to 122 participants (Ashing-Giwa et al., 2004). Results are reported by study design as follows: 
Quantitative studies. Thirty cross sectional studies were appraised. Figure 6 displays results of 
appraisal by each quality criterion. A major strength noted in the majority of studies was that the sample 
recruited was representative of the different population sub-groups, such as age, gender, and 
race/ethnicity (criterion 3.1). The majority of studies met criterion 3.2 for the appropriateness of 
measurements and definition of dependent and independent variables. Skevington (2010), for example, 
conducted secondary analysis of data collected about the QOL of 9,404 sick and healthy adults across 24 
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diverse cultures. Skevington (2010) reported that participants without education reported much poorer 
QOL than those who completed any educational level; and QOL was better in highly developed countries. 
A major weakness of the quantitative studies was poor survey response rate in studies that either 
mailed questionnaires or conducted interviews via telephone; and poor complete outcome data in studies 
that administered questionnaires in clinical or community setting (criterion 3.4). Of 7 studies where 
questionnaires were either distributed via mail or telephone, 5 authors reported response rates of 60% or 
greater (Bhandari et al. 2012; Faresjo et al. 2006; Pfennings et al. 1999; Soulsby et al., 2010; Wildes et 
al., 2009). 
In 24 studies, questionnaires were administered in clinical or community settings. Of these, 11 
authors reported complete outcome data (where almost all the participants contributed to almost all 
measures) of >80% (Alaloul et al., 2016; Bernhard et al., 1998; Forjaz & Guarnaccia, 2001; Fu et al., 
2007; Huang et al., 2010; Jafari et al., 2013; Kang, 2009; Kim & Sok, 2010; Myaskovsky et al., 2011; 
Owolabi, 2011; Urizar & Sears, 2006; Urzua et al., 2013), while 3 authors reported complete outcome 
data <80% (Brice et al., 2011; Brown et al., 2004; Tatis et al., 2005) and complete outcome data were 
unknown for 9 studies (Aznar & Castañón, 2005; Fielding et al., 2013; Lim et al., 2009; Molzahn et al., 
2011; Pluta-Fuerst et al., 2011; Power et al., 1999; Scott et al., 2008; Skevington, 2010; Utsey et al., 
2007).  
 
Figure 6 Quality Appraisal Assessments of Quantitative Studies  
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Figure 7 summarizes the overall quality scores of the quantitative studies. The majority of studies 
met at least 3 of the 4 criteria and scored ≥75% in overall quality.  
Figure 7 Number of Criteria Met in Quantitative Studies  
Qualitative studies. Six qualitative studies were appraised. The majority of authors successfully 
described the context in which data were collected (criterion 1.3). Ashing-Giwa et al. (2004) for example, 
stated that focus groups of Latina and Asian cervical cancer survivors were conducted at the recruitment 
sites where participants attended clinic. Conducting research at this clinical site was meant to provide a 
familiar, facilitative, non-threatening group environment experience to participants. However, in none of 
the studies did the authors explain how findings related to their perspective, role, and interactions with 
participants (criterion 1.4). Figure 8 depicts methodological quality assessment of the qualitative studies 
by specific criterion. 
 
 
Figure 8 Quality Appraisal Assessments of Qualitative Studies 
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Characteristics of Studies. Regarding study purpose for quantitative studies, 14 studies 
examined the relationship between cultural factors and QOL (Bernhard et al., 1998; Graves et al., 2012; 
Jafari et al., 2013; Kalyva et al., 2016; Olmedo-Alguacil et al. 2016; Myaskovsky et al., 2011; Scott et al., 
2008; Skevington, 2010; Soulsby et al., 2010; Urizar & Sears, 2006; Urzua et al., 2013; Utsey et al., 2007; 
Verhagen et al., 2014; Wildes et al., 2009). Four studies examined predictors of QOL (Alaloul et al., 2016; 
Ashing-Giwa et al., 2007; Lim et al., 2009; Brice et al., 2011), 3 studies examined perception of QOL 
(Bhandari, 2012; Brown et al., 2004; Molzahn, et al., 2011), and 1 examined the effect of intervention 
consisting of training for asthma educators, development of educational materials in English and Spanish, 
and collaborating with medical staff, on QOL (Tatis et al., 2005). Twelve studies compared perception of 
QOL across countries (Forjaz & Guarnaccia, 2001; Huang et al., 2011; Kang, 2009; Faresjö et al., 2006; 
Pluta-Fuerst et al., 2011; Fu et al., 2007; Pfennings et al., 1999; Fielding et al., 2013; Power et al., 1999; 
Aznar & Castañón, 2005; Kim & Sok, 2010; Owolabi, 2011). Some authors used 1 instrument or a 
combination of instruments to measure cultural factors associated with QOL. Fu et al. (2007), for 
example, used 1 contextual measure of culture - the individualism and collectivism scale (INDCOL) in 
combination with the World Health Organisation QOL BREF (BREF is the abbreviated version of the 
WHOQOL-100) (WHOQOL-BREF) to measure QOL. In their cross-cultural study, Graves et al. (2012) 
used a combination of instruments to examine whether contextual and cultural factors influence QOL. 
Cultural factors were measured using: (1) items from the Body Image after Breast Cancer Questionnaire 
(shame/stigma); (2) a modified, validated Spanish version of Powe Fatalism Inventory (cancer fatalism); 
(3) a modified version of the Familism Scale (familism); (4) a modified Spanish version of the Religious 
Coping Scale (religious and spiritual coping); and (5) the Spanish-language Short Acculturation Survey 
(acculturation). 
Religiosity/Spirituality. Seven studies examined the relationship between religiosity/spirituality 
and QOL (Ashing-Giwa et al. 2004; Choe et al. 2001; Fu et al. 2007; Graves et al. 2012; Leung et al. 
2004; Skevington, 2010; Wildes et al. 2009) All authors reported a positive association between 





Table 3 Cultural Factors and Their Associations with Quality of Life 
Study Design; 
Author, Year 
% Latinos; Country of Origin Concept/Construct Association 
with QOL: +, -, 
or None 
Quantitative   
Religiosity/spirituality   
 
Fu et al. (2007) 0%  + 
Graves et al. (2012) 100%; USA  + 
Skevington (2010) 1%; Argentina   + 
Wildes et al. (2009) 100%; Central & South 
America, Mexico, Puerto Rico, 
USA  
 + 
  Latino ethnicity  
Ashing-Giwa et al. (2007) 26%; Central & South 
America, Mexico 
 - 
Brice et al. (2011) 40%; USA  - 
Brown et al. (2004) 50%; USA  + 
Lim et al. (2009) 47%; USA  - 
Scott et al. (2008) 6%+; Argentina  - 
  Familism  
Graves et al. (2012) 100%; USA  + 
Urizar and Sears (2006) 100%; Central & South 
America, Cuba, Puerto Rico 
 + 
  Acculturation  
Bhandari (2012) 0%;   - 
Graves et al. (2012) 100%; USA  None 
Lim et al. (2009) 47%: USA  + 
Urizar and Sears (2006) 100%; Central & South 
America, Cuba, Puerto Rico 
 + 
Wildes et al. (2009) 100%; Central & South 
America, Mexico, Puerto Rico, 
USA 
 + 
  Fatalism  
Graves et al. (2012) 100%; USA  - 
Urizar and Sears (2006) 100%; Central & South 
America, Cuba, Puerto Rico 
 - 
  Disease stigma/shame  
Graves et al. (2012) 100%; USA  - 
  Patient-provider 
relationship  
 
Lim et al. (2009) 47%; USA  + 
Wildes et al. (2009) 100%; Central & South 
America, Mexico, Puerto Rico, 
USA 
 + 
  Gender (male)  
Bhandari (2012) 0%  + 
Kang (2009) Unknown  None 
Urizar and Sears (2006 100%; Central & South 
America, Mexico, Puerto Rico, 
USA 
 + 
    
Qualitative   Relevant 
Themes that 
Influenced 





% Latinos; Country of Origin Concept/Construct Association 
with QOL: +, -, 
or None 
  Religiosity/spirituality    
Ashing-Giwa et al. (2004) 25%; USA  + 
Choe et al. (2001) 0%  + 
Juarez et al. (1998) 100%; USA  + 
Leung et al. (2004) 0%  + 
Lopez-Class et al. (2011) 100%; USA  + 
  Familism   
Ashing-Giwa et al. (2004) 25%; USA  + 
Choe et al. (2001) 0%  + 
Juarez et al. (1998) 100%; USA  + 
Lopez-Class et al. (2011) 100%; USA  + 







+ or - 
  Fatalism  
Lopez-Class et al. (2011) 100%; USA  - 
  Disease stigma/shame  
Lopez-Class et al. (2011) 100%; USA  - 
  Patient-provider 
relationship 
 
Lopez-Class et al. (2011) 100%; USA  - 
    
Mixed Method    
 
 Acculturation   
Lieber et al. (2001)  0%  + 







Disease/disorder. In 13 studies, researchers examined the association of culture and QOL in 
participants diagnosed with cancer. Of these, the majority focused on breast cancer (Ashing-Giwa et al., 
2004; Lopez-Class et al., 2011; Ashing-Giwa et al., 2007; Graves et al., 2012; Lim et al., 2009; Wildes et 
al., 2009; Bernhard et al., 1998; Jafari et al., 2013). Four studies examined QOL for participants with 
other forms of cancer: colorectal cancer (Fielding et al., 2013), hematopoietic stem cell transplantation 
(Brice et al., 2011), hematologic malignancies (Forjaz & Guarnaccia, 2001), and “various cancers” (Scott 
et al., 2008). One study, Juarez et al. (1998), did not specifically note the type(s) of cancer(s) researched 
but instead researched perceptions of QOL in participants who were experiencing pain as a result of 
cancer.  
Four studies measured QOL in participants with cardiac disorders. Kang (2009) studied a sample 
of American and Korean participants with atrial fibrillation using the SF-36 survey (100 point scale). 
Quality of life scores differed but were not statistically significant between genders: Korean men rated 
their QOL as better (49.32) than American men (46.12) and American women rated their QOL as slightly 
better (51.43) than Korean women (45.44). In Taiwanese and American participants with heart failure, 
Huang et al. (2010) reported that American participants rated their QOL as poorer (52.6) than Taiwanese 
participants (43.8) on the Minnesota Living with Heart Failure Questionnaire (0 –105 point scale with 
higher scores indicating poorer QOL). Urizar and Sears’ (2006) study of QOL in non-Cuban- and Cuban-
American participants with coronary heart disease reported that women had clinically significant lower 
global and emotional functioning compared to men.  
Twelve studies measured QOL in healthy samples using various QOL measures (Azner & 
Castañón, 2005; Bhandari, 2012; Fu et al., 2007; Kim & Sok, 2010; Lieber et al., 2001; Molzahn et al., 
2011; Olmedo-Alguacil et al. 2016; Power et al., 1999; Skevington, 2010; Urzua et al., 2013; Utsey et al., 
2007; Verhagen et al., 2014). Four studies (Fu et al., 2007; Skevington, 2010; Urzua et al., 2013; Utsey et 
al., 2007) used the WHOQOL-BREF, a 26-item Likert scale instrument that assessed 4 domains of QOL: 
physical health, psychological, social relationships, and environmental well-being.  The remaining studies 
used various QOL measures.  
Ethnicity. Of the 18 studies with Latino participants (Ashing-Giwa et al., 2004; Ashing-Giwa et 
al., 2007; Aznar & Castañón, 2005; Brice et al., 2011; Brown et al., 2004; Cruz-Oliver & Sanchez-Reilly, 
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2016; Graves et al., 2004; Juarez et al; 1998; Lim et al., 2009; Lopez-Class et al., 2011; Molzahn et al., 
2011; Power et al., 1999; Scott et al., 2008; Skevington, 2010; Tatis et al., 2005; Urizar & Sears, 2006; 
Urzua et al., 2013; Wildes et al., 2009), 5 studies (Ashing-Giwa et al. 2007; Brice et al. 2011; Brown et al. 
2004; Lim et al. 2009; Scott et al. 2008) examined the relationship between Latino ethnicity and QOL 
rating. All studies except Brown et al. (2004) reported lower QOL ratings for Latino participants compared 
to other ethnic groups after controlling for demographic and individual characteristics such as stage of 
disease. 
Three of the 6 quantitative breast cancer studies (Ashing-Giwa et al., 2007; Bernhard et al., 1998; 
Lim et al., 2009) found variations in cultural factors affecting QOL. Lim et al. (2009) found Latinas more 
likely to believe that God, health professionals, and luck have an effect on their health compared to Asian 
Americans. In their study of 703 breast cancer survivors, Ashing-Giwa et al. (2007) found greater 
emotional burden and socio-ecologic strain (which are associated with poorer QOL) among Latinas 
compared to African-, Asian-, and European-Americans. Bernhard et al. (1998) found cultural and 
language factors had a statistically significant impact on baseline patient-rated QOL. 
Latino cultural groups in studies. A wide variety of Latino cultural groups were represented. 
Several studies included participants from one or more Latin American countries. Six studies included 
participants with Mexican nativity (Ashing-Giwa et al., 2007; Aznar and Castañón, 2005; Graves et al., 
2012; Juarez et al. 1998; Lopez-Class et al., 2011; Wildes et al., 2009), 10 studies included participants 
with South American nativity (Ashing-Giwa et al., 2007; Aznar and Castañón, 2005; Graves et al., 2012; 
Lopez-Class et al., 2011; Molzahn et al. 2011; Scott et al., 2008; Skevington et al., 2010; Urizar & Sears, 
2006; Urzua et al., 2013; Wildes et al., 2009), 8 studies included participants with Caribbean nativity 
(Ashing-Giwa et al., 2007; Aznar and Castañón, 2005; Graves et al., 2012; Lopez-Class et al., 2011;  
Power et al., 1999; Urizar & Sears, 2006; Urzua et al., 2013; Wildes et al., 2009), and 7 studies included 
participants with Central American nativity (Ashing-Giwa et al., 2007; Aznar and Castañón, 2005; Graves 
et al., 2012; Lopez-Class et al., 2011; Power et al., 1999; Urizar & Sears, 2006; Wildes et al., 2009). 
Familism.  Several studies examined the relationship between familism and QOL (Ashing-Giwa 
et al. 2004; Choe et al. 2001; Graves et al. 2012; Lopez-Class et al. 2001; Urizar & Sears, 2006). Ashing-
Giwa et al. (2004), Choe et al. (2001), Graves et al. (2012) and Lopez-Class et al. (2001) reported a 
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positive association between familism and QOL, and Urizar and Sears (2006) reported a negative 
association between familism and QOL.  
Acculturation. Several studies examined the association between acculturation and QOL. 
Results varied. Four authors reported acculturation as having a positive association with QOL (Lieber et 
al. 2001; Lim et al. 2009; Urizar & Sears, 2006; Wildes et al. 2009). In Lim et al.’s (2009) study of Latina 
and Asian breast cancer survivors, researchers found a positive association between acculturation and 
QOL. Urizar and Sears (2006) examined the relationship between cultural factors (acculturation, familism, 
and fatalism) and psychosocial factors such as depression and social support, and QOL in a sample of 
Latinos diagnosed with coronary heart disease. The researchers reported that higher levels of 
acculturation were associated with lower levels of familism and a higher socio-economic status but there 
was no association between cultural factors and QOL. Bhandari et al. (2012) examined the relationship 
between perceived and acculturative stress and QOL in their cross sectional study of Nepalese students 
studying in South Korea. They found that acculturative stress was negatively associated with QOL. 
Lim et al. (2009) and Bhandari (2012) reported that individuals who are better acculturated are more likely 
to have a better grasp of the language and display greater language fluency. Graves et al. (2012) 
examined independent associations of culture, social and medical context with QOL in their cross 
sectional study of Latina breast cancer survivors. They found that acculturation was not independently 
related to QOL. 
Language. All authors reported using questionnaires and/or interviews according to participant’s 
language preference. Several studies examined the relationship between perceived QOL and language 
choice for questionnaire/interview completion. In their cohort study of 2220 breast cancer survivors, 
Bernhard et al. (1998) examined how culture, described as language/country groups (example 
English/Australia, and English/South Africa), biomedical factors (age, treatment assignment, and tumor 
size), marital status and education are associated with QOL. They found that culture had the strongest 
impact on baseline QOL. In a sample of 389 Latina- and Asian-American breast cancer survivors Lim et 
al. (2009) examined: (1) health behaviors and QOL of Latina and Asian-American breast cancer 
survivors, (2) the association between cultural predictors (acculturation, treatment-related decisions, 
cultural health beliefs, and doctor–patient relationships) of health behaviors and QOL, and (3) pathways 
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for predicting health behaviors and QOL in their cross sectional study. The authors did not find a 
significant relationship between survey language (English, Spanish, Korean, and Chinese) and QOL in 
Latina (n = 183) and Asian American (n = 206) participants with breast cancer.  
Fatalism. All studies that examined the relationship between fatalism and QOL included Latino 
participants; consistent across studies, a negative association between fatalism and QOL (Graves et al., 
2012; Urizar & Sears, 2006) was reported. For example, in their study of QOL among Latino cardiac 
patients, Urizar and Sears (2006) found fatalism was related to lower social functioning in female 
participants with coronary heart disease but no differences between non-Latino and Latino participants 
regarding levels of fatalism were found.   
Disease Stigma/Shame. All studies that examined how disease stigma/shame affected QOL in 
women diagnosed with breast cancer included Latinas (Graves et al., 2012; Lopez-Class et al., 2001). 
Both studies reported that disease stigma/shame had a negative association with QOL.  
Patient-provider relationship. Lim et al. (2009) and Wildes et al. (2009) both examined the 
relationship between patient-provider relationship and QOL. In their study of cultural health beliefs and 
health behaviors between Latina and Asian-American breast cancer survivors, Lim et al. (2009) reported 
a positive relationship between patient-provider relationship and QOL.  
Gender. Perception of QOL varied by gender in several studies: Kang (2009) examined gender 
and cultural QOL differences between Americans and Koreans with atrial fibrillation and found that QOL 
perception varied according to gender, with men reporting better physical functioning but having worse 
mental health. Women also reported lower QOL than men in a study of Latino patients with 
cardiovascular disease (Urizar & Sears, 2006) and in a study of Nepalese students studying in South 
Korea (Bhandari, 2012). Data regarding disease/disorder, authorship, methodology, demographics, 
instruments, and QOL rating are presented in the first portion of Table 4 and major themes are presented 
in the latter portion of Table 4. 
Qualitative themes. Researchers in all 6 studies reported that religiosity/spirituality and 
familism/family centeredness had a positive impact on study participants. Ashing-Giwa et al. (2004) 
conducted research with 74 breast cancer survivors using focus groups (n = 51) and key informant 
interviews (n = 23). Ashing-Giwa et al. (2004) reported that less acculturated Asian American breast 
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cancer survivors believed that religion/spirituality were important in dealing with an illness. In Lopez-Class 
et al.’s (2011) study of 28 Latina breast cancer survivors using focus group (n = 9) and individual 
interviews (n = 19), fatalism was reported as being important to participants in the early stages after 
diagnosis but not as important after learning about breast cancer treatment and outcomes. Disease 
stigma/shame had a negative impact on participants in 3 studies (Ashing-Giwa et al., 2004; Juarez et al., 
1998; Lopez-Class et al., 2011), all of which were conducted with cancer survivors. 
Summary of Cultural Factors Associated with Quality of Life Review 
In conclusion, this literature review of how cultural factors are associated with QOL found that 
individual perception of QOL differs among cultures (Utsey et al., 2007; Aznar & Castañón, 2005; Faresjö 
et al., 2006; Graves et al., 2012; Pluta-Fuerst et al., 2011; Scott et al., 2008; Wildes et al., 2009; Tatis et 
al., 2005). Eight cultural factors were identified as important to participants’ QOL: religiosity/spirituality, 
Latino ethnicity, familism, acculturation, fatalism, disease stigma/shame, patient-provider relationship, and 
gender. Of these, religiosity/spirituality, familism, and patient-provider relationship were positively 
associated with QOL while fatalism and disease stigma/shame were negatively associated with QOL.  
Diseases/disorders not only affect patients physically but also psychologically. Some Latinos, for 
example, may be of the belief that what will happen with illness has already been decided and cannot be 
changed (Graves et al., 2012; Urizar & Sears, 2006; Lopez-Class et al., 2011). Some cultures believe 
religion and/or spirituality play a role in their health. Spiritual well-being was found to have some 
mediating effects between culture-specific coping and QOL in a sample of African Americans (Utsey et 
al., 2007). Wildes et al. (2009) and Lim et al. (2009) reported that Latinos were found to have more 
religious/spiritual beliefs than individuals from other cultures. Amongst diseases/disorders researched, 
cancer was the most frequently studied, followed by cardiac disorders. Almost half of studies included 
Latinos, the majority of which were female.  
A variety of QOL instruments were used. The instrument used most was the Short Form-36, 
which was used in 9 studies (Alaloul et al., 2016; Brown et al., 2004; Faresjö et al., 2006; Forjaz & 
Guarnaccia, 2001; Kang, 2009; Kim & Sok., 2010; Olmedo-Alguacil et al., 2016; Pfennings et al., 1999; 
Verhagen et al., 2014), followed by FACT-G, which was used in 4 studies (Ashing-Giwa et al., 2007; 
Graves et al., 2012; Lim et al., 2009; Wildes et al., 2009) and WHOQOL-BREF, used in 4 studies (Fu et 
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al., 2007; Skevington, 2010; Urzua et al., 2013; Utsey et al., 2007). Fourteen studies used disease-
specific instruments (Ashing-Giwa et al., 2007; Fielding et al., 2013; Graves et al., 2012; Huang et al., 
2010; Jafari et al., 2013; Kalyva et al., 2016; Lim et al., 2009; Owolabi, 2011; Pluta-Fuerst et al., 2011; 
Scott et al., 2008; Soulsby et al., 2010; Tatis et al., 2005; Urizar & Sears, 2006; Wildes et al., 2009) and 
20 studies used generic instruments (Alaloul et al., 2016; Aznar & Castañón, 2005; Bhandari, 2012; 
Bernhard et al., 1998; Brice et al., 2011; Brown et al., 2004; Faresjö et al., 2006; Forjaz & Guarnaccia, 
2001; Fu et al., 2007; Kang, 2009; Kim & Sok, 2010; Molzahn et al., 2011; Myaskovsky et al., 2011; 
Olmedo-Alguacil et al., 2016; Pfennings et al., 1999; Power et al., 1999; Skevington, 2010; Urzua et al., 
2013; Utsey et al., 2007; Verhagen et al., 2014). 
   
  
 
Table 4 Quality of Life Rating in Different Cultural Samples Using Various Quality of Life Instruments 
Disease/ 
Disorder 
Author, Year Study Design; 
Sample Demographics 
Instrument Score 





QOL Rating/Major Themes 
 
Quantitative Studies 
Asthma  Tatis et al. 
(2005) 
Quasi-experimental 
Total sample (N = 198) 
Mean age = 38 years 
91% Latinos 
Mini-Juniper  




Patients who completed all 4 
questionnaires  
2.68 (1.07)* 3 months posttest 
3.35 (.88)* 12 months posttest 
Atrial 
Fibrillation 
Kang (2009) Cross Sectional 
Total sample (N = 129) 




0 (worst) – 100 
(best) 
Generic  Mean (SD) 
Mental health subscale 
46.12 (12.59) American men 
49.32 (13.84) Korean men 
51.43 ((9.66) American women 
45.44 (9.84) Korean women 
Breast Cancer Ashing-Giwa 
et al. (2007) 
Cross Sectional 
Total sample (N = 703) 
Mean age = 55 years 
26%  Latinos 
FACT-G  
0 (worst) -100 




86.1(16.3) Total sample p<.05 
80.1 (17.4) Latina p<.0001 
Breast Cancer Graves et al. 
(2012) 
Cross Sectional 
Total sample (N = 264) 
Mean age = 51 years   
100% Latinos 
FACT-G  






Breast Cancer Lim et al. 
(2009) 
Cross Sectional 
Total sample (N = 389)  
Mean age range = 53-54 years    
47% Latinos 
53% Asian Americans 
FACT-G  







65.96 (17.1) Latina p<.001 
72.4 (18.5) Asian American 
Breast Cancer Wildes et al. 
(2009) 
Cross Sectional  
Total sample (N = 117) 
Mean age = 55 years  
100%  Latinos 
FACT-G  













Author, Year Study Design; 
Sample Demographics 
Instrument Score 





QOL Rating/Major Themes 
Breast Cancer Bernhard et 
al. (1998) 
Cross Sectional 
Total sample (N = 1231) 
Pre- and peri-menopausal 
women age = <45 or 45+  
11 countries  
0% Latinos 
 
Total sample (N = 989) 
Postmenopausal women age = 








Mean (95% CI) 
54.6 (48.9 - 60.0)† 
Slovenian/Slovenia – lowest QOL rating 
83.8 (77.4 - 89.1)† 
Italian/Switzerland – highest QOL rating  
 
 
66.5 (62.4 – 70.0)† Swedish/Sweden – 
lowest QOL rating 
84.4 (79.0 - -89.1)† Italian/Switzerland – 
highest QOL rating 
Breast Cancer Jafari et al. 
(2013) 
Cross Sectional 
Total sample (N = 68) 
Mean age = 48 years   
100% Iranians 
EORTC QLQ-C30 






41.42 (18.02) Iranians 
Cancer Fielding et al. 
(2013) 
Cross Sectional 
Total sample (N = 552) 
Mean age range = 58-66 years   










Mean (SD)  
Psychological subscale 
9.7 (14.50) Hong Kong 
17.84 (17.15) Taiwanese 
40.73 (27.27) Japanese 
Cancer Scott et al. 
(2008) 
Cross Sectional 
Total sample (N = 21,743) 
Mean age range = 51-63 years    
11 international cultures 
<1% Latinos 
EORTC QLQ-C30 





55.0 (22.6) South Asia – lowest QOL 
rating 







Total sample (N = 120) 
Mean age = 66 years   
100% Latinos 
QLMI 














Author, Year Study Design; 
Sample Demographics 
Instrument Score 





QOL Rating/Major Themes 
Heart Failure Huang et al. 
(2010) 
Cross Sectional 
Total sample (N = 175) 




with Heart Failure 
Questionnaire 





43.8 (25.1) Taiwanese 







Total sample (N =105) 
Mean age range = 49-55 years   
23%  Portuguese 
77% American 
Short Form-36 
0 (worst) -100 
(Best) 
Generic Mean (SD) 
Mental health subscale 
67.04 (23.45) Portuguese 




Brice et al. 
(2011) 
Cohort  
Total sample (N = 95) Youths’ 





0 (worst) – 100 
(Best) 
Generic Mean (SD) 
74.07 (13.71) Pre-transplant 
79.80 (17.17) 365 days post-transplant 
Irritable Bowel 
Syndrome 
Faresjö et al. 
(2006) 
Case Control  
Total sample (N = 420) 
Age range = 18-64 years   
7% Cretans 
21% Swedish 
71% Swedish control group 
Short Form-36 
0 (worst) -100 
(best) 
Generic Mean (SD) 
Mental health subscale 
50.0 (26.0) Cretans 
72.1 (17.1) Swedish 





Brown et al. 
(2004) 
Cross Sectional  
Total sample (N = 218) 
Mean age=34 years    
50% Latinos 
Short Form-36 
0 (worst) -100 
(best) 
Generic Mean (SD) 







Total sample (N = 457) 
Mean age range = 43-46 years    
5 countries 
Short Form-36 
0 (worst) - 100 
(best) 
Generic Mean  
Mental health subscale 
54.7 France – lowest rating 
69.7 Netherlands – highest rating 








Author, Year Study Design; 
Sample Demographics 
Instrument Score 









et al. (2011) 
Cross Sectional 
Total sample (N = 484) 













3.74 (0.75) Austrian 
3.53 (0.68) German 




et al. (2011) 
Cross Sectional  
Total sample (N = 252) 
Mean age = 26 years 
62% Whites 
38% African Americans 
Satisfaction With 
Life Scale 
1 (worst) – 7(best) 
Generic  Mean (SD) 
4.20 (1.54) Total sample 
4.15 (1.53) African American 
4.24 (1.55) Whites 
Stomas  Soulsby et al. 
(2010) 
Cross Sectional  
Total sample (N = 122) 












46 (13) Asian 
60 (12) Non-Asian 
Stroke  Owolabi 
(2011) 
Cross Sectional 
Total sample (N = 353) 









73.5 (9.1) Nigerian p<.002 
62.8 (8.9) German p<.000001 
None  Aznar and 
Castañón 
(2005) 
Cross Sectional  
Total sample (N = 180) 
Age not reported 
38% Phase II 
Topologic model 
of QOL 
(Score range not 
reported) 
Generic  Mean (SD) 
4.23 (0.89) 
None  Bhandari 
(2012) 
Cross Sectional 
Total sample (N = 130) 
Age range = 20-50 years   
100% Nepalese 
Short Form-12 
0 (worst) – 100 
(best) 
Generic  Mean (SD) 









Author, Year Study Design; 
Sample Demographics 
Instrument Score 





QOL Rating/Major Themes 
None  Fu et al. 
(2007) 
Cross Sectional 
Total sample (N = 676) 




4 (worst) – 20 
(best) 
Generic  Mean (SD) 
Psychological health subscale 
13.38 (2.38) Taiwanese 
14.94 (2.98) Australian 
 
None  Kim and Sok 
(2010) 
Cross Sectional  
Total sample (N = 430) 




36 (worst) -146 
(best) 
Generic  Mean  
70.66 Korean 
57.44 Chinese 
None Molzahn et al. 
(2011) 
Cross Sectional 
Total sample (N = 7,401) 
Mean age = 73 years 
22 international centers 
WHOQOL-OLD 
1 (worst) – 5 (best) 
Generic  Mean  
3.40 Lithuania-lowest QOL rating 
4.33 Uruguay-highest QOL rating 
None  Power et al. 
(1999) 
Cross Sectional  
Total sample (N = 4,802) 
Mean age = 43 years   
15 international centers 
WHOQOL-100 
(Score range not 
reported) 
Generic  Mean 
Subscales: Physical; Psychological; 
Social; Environment 
13.9; 13.8; 14.2; 3.4 Thailand  
13.8; 13.8; 14.2; 3.7 Israel 
14.1; 13.9; 14.2; 3.5 Madras, India 
14.2; 13.9; 14.3; 3.6 Australia 
13.9; 13.8; 14.2; 3.5 New Delhi 
13.9; 13.8; 14.2; 3.5 Panama 
13.8; 13.8; 14.2; 3.7 U.S. 
13.7; 13.8; 14.2; 3.7 Netherlands 
13.8; 13.8; 14.2; 3.6 Croatia 
13.9; 13.8; 14.2; 3.7 Japan 
13.8; 13.8; 14.2; 3.6 Russia 
13.8; 13.8; 14.2; 3.6 Zimbabwe 
13.8; 13.8; 14.2; 3.6 Spain 
14.0; 13.9; 14.3; 3.6 France 








Author, Year Study Design; 
Sample Demographics 
Instrument Score 





QOL Rating/Major Themes 
None  Skevington 
(2010) 
Cross Sectional 
Total sample (N = 9,404) 
Age range = 32-61 years   
24 cultures in 23 countries 
WHOQOL-BREF 
0 (worst) - 100 
(best) 
Generic  Mean (SD) 
Countries with high Human Development 
Index: Australia; USA; Netherlands; 
Norway; Japan; UK; Germany; Italy; 
Spain; Israel; Greece; Argentina; 
Hungary; Croatia. 
Subscales: Physical; Psychological; 
Social; Environment 
66.4 (20.4); 66.8 (17.9); 66.8 (20.3); 64.9 
(16.4) 
 
Countries with medium Human 
Development Index: Russia; Malaysia; 
Romania; Bulgaria; Brazil; Turkey; China; 
India, Delhi; India, Madras. 
Subscales: Physical; Psychological; 
Social; Environment 
60.4 (17.0); 59.7 (16.6); 63.2 (19.6); 55.2 
(16.3)  
None  Urzua et al. 
(2013) 
Cross Sectional 
Total sample (N = 821) 





4 (worst) – 20 
(best) 
Generic  Mean (SD) 
Psychological health subscale 
13.09 (2.11) Chilean 
13.99 (1.74) Spaniard 
12.11 (2.27) Cuba 
None  Utsey et al. 
(2007) 
Cross Sectional; 
Total sample (N = 281) 
Mean age = 25 years   
100% African Americans 
WHOQOL-BREF 




Generic  Mean (SD) 
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Sample Demographics 
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QOL Rating/Major Themes 




Lieber et al. 
(2001) 
 
Total sample (N = 83) 









Total Life Satisfaction subscales 
3.05 (0.49) 
Qualitative Results/Major Theme 
Groups were distinguished by how well 
the participants seemed to understand or 
appreciate 
cultural differences and the strategies they 
took to manage the challenges 
Qualitative Studies 
Breast Cancer Ashing-Giwa 
et al. (2004) 
Qualitative Descriptive: 
Focus Groups (N = 51): 
Age range = 25-70 years 
6 Chinese 
4 Mixed Asian   
5 Caucasian  
10 African American  26 Latina 
Age range = 22-73 years;  
Key Informant Interviews        
(N = 23)  
7 African American, 
6 Asian American,  










1. Spirituality is significant to QOL for 
breast cancer survivors 
 
Breast Cancer Lopez-Class 
et al. (2011) 
Qualitative Descriptive 
Individual Interviews (N = 19) 
Focus Group (N = 9); 


















Author, Year Study Design; 
Sample Demographics 
Instrument Score 





QOL Rating/Major Themes 
Cancer Juarez et al. 
(1998) 
Qualitative Descriptive  
Total sample (N = 17) 






Major Themes  
1. Spiritual beliefs 
2. Family support 
Diabetes, 
Type II 
Choe et al. 
(2001) 
Qualitative Descriptive 
Total sample (N = 22) 







1. Satisfactory family relationships 
2. Spiritual life, relationship with God 
None  Leung et al.   
(2004) 
Qualitative Descriptive  
Total sample (N = 44) 







1. Religion and death 
2. Economic status 
None  Cruz-Oliver 
and Sanchez-
Reilly (2016) 
Qualitative Descriptive  
Total sample (N = 45) 








1. Language  
2. Religion 
3. Familism  
4. Education 
5. Community leaders 
6. Use of leaders 
FACT-G: Functional Assessment of Cancer Therapy; LASA: Linear Analogue Self-Assessment; EORTC QLQ-C30: The European Organisation 
for Research and Treatment of Cancer QOL; QLMI: MacNew QOL after Myocardial Infarction; FAMS: Functional Assessment of Multiple 
Sclerosis; SF-12: Medical Outcomes Study Short Forms; WHOQOL-BREF: World Health Organisation QOL BREF; HRQOLISP: Health Related 
QOL in Stroke Patients  
* Mean (SE) 






Chapter III: Methodology 
 The aims of this dissertation were three-fold. In Aim 1, we completed the final phase of linguistic 
validation of the Spanish version of PedsQL Sickle Cell Disease Module. Aim 2 compared perceptions of 
disease-specific and generic QOL in a sample of Latino and non-Latino youth with sickle cell disease 
aged 10-17 years and their parents who participated in an NIH funded feasibility study (Hydroxyurea 
Adherence for Personal Best in Sickle Cell Treatment [HABIT]; R21 NR013745) (Green et al., 2017; 
Smaldone et al., 2016; Smaldone et al., in press). Also using data from the HABIT study, Aim 3 explored 
the relationship between disease-specific QOL as it relates to sickle cell disease life burden and poorer 
health. This chapter presents a description of the research design for this dissertation. The methods for 
Aim 1 are presented first and those for Aims 2 and 3 follow. Study procedures, survey instruments, 
description of concepts and variables, data management, data analysis plan, and protection of human 
subjects are described. 
Research Design 
 The dissertation employed a mixed methods study approach. Mixed methods research involves 
the collection and analysis of data, the integration of findings, and the making of inferences using both 
qualitative and quantitative methods in a single study (Creswell, 2009). The mixed-methods design was 
chosen because it uniquely addressed our data collection process: Aim 1 used an approach that 
combined the collection of data using a Spanish language translation of the PedsQL Sickle Cell Disease 
Module in conjunction with an open-ended cognitive interview for Latino youths with sickle cell disease 
age 8-18 years and their parents. Aims 2 and 3 quantitatively examined the perception of QOL of youth 
with sickle cell disease using baseline data collected as part of the HABIT study. Hypotheses for Aims 2 
and 3 were driven by the literature review that is presented in Chapter II. Aims 2 and 3 were guided by a 
conceptual model that was adapted from Ashing-Giwa’s (2005) Contextual Model of Health-Related QOL.  
Aim 1 
Sample and setting 
Participants were sampled from 2 clinics at New York Presbyterian/Columbia University Medical 
Center: Columbia’s Pediatric sickle cell disease clinic, and the Transplant Center. Columbia Pediatric 
sickle cell disease clinic delivers service tailored to the pediatric hematology communities of Harlem, 
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Northern Manhattan, and the tristate area. Services provided include newborn screening, stroke 
prevention, chronic transfusion and iron-chelating therapy, stem cell transplantation, pain management, 
community outreach and patient education programs. Columbia Pediatric sickle cell disease clinic 
provides comprehensive services to approximately 200 youth aged 0-19 years with sickle cell disease, 
almost half of whom are of Latino descent.  
The New York-Presbyterian Hospital/Columbia University Medical Center (NYP/CUMC) provides 
services for heart, liver, lung, and kidney, pancreatic, intestinal and multi-visceral transplantation. Patients 
from across the U.S. and the globe, who have complex and challenging problems, including multi-organ 
transplant recipients, are treated at NYP/CUMC’s organ transplantation program. 
Subject recruitment 
A list of participants who fit the inclusion/exclusion criteria were obtained from both clinics. Using 
a telephone script that was approved by Columbia’s IRB, participants were recruited by telephone by our 
bilingual research assistant. Participants were informed regarding study purpose and procedures (i.e. the 
completion of PedsQL Sickle Cell Disease Module and demographic questionnaires using pen and paper, 
and audio-taping during cognitive interviews). Participants were informed that they may choose to 
complete questionnaires and participate in cognitive interviews either at their home or at the clinic based 
on their preference and convenience. 
Inclusion/exclusion criteria 
Because this aim related to the linguistic validation of the Spanish version of PedsQL Sickle Cell 
Disease Module, dyads were included based on the following criteria: (1) both youth and parent identify 
as Latino and speak Spanish as their primary language, (2) youth is between 8-18 years, and (3) youth 
has diagnosis of sickle cell disease.  
Study Procedures 
 Following informed parental consent and youth assent, parents completed a 5-item demographic 
survey and the translated 43-item Spanish PedsQL Sickle Cell Disease Module. After questionnaires 
were completed, participants partook in a one-on-one cognitive interview to determine whether the 
Spanish survey directions, questions, and choices were clear and easy to understand. While all 
participants completed Spanish language surveys, cognitive interviews were conducted in Spanish or 
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English depending on participant’s preference. Cognitive interviews were audiotaped. The time taken to 
complete surveys and interviews was timed. 
Data Collection 
Participants completed the PedsQL Sickle Cell Disease Module, which had been previously 
linguistically translated for the HABIT study using forward and backward translation methodology. Parents 
completed the Demographic Survey. The PedsQL Sickle Cell Disease Module was completed by parent 
and youth independently. Following completion of the questionnaire audiotaped face-to-face cognitive 
interviews regarding the usability of the questionnaire items were conducted separately with parent and 
child.  
Survey Questionnaires 
PedsQL Sickle Cell Disease Module 
The 43-item PedsQL Sickle Cell Disease Module is used to measure disease-specific QOL in 
youth aged 2-18 years with sickle cell disease by Panepinto et al. (2013). The PedsQL Sickle Cell 
Disease Module has 9 subscales that measure concepts that are specific to sickle cell disease. A 
complete description of the PedsQL Sickle Cell Disease Module can be found on page 75 and 76. 
Demographic Questionnaire 
The 5-item demographic questionnaire was completed by the parent to capture data pertaining to 
parent and youth age, gender, ethnicity, sickle cell disease status, the number of years living in the U.S. 
This questionnaire was available in Spanish and English (Appendix A).  
Cognitive Interview Guide 
Six cognitive open-ended questions with probes were designed to prompt information regarding 
clarity, relevance, appropriateness, and understandability of questionnaire directions, questions, and 
response choices as they were intended. The cognitive interview guide was made available in Spanish 
and English and was administered by the bilingual Spanish research assistant. Participants were asked 
for their opinion regarding what each item on the questionnaire meant (Mapi Research Trust, 2002). 






Participants’ confidentiality was maintained throughout the research process. All study-related 
materials and data were maintained in a locked file cabinet. Each research participant was assigned a 
non-identifiable numeric code and data were entered into a password protected database. 
Data Analysis Plan 
Audio files of each cognitive interview were transcribed and translated to English by a native 
Spanish speaker. Item-by-item analysis was conducted using the interview transcript and review notes to 
examine participant responses and understanding of the PedsQL Sickle Cell Disease Module’s directions, 
questions, and choices, and the questionnaire as a whole. A table was constructed in order to perform a 
side by side comparison of each section of the Spanish version with the English version and the PedsQL 
Sickle Cell Disease Module was revised as necessary based on the results of the cognitive interviews.  
A report of the cognitive interviews was revised and sent to Mapi Research Trust for approval per 
their guidelines (Mapi Research Trust, 2002). This report summarized the number and age of parents and 
youth interviewed for each version of the instrument by age group (8-12 year old; 13-18 year old), the 
time it took to complete the questionnaire, any difficulties encountered, suggestion of changes to be made 
and retained, and the final suggested Spanish language version of the questionnaire was produced. The 
final version of the questionnaire was proof-read prior to being considered as final. 
Aims 2 and 3 
Aims 2 and 3 were guided by a conceptual model that was adapted from Ashing-Giwa’s (2005) 
Contextual Model of Health-Related QOL. Figure 9 illustrates the adapted Conceptual Model of Health-
related QOL for Youth with sickle cell disease. Ashing-Giwa’s (2005) Contextual Model of Health-Related 
QOL was developed to investigate health disparities and risk factors for poor outcomes in health-related 
QOL research with cancer survivors. This model was adapted for this dissertation by tailoring components 
of life burden (in Socio-ecological Context) by adding 3 variables to form “Sickle Cell Disease Life 
Burden”. Additionally, cancer-specific components from General Health Status such as cancer 
characteristics and age at diagnosis were changed to the sickle cell disease-specific component of 
Poorer Health (a higher number of emergency room treatments or hospitalizations within the past year 









































Figure 9 The adapted Conceptual Model of Quality of Life for Youth with Sickle Cell Disease. This model 






























 Youth’s grade level  
 Parent’s marital status 
and level of education  
 
General Health Status 
Poorer Health 













Sickle Cell Disease Life 
Burden 
 Other family members 
with in the home have 
sickle cell disease 
 Greater medication 
barriers to 
hydroxyurea 
 Greater discordance 
between parent and 
youth regarding Sickle 





Concepts and Variables in Adapted Conceptual Model  
The concepts and variables included in the adapted conceptual model are described below. 
Table 5 lists each variable, its operational definition and its questionnaire source within the HABIT 
dataset. 
Systemic-level Context 
Demographic Information. Demographic information was collected from the parents using the 
28-item questionnaire (Appendix B), which contained information on youth-parent demographic, sickle 
cell disease history, prescribed medications, and emergency room and hospital resource use (emergency 
room and hospital resource use in the prior 12 months). For this dissertation, demographic information 
was restricted to survey language, age, gender, ethnicity, race, number of years lived in the United 
States, level of education, employment/grade level in school, and marital status as listed in Table 5.  
Socio-ecological Status. Socio-ecological status contains socio-economic (e.g. income, 
education, employment) status, life burden (e.g. living situation, neighborhood character, day-to-day 
strain), and social support (e.g. emotional, social networks) components (Ashing-Giwa, 2005). For this 
dissertation socio-ecological status was defined by sickle cell disease life burden. Life burden increases 
when a disease is present and results in poorer perception of QOL (Moorthy et al. 2007; Panepinto et al. 
2013). Two studies of adults that examined medication adherence and QOL found that greater barriers to 
medication adherence were related to worse QOL (Holt, Muntner, Joyce, Webber, & Krousel-Wood, 
2010; Williams et al., 2009). In a study of youth aged 10-18 years with diabetes and their parents, greater 
concordance of treatment responsibility was associated with better QOL (Cousino, Hazen, MacLeish, 
Gubitosi-Klug, & Cutter, 2013). Conversely, 1 study of youth aged 5-19 years with sickle cell disease 
found that treatment adherence was associated with poorer QOL (Barakat, Lutz, Smith-Whitley, & Ohene-
Frempong, 2005). 
For this dissertation, three variables were used to examine sickle cell disease life burden: (1) 
other family members in the home have sickle cell disease, (2) greater medication barriers to 
hydroxyurea, and (3) greater discordance between parent and youth regarding sickle cell disease 
responsibility. Two items were culled from the Parent Demographic Questionnaire to form the first 
variable “sickle cell disease in family members”: “Do you (parent) have sickle cell disease” and “Do other 
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people in the home (excluding participating youth) have sickle cell disease.” The second variable greater 
medication barriers to hydroxyurea, was measured using the Medication Barriers Scale. The third variable 
greater discordance between parent and youth regarding sickle cell disease family responsibility was 
measured using the Sickle Cell Family Responsibility Scale.  
Medication Barriers Scale. Socio-ecological status was measured with the 26-item Medication 
Barriers Scale (youth) and the 25-item Medication Barriers Scale (parent). The Medication Barriers Scale 
for youth and parent were adapted from Simons and Blount’s (2007) 16-item Parent Medication Barriers 
Scale which had a maximum score of 80, and the 17-item Adolescent Medication Barriers Scale which 
had a maximum score of 85, by adding 9 hydroxyurea-specific items. Simons and Blount’s scales were 
created to assess perceived barriers to medication adherence in adolescent transplant recipients using a 
sample of 78 pediatric patients aged 11-21 who had received solid organ transplants and their parents. 
Response choices were scored on a 5-point Likert scale as follows: 1 = Strongly disagree, 2 = Disagree, 
3 = Not sure, 4 = Agree, and 5 = Strongly agree. Construct and criterion validity were supported by 
significant associations between barriers scale scores and relevant disease, medical regimen, child, and 
family factors. Internal consistency for parent and adolescent scales were reported as Cronbach alphas of 
0.87 for the parent and 0.86 for the adolescent versions (Simons & Blount, 2007).  
Response choices for the adapted scale used in this dissertation were similar to the original scale 
by Simons and Blount (2007). This scale has a maximum of 25 items for parents and 26 items for youth. 
Items 1-23 (with a raw score range of a minimum of 23 to a maximum of 115) pertain to parents of male 
youth while items 1-25 (with a raw score range of a minimum of 25 to a maximum of 125) pertain to 
parents of female youth. Items 1-24 (with a raw score range of a minimum of 24 to a maximum of 120) 
pertain to male youth while items 1-26 (with a raw score range of a minimum of 26 to a maximum of 130) 
pertain to female youth. Scores were calculated and transformed from a raw score to a 100-point score 
by dividing the raw score by the maximum obtainable score and multiplying it by 100. Higher scores are 
associated with higher barriers to medication adherence (Simons & Blount, 2007). 
Sickle Cell Family Responsibility Questionnaire. The 11-item Sickle Cell Family Responsibility 
Questionnaire was used to measure greater discordance between parent and youth regarding sickle cell 
disease family responsibility. The Sickle Cell Family Responsibility questionnaire was adapted from the 
74 
 
17-item Diabetes Family Responsibility Questionnaire that was developed by Anderson, Auslander, Jung, 
Miller and Santiago (1990). The Diabetes Family Responsibility Questionnaire has also been adapted for, 
and applied to, other diseases like asthma (McQuaid et al., 2001), cystic fibrosis (Drotar & Ievers, 1994), 
and inflammatory bowel disease (Greenley, Doughty, Stephens, & Kugathasan, 2010). McQuaid et al. 
(2001) used the 10-item Asthma Responsibility Questionnaire to rate mother-child dyads (N = 351). 
Response choices were on a 5-point Likert scale that ranged from 1 (parent is completely responsible) to 
5 (child is completely responsible). Cronbach’s alpha was 0.88 for items 1-10 which suggests very good 
internal consistency.  
Based on the scoring method used by Anderson et al. (2009) which captured extreme reports (as 
recommended for the Diabetes Family Responsibility Questionnaire), dyad responses were grouped into 
3 dyadic variables: parent takes charge (Parent(s) take responsibility all of the time or Parent(s) take 
responsibility most of the time), perfect agreement (Parent(s) and child share responsibility about 
equally), and child takes responsibility (Child takes responsibility most of the time or Child takes 
responsibility all of the time).  
Each item was examined to determine the extent to which parent and child disagreed regarding 
who was responsible for that aspect of sickle cell management. Discordance between parent and youth 
was identified when, for example, the parent reported that the youth was primarily responsible for sickle 
cell related tasks and the youth reported that the parent was primarily responsible for sickle cell related 
tasks. The number of items where there was dyadic discordance was summed to obtain a total 
discordance score. Dyadic scores were composed by summing the number of items of self-care where 
parents and youth disagreed regarding who was responsible for the self-management task. Scores could 
range from 0 (no discordance regarding who was responsible) to 10 (discordance for all self-management 
items). 
Individual-level Context 
General Health Status. Poorer health was measured 2 ways: (1) by using self-reported 
emergency room visits and/or hospitalizations within the past year (obtained from the Parent 
Demographic Questionnaire) and, (2) by electronic medical record review of the number of emergency 
room visits and/or hospitalizations within the past year. Currently there is no universal scale for classifying 
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sickle cell disease severity (Cameron, Christian, Lobel, & Gaston, 1983; Panepinto et al., 2013). In this 
study, higher resource use was a proxy for poorer health and greater disease severity. 
Quality of Life Outcome  
Sickle Cell Disease Quality of Life. The 43-item PedsQL Sickle Cell Disease Module is a 
modular instrument used to measure disease-specific QOL in youth aged 2-18 years with sickle cell 
disease by Panepinto et al. (2013). Items were developed using a multiphase methodology of sickle cell 
disease literature review to create interview guides, and the development of a conceptual model with the 
aid of 10 healthcare experts. Interviews were conducted with youth with sickle cell disease aged 5-18 
years and their parents using focus groups (n = 13) and cognitive interviews (n = 33). This initial 
development process resulted in 48 items and 6 scales (Panepinto, Torres, & Varni, 2012). Nationwide 
multisite field testing for the psychometric validation phase of instrument development resulted in 43 
items and 9 subscales that measure concepts that are specific to sickle cell disease: (1) Pain and Hurt, 
(2) Pain Impact, (3) Pain Management and Control, (4) Worry I, (5) Worry II, (6) Emotions, (7) Treatment, 
(8) Communication I, and (9) Communication II (Panepinto et al., 2013). Participants respond to each 
item/statement using a 5-point Likert scale rated from never (0) to always (4). Items are reverse-scored 
and linearly transformed to a 100 point scale with higher scores indicating better QOL. Cronbach’s alpha 
exceeded 0.90 for both youth self-report and parent proxy-report. Confirmatory factor analysis 
demonstrated an acceptable to excellent model fit and intra-class correlation coefficient (ICC) ranged 
between poor to fair agreement for youth self-report and moderate agreement for parent proxy-report. 
The majority of inter-correlations were in the medium to large effect size range which supported construct 
validity. Participants in the psychometric validation phase of this instrument were 98.1% self-reported 
Black non-Hispanic (Panepinto et al., 2013). 
The PedsQL Sickle Cell Disease Module has 9 subscales: Pain and Hurt (9 items); Pain Impact 
(10 items); Pain Management and Control (2 items); Worry I (5 items that pertain to situations surrounding 
sickle cell disease); Worry II (2 items that pertain to having a stroke and having a chest crisis); Emotions 
(2 items); Treatment (7 items); Communication I (3 items that pertain to telling others about sickle cell 
disease); and Communication II (3 items that pertain to having difficulty regarding others not 
understanding about sickle cell disease and/or pain; difficulty telling others that he/she has sickle cell 
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disease). For Aim 1, the Spanish version of this questionnaire was used to determine whether the 
questionnaire directions, questions, and response choices were clear, relevant, appropriate, and easily 
understood. 
Generic Quality of Life. Generic QOL was measured with the 23-item PedsQL Generic Core 
Scale (Varni et al. 1999). Scoring is the same as with the PedsQL Sickle Cell Disease Module where 
items are reverse-scored and linearly transformed to a 100 point scale with higher scores indicating better 
QOL. The PedsQL Generic Core Scale was developed by Varni et al. (1999), using a sample of 291 
youth aged 8-18 years with cancer and their parents, using multiple cycles of two iterative phases: Phase 
I, item generation (assembling of multiple choice and open-ended questions) and Phase 2, item revision 
with administration to patients, families, and healthcare professionals who were not included in phase 1 
(Varni et al. 1999). Cronbach’s alpha was 0.83 for youth self-report and 0.86 for parent proxy-report. The 
PedsQL Generic instrument has been used to assess QOL in youth with various diseases, including 
cancer (Varni et al., 1999), Duchenne muscular dystrophy (HU et al., 2013), and sickle cell disease 
(Panepinto et al., 2008). 
The PedsQL Generic Core Scale is a modular questionnaire that measures generic QOL in 2-18 
year old youth. This questionnaire has multidimensional youth self-report and parent proxy-report scales 
that were developed as the generic core measure, and may be combined with other PedsQL disease-
specific modules, such as the PedsQL Sickle Cell Disease Module. This questionnaire includes 4 
subscales: (1) Physical Functioning (8 items), (2) Emotional Functioning (5 items), (3) Social Functioning 
(5 items), and (4) School Functioning (5 items) (Varni et al., 1999).     
Sample and Setting 
Data for aims 2 and 3 of this dissertation were obtained from baseline data collected as part of 
the Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) study, NINR # R21 
NR013745 (Green et al., 2017; Smaldone et al., 2016; Smaldone et al., in press). The sample included 
Latino and non-Latino youth 10-18 years with sickle cell disease who received care either at Columbia 
University Medical Center or Albert Einstein/Montefiore Medical Center, were treated with hydroxyurea, 
and had a history of suboptimal adherence to hydroxyurea.     
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The purpose of the HABIT’s feasibility study was to test the feasibility and acceptability of a 
community health worker intervention augmented by text messaging designed to improve adherence to 
hydroxyurea therapy. Participants were recruited from Columbia and from Albert Einstein/Montefiore 
Medical Center. Inclusion criteria for youth were: (1) 10-18 years of age, (2) had a diagnosis of sickle type 
HbSS or HbS-B0 thalassemia, (3) had been treated with hydroxyurea for a minimum of 15 months, (4) 
youth’s average fetal hemoglobin assessments over the past year were greater than10% below the 
youth's personal best value; (5) both youth and parents had to be able to read/speak English or Spanish, 
(6) had no cognitive disabilities, and (7) have a cell phone with text messaging capability. Female youth 
were excluded if they were pregnant or sexually active and not using a reliable method of contraception. 
Fetal hemoglobin samples were collected and self-reported adherence and resource use questionnaires 
were completed during 6 clinic appointments.  
Participants were randomized prior to study initiation to intervention group (community health 
workers augmented by customized text messages) or to control group (usual clinic-based care). Youth 
and parents completed questionnaires, the youth's hemoglobin F was measured monthly, and 
prescription refill information was obtained from the youth's pharmacy over the six month study period.  
Hospitalizations and emergency room visits for the year prior to study entry were obtained by both self-
report and review of the electronic medical record. 
  For this dissertation baseline parent and youth questionnaire data and electronic medical record 
review of hospitalization and emergency room use for the year preceding study entry were used. Baseline 
questionnaire data included Parent demographic questionnaire, PedsQL Sickle Cell Disease Module, 
PedsQL Generic Core scale, Medication Barriers scale, and the Sickle Cell Family Responsibility scale.  
Data management 
Baseline data were downloaded from a RedCap database and maintained on a password-
protected computer throughout the dissertation process.  
Data Analysis Plan 
Aim 2. Aim 2 compared the perception of disease-specific and generic QOL in a sample of Latino 




Table 5 Operational Definition of Variables for Aims 2 and 3 
Variable Operational Definition Variable 
Type  
Source/Questionnaire,  
item(s) number  
Demographics     
Survey language Spanish or English  Categorical  (Obtained from 
database) 
Gender  Male or Female  Categorical  (Obtained from 
database) 
Age Age in years  Continuous  Demographic, #4; #19 
Ethnicity Hispanic or Latino? Yes/No  Categorical  Demographic, #5; #20 
Race Black, White/Caucasian, Asian, Other  Categorical  Demographic, #6; #21 
Number of years 
living in U.S. 
Number of years  Continuous  Demographic, #7; #22 
Youth’s grade level 1 through 12  Continuous  Demographic, #23 
Parent’s education 
level 
Elementary school through graduate 
school  
Categorical  Demographic, #8 
Parent’s 
employment status 
Full time, part time, laid off, unemployed, 
disabled, or attending school  
Categorical  Demographic, #10 
Parent’s marital 
status 
Married, single, separated, or divorced  Categorical  Demographic, #11 
Socio-ecologic 
Status 
   
Sickle cell disease 
life burden 
(1) Do other people in the home have 
sickle cell disease? 
(2) Greater medication barrier to 
hydroxyurea. The number of items is 
different for boys versus girls (24 vs 26) 
and for parents of boys versus parents 
of girls (23 vs 25). Total scores were 










 (3) Greater discordance between parent 
and youth regarding sickle cell disease 
family responsibility. Self-care task 
where parents and youth do not 
completely agree about who is 
responsible for task. Discordant scores 
range from 0-10  




   
Poorer health 
 
(1) Self-reported emergency room visits 
and/or hospitalizations within the past 
year  
(2) Electronic medical record data of the 
number of emergency room visits and/or 








Outcome    
Sickle Cell Disease 
QOL 
Higher scores indicate better disease-
specific QOL  
Continuous  PedsQL Sickle Cell 
Disease Module 
Generic QOL Higher scores indicate better disease-
specific QOL 
Continuous  PedsQL Generic Core 
Scale 




Hypothesis 2.1: Youth perception of disease-specific and generic QOL will be higher compared 
to parent proxy perception.  
Hypothesis 2.2: Perception of disease-specific and generic QOL in Latino youth and parents will 
be lower compared to non-Latino youth and parents. 
Data were exported from the HABIT REDCap database to SPSS. First, data were cleaned to 
verify that there were no data entry errors. New variables were transformed where necessary. Total and 
subscale scores for parent and youth were created for PedsQL Sickle Cell Disease Module and the 
PedsQL Generic Core Scales. 
Descriptive statistics were computed to describe the sample (Shi & McLarty, 2009), and included 
frequencies, percentages, means, and standard deviations. The distribution of disease-specific and 
generic QOL scores was visually inspected for assumption of normality using a Q-Q plot. Scores were 
assessed as not normally distributed; therefore to test these hypotheses, Wilcoxon Signed Ranks Test 
and Mann-Whitney test were conducted where total scale and subscale scores for disease-specific and 
generic QOL questionnaires were calculated. Because our sample size was small in this exploratory 
study, we did not consider using multivariate analysis to compare QOL means. 
To interpret the differences in disease-specific and generic QOL questionnaire scores between 
Latino and non-Latino youth and parents, minimal clinically important difference (MCID) values were 
calculated. Jaeschke, Singer, and Guyatt (1989) defined MCID as the minimum difference in a score in 
an area of interest which patients perceive as beneficial and which may require a change in the patient's 
management. As used by Varni, Burwinkle, Seid and Skarr (2003), the MCID for PedsQL Generic Core 
Scale was calculated using Standard Error of Measurement (SEM). Standard Error of Measurement was 
estimated using the standard deviation (SD) of the total score and subscale score multiplied by the 
square root of 1 minus the Cronbach alpha reliability coefficient (Hilliard et al., 2013; Junger, Morita, & 
Modi, 2015; Varni et al., 2003). MCIDs were calculated for disease-specific QOL total and subscale 
scores, and generic QOL total and subscale scores.  
Absolute differences and 95% confidence intervals (CI) were calculated between Latinos and 
non-Latinos for disease-specific and generic QOL scores. Absolute difference was calculated as follows: 
the mean QOL scores for Latinos minus the mean QOL scores for non-Latinos. Ninety five percent 
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confidence intervals were calculated using independent samples confidence interval calculator 
(“Independent samples confidence interval calculator,” n.d.) that uses a t statistic and 2 sample means to 
produce an estimate of the difference between the 2 means (which for our study meant QOL scores of 
Latino and non-Latino youth and parents). We calculated a MCID score for each total score and its 
respective subscales. Where the absolute difference exceeded the MCID, the difference in score between 
Latino and non-Latino subjects was considered clinically relevant. 
Aim 3. Aim 3 explored the relationship between disease-specific QOL and sickle cell disease life 
burden and poorer health in Latino and non-Latino youth with sickle cell disease aged 10-17 years and 
their parents. We considered Latino ethnicity the most important predictor because of its theoretical 
relevance to our study. 
Hypothesis 3.1: Youth with sickle cell disease and their parents with higher sickle cell disease 
life burden will have lower disease-specific QOL compared to those with lower sickle cell disease life 
burden.  
Sickle cell disease life burden was operationalized with 3 variables: (1) other family members in 
the home have sickle cell disease, (2) greater medication barriers to hydroxyurea, and (3) greater 
discordance between parent and youth regarding sickle cell disease responsibility. We looked at 3 simple 
linear regression models for hypothesis 3.1. If the model was statistically significant (p<0.05), we added 
ethnicity as a second step. Multivariate models were tested for collinearity once the model was significant. 
Tolerance and variance inflation factor (VIF) determined whether multicollinearity was a factor in any of 
the models. Multicollinearity was considered an issue if the value of tolerance was <0.2 and the VIF was ≥ 
5 or the tolerance was <0.1 and the VIF was ≥10.   
Adjusted R-square (R
2
) was obtained from the multivariate regression model. The adjusted R
2
 is 
a modified version of R
2
 that has been adjusted for the number of predictors in the model (Miles, 2014). 
For Aim 3.1, the adjusted R
2
 represents the proportion of variance in disease-specific QOL which was 
explained by the following predictor variables: others in the home have sickle cell disease; greater 
barriers to hydroxyurea; and youth-parent discordance.  
Two items from the Parent Demographic Questionnaire (Do you [parent] have sickle cell disease; 
Do other people in the home [excluding participating youth] have sickle cell disease) were combined to 
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form the variable “Other family members in the home have sickle cell disease”. To examine the 
relationship between other family members in the home have sickle cell disease and disease-specific 
QOL, simple linear regression modeling for youth and parents was used. Greater medication barriers to 
hydroxyurea were measured with the Medication Barriers Scale, while greater discordance between 
parent and youth regarding sickle cell family responsibility was measured using the Sickle Cell Family 
Responsibility Questionnaire.  
Hypothesis 3.2: Youth with poorer health and their parents will have lower perception of disease-
specific QOL compared to those with better health.  
Poorer health was measured 2 ways: by self-reported number of emergency room visits and 
hospitalizations within the prior year obtained from the Parent Demographic Questionnaire, and by 
electronic medical records from Columbia University Medical Center and Montefiore Medical Center 
regarding the number of emergency room visits and hospitalizations within the prior year.  
 Four simple linear regression models were executed for hypothesis 3.2. If the model was 
statistically significant (p<0.05), we added ethnicity as a second step. Multivariate models were tested for 
collinearity once significance was established. Variance inflation factor and tolerance determined 
whether multicollinearity was a factor in any of the models. Collinearity was considered an issue if the 
value of tolerance was <0.2 and the VIF was ≥ 5 or the tolerance was <0.1 and the VIF was ≥10. Table 6 
provides a summary of the data analysis plan. For Aim 3.2, the adjusted R
2
 represents the proportion of 
variance in disease-specific QOL which was explained by emergency room visits and/or hospitalizations 
during the past year. 
Protection of Human Subjects 
The HABIT study was approved by the IRBs at CUMC and Montefiore Medical Center.  For this 
dissertation’s Aim 1, the study received approval by CUMC IRB.   
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Table 6 Summary of Data Analysis Plan for Aims 2 and 3 
Aims & Hypotheses Analysis Plan 
Aim 2: To compare perception of disease-specific and generic 
QOL in a sample of Latino and non-Latino youth with sickle 
cell disease aged 10-17 years and their parents who 
participated in a NIH funded study to improve adherence to 
hydroxyurea therapy.  
Aim 2: Wilcoxon Signed Ranks Test 
was used for hypothesis 2.1 and Mann-
Whitney U test was used for hypothesis 
2.2. Total scale scores and subscale 
scores for youth and parents were 
analyzed for disease-specific and 
generic QOL questionnaires.  
Hypothesis 2.1: Perception of disease-specific and generic 
QOL will be higher in youth compared to parent proxy 
perception. 
 
Hypothesis 2.2: Perception of disease-specific and generic 
QOL in Latino youth and parents will be lower compared to 
non-Latino youth and parents 
 
  
Aim 3: To explore the relationship between disease-specific 
QOL as it relates to systemic- (sickle cell disease life burden) 
and individual-level context factors (poorer health) in Latino 
and non-Latino youth with sickle cell disease aged 10-17 years 
and their parents. 
Aim 3: Simple linear regression model. 
If model was statistically significant, 
then ethnicity was added to the model. 
Hypothesis 3.1: Youth with sickle cell disease and their 
parents with higher sickle cell disease life burden (other family 
members have sickle cell disease; greater medication barriers 
to hydroxyurea; greater discordance between parent and 
youth regarding sickle cell disease family responsibility) will 
have lower disease-specific QOL compared to those with 
lower sickle cell disease life burden. 
One regression model for parents and 1 
model for youth was explored for: 
 Other family members in the 
home have sickle cell disease 
 Sickle cell disease family 
responsibility 
 Medication barriers 
If a model achieved statistical 
significance, ethnicity was added 
Hypothesis 3.2: Youth with poorer health and their parents will 
have lower disease-specific QOL compared to those with 
better health. 
One regression model for parents and 1 
model for youth were explored. If model 
was statistically significant, then 




Chapter IV: Results 
 Chapter IV presents the results of the study by Aim. Findings for Aim 1 are based on a sample of 
Spanish speaking youth-parent dyads who participated in the linguistic validation of the Spanish language 
version of the sickle cell disease-specific QOL instrument. Findings for Aims 2 and 3 are based on 
baseline data of youth-parent dyads who participated in the HABIT randomized controlled pilot study, 
hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT (R21 NR013745). 
Specific Aim 1      
Specific Aim 1: To complete the final phase of linguistic validation of the Spanish version of PedsQL 
Sickle Cell Disease Module. 
Characteristics of the Linguistic Validation Sample 
A sample of 10 Spanish speaking youth-parent dyads was recruited from 2 sources: those who 
participated in the HABIT study (5 dyads), and the Division of Pediatric Hematology, Oncology, and Stem 
Cell Transplantation at the New York Presbyterian Morgan Stanley Children’s Hospital at Columbia 
University Medical Center (5 dyads). All participating youth had sickle cell disease. One youth who had 
been recruited from the Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation had 
received hematopoietic stem cell transplantation, while the remaining youth were awaiting transplantation 
at the time of the study.  
Recruitment occurred between February and April of 2016. Five dyads participated in linguistic 
validation of the PedsQL Sickle Cell Disease Module designed for youth 8-12 years of age with the 
remaining dyads participating in validation of the instrument designed for youth 13-18 years of age. 
Table 7 provides characteristics of the linguistic validation sample. The mean age of youth in the 
8-12 year age group was 10.8 ± 1.1 years, while in the 13-18 year age group it was 16 ± 1.0 years. The 
majority of youth (80%) was male, and was born in the U.S. The mean age of parents was 36.9 ± 7.3 
years and the majority (90%) was female. All parents reported the Dominican Republic as their country of 
birth. One parent reported having sickle cell disease. All interviews were conducted in Spanish and the 




Table 7 Characteristics of the Linguistic Validation Sample  
            8-12 Group (n = 5)       13-18 Group (n = 5) 
         Youth 
n        (%) 
    Parent 
n        (%) 
   Youth 
n        (%) 
         Parent 
n        (%) 
      
Age in Years (Mean ± SD) 10.8 ± 1.1 35.2 ± 7.0  16.0 ± 1.0 38.6 ± 8.1 
Gender (Male)      4    (80.0) 0     (0.0)  4     (0.0)      1   (20.0) 
Country of birth (Dominican Republic)       0      (0.0)     5    (100)     2   (40.0)     5    (100) 
Recruitment Site      
        NIH HABIT Study 3    (60.0)            --  3   (60.0)         -- 
        Pediatric Hematology, Oncology, & Stem Cell Transplant Clinic 2    (40.0)            --  2   (40.0)         -- 
Location of Interviews      
         Home            --  5    (100)        -- 2   (40.0) 
         Pediatric Hematology, Oncology, & Stem Cell Transplant Clinic            --  0     (0.0)        -- 2   (40.0)  
         St. Giles Comprehensive Sickle Cell and Thalassemia Center            --  0     (0.0)        -- 1   (20.0) 
Survey completion time (Minutes) (Mean ± SD) 10.4 ± 3.1 9.4 ± 2.4  9.0 ± 2.0    8.6 ± 1.9 
Notes. SD = Standard deviation; HABIT = Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment; Sickle Cell Transplant Program = 






 On average, survey completion time was 10 minutes or less. During cognitive interviews parents 
and youth reported that the PedsQL Sickle Cell Disease Module items were clear, appropriate, and easy 
to understand. Only 1 youth (female, age 16 years) had a suggestion to improve the wording of an item 
(#18) of the questionnaire. She suggested that the item “I wake up at night when I have pain” should “ask 
if it is hard to sleep during the night when you have pain, or if you wake up many times?” Results of the 
linguistic validation were summarized and sent to Mapi Research Trust. Questionnaires validated by 
independent parties must first be sent to Mapi Research Trust for approval prior to being used. The 
Spanish language versions of the PedsQL Sickle Cell Disease Module are now available to researchers 
upon request to the Mapi Research Trust. The report of the validation process is included as Appendix C. 
Specific Aim 2 
Specific Aim 2: To compare perception of disease-specific and generic QOL in a sample of Latino and 
non-Latino youth with sickle cell disease aged 10-18 years and their parents who participated in the 
HABIT study. 
Characteristics of the HABIT Sample 
Demographics  
Table 8 provides baseline characteristics of youth and parents who participated in the HABIT 
study. The sample was equally divided between Latinos and non-Latinos. The mean age of youth was 
13.6 ± 2.4 years and the majority (57%) was male. Most youth were born in the U.S. and completed 
surveys in English. The mean age of parents was 42.9 ± 9.3 years. The majority of parents (79%) had 
immigrated to the U.S. and had lived in the U.S. for 6 or more years; 43% completed surveys in Spanish. 
The majority of parents (57%) reported having a high school education or less. Almost half of the parent 
sample was employed 35 hours or more per week. 
Resource Use 
Parents reported higher hospitalization and emergency room use compared to that obtained by 
electronic medical record review. Parents reported that youth had visited the emergency room for sickle 
cell disease in the prior year 2.0 ± 3.5 times versus 0.8 ± 2.1 times identified by medical record review. 
  
 
Table 8 Characteristics of the Sample for Aims 2 and 3   
 Youth  Parents   
 n = 28  n = 28   
Demographics         
Ethnicity (Latino) n, (%) 14 (50)  14 (50)   
Age (years) (Mean ± SD) 13.6 2.4  42.9 9.3   
        n     (%)         n (%)   
Gender (Male) 16 (59)  -- --   
Survey completion in Spanish 7 (25)  12 (43)   
Time lived in the United States        
             1 to 5 years 3 (11)  1 (4)   
             6 or more years 3 (11)  22 (79)   
             Born in the U.S. 22 (79)  5 (18)   
School grade         




   7 (26)  -- --   




  6 (22)  -- --   




  14 (52)  -- --   
Marital status         
             Married  -- --  13 (46)   
             Single -- --  13 (46)   
             Divorced or Separated -- --  2 (7)   
Education         
             ≤ High school graduate -- --  16 (57)   
             Some college or more  -- --  12 (43)   
Employment        
             Full time -- --  13 (46)   
             Part time -- --  6 (21)   
             Not currently employed  -- --  9 (32)   
Other family members in the home have sickle cell disease -- --  6 (22)   
Number of children in the home (Mean ± SD) -- --  2.7 1.7   
Resource Use        
 n (%)      
Self-report - ≥1 Emergency room visit for Sickle Cell Disease in 
past year 
15 (58)  -- --   






 Youth  Parents   
 n = 28  n = 28   
year  
        
EMR - ≥1 Emergency room visit 8 (29)  -- --   
EMR - ≥1 Hospitalization 7 (25)  -- --   
Psychosocial Measures           
 Mean ± SD  Mean ± SD  P-value
§
 
Medication Barriers total scores 
a 
47.3 ± 12.5  42.8 ± 10.3  0.02 
SCFR total scale scores
 b
  27.4 ± 7.9  19.9 ± 8.2  0.001 
SCFR dyadic discordant scores 
c
      --  5.3 ± 2.7  -- 
Notes. EMR = Electronic medical records review; 
a
Scores range 0-100 where higher scores indicate higher barriers to medication adherence; 
b
Total Scale scores range from 10 (more parent responsibility) – 30 (more youth responsibility); 
c
Dyadic discordant scores range from 0 (no 






While parents reported that more than half (58%) of youth had visited the emergency room during the last 
year for treatment of sickle cell disease, electronic medical records review identified 29% of youth having 
received similar care over the same time period. Similarly, parents reported that their youth had been 
admitted to the hospital 1.4 ± 2.7 times during the prior year versus 0.5 ± 1.0 times during the past year 
identified through electronic medical records review.  
Psychosocial Measurements 
Internal consistency for all parent and youth surveys was high with all alpha results ≥ 0.78. 
Medication barriers mean total scores were higher (higher barriers to medication adherence) for youth 
compared to parents were (47 ± 12.5 versus 42.8 ± 10.3, p = 0.02). Youth reported greater responsibility 
for sickle cell disease self-management compared to parent responsibility (27.4 ± 7.9 versus 19.9 ± 8.2, p 
= 0.001), with high discordance between youth and parents regarding who was responsible for self-care 
(5.3 ± 2.7). Of the 10 self-management items, more than half of dyads reported discordance for 4 self-
management tasks: “Making decisions about adjusting activity when pain starts” (68%), “Telling teachers 
about sickle cell anemia” (64%), “Telling friends about sickle cell” (61%), and “Noticing signs and 
symptoms of a sickle cell pain crisis” (61%). Least discordance was present for 2 self-management tasks: 
“Remembering day of clinic appointment” (36%) and “Remembering to take daily medications” (36%).  
Hypothesis 2.1: Perception of disease-specific and generic QOL will be higher in youth compared to 
parent-proxy perception.  
Hypothesis 2.1 was partially supported for perception of total disease-specific but not perception 
of total generic QOL. Table 9 provides disease-specific and generic QOL scores as reported by youth and 
parents. On average, youth reported significantly higher total disease-specific QOL scores compared to 
parents (68.7 ± 16.8 versus 61.4 ± 21.1, p = 0.02). Additionally, compared to parents, youth reported 
significantly higher scores for 3 of 9 subscales: Worry I (youth worried less about having pain, being 
treated in the emergency room, and/or being hospitalized; 67.1 ± 26 versus 43.5 ± 31.4, p = 0.007), 
Worry II (youth worried less about having a stroke and/or chest crisis; 75.4 ± 25.1 versus 57.9 ± 39.4, p = 
0.03), and Treatment (youth had less problems with medication, e.g. administration, taste, side effects, 
and efficacy; 79.1 ± 17.4 versus 71.3 ± 23.1, p = 0.045).  
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There were no significant differences in total generic QOL scores between youth and parents. 
However, youth reported higher scores than parents for School subscale (youth reported having  
less problems relating to paying attention in class, forgetting things, schoolwork, and missing school 
because of illness/appointments) than parents; 68.4 ± 22.8 versus 57.8 ± 28, p = 0.04).  
Table 9 also presents the MCID for both youth self-report and parent proxy-report. The MCID for 
the youth PedsQL Sickle Cell Disease Module total scale was 4.2 and for parent proxy-report 4.2. For 
PedsQL Generic Core total scale, the MCID for youth self-report was 4.8 and for parents 5.1.  
Hypothesis 2.2: Perception of disease-specific and generic quality of life in Latino youth and parents will 
be lower compared to non-Latino youth and parents. 
Youth 
Hypothesis 2.2 was partially supported. Overall, Latino youth reported higher QOL scores than 
non-Latino youth for all QOL measures except for the Worry II subscale of the disease-specific QOL 
measure (see Table 9). There were no significant differences in total generic QOL or its subscales or 
disease-specific QOL total score between Latino and non-Latino youth. However, compared to non-Latino 
youth, Latino youth reported significantly higher QOL scores for 3 of the 9 subscales: Emotions (Latino 
youth had less anger about having sickle cell disease and/or pain; 84.8 ± 26.9 versus 46.4 ± 34.8, p = 
0.002), Treatment (Latino youth had less problems with medication, e.g. administration, taste, side 
effects, and efficacy; 85.7 ± 15.7 versus 72.4 ± 17, p = 0.04), and Communication II (Latino youth had 
less difficulty regarding others not understanding about sickle cell disease and/or pain; less difficulty 
telling others that he/she has sickle cell disease; 86.9 ± 17.8 versus 46.4 ± 34.1, p = 0.004).  
The absolute differences between Latino versus non-Latino youth QOL scores are shown in 
Table 10. All exceeded its respective MCID except Worry I subscale and Physical subscale.  
 
Parents 
Hypothesis 2.2 was partially supported in parents. While there were no significant differences in 
perception of disease-specific QOL total score between Latino and non-Latino parents (66.4 ± 16.7 
versus 56.7 ± 24.1, p = 0.28), Latino parents reported lower subscale scores for Worry II (Latinos worried 
more about their child having a stroke and/or chest crisis; 41.3 ± 42.2 versus 73.2 ± 30.6, p = 0.04).
  
 
Table 9 Comparison of Disease-specific and Generic Quality of Life Scales between Youth and Parents 
 Youth   Parents 








Disease-specific QOL total scores* 68.7 ±18.8 0.95 4.2  61.4 ± 21.1 0.96 4.2 
Subscales (Number of items)          
      Pain and Hurt (9) 73.7 ± 24.4 0.93 6.5  69.0 ± 26.0 0.94 6.4 
      Pain Impact (10) 57.6 ± 26.2 0.92 7.4  50.2 ± 28.2 0.94 6.9 
      Pain Management and Control (2) 56.7 ± 33.6 0.92 9.5  58.3 ± 34.8 0.97  6.0 
      Worry I (5)** 67.1 ± 26.0 0.80 11.6  43.5 ± 31.4 0.84 12.6 
      Worry II (2)* 75.4 ± 25.1 0.66 14.6  57.9 ± 39.4 0.95  8.8 
      Emotions (2) 65.6 ± 36.3 0.90 11.5  61.1 ± 39.4 0.91 11.8 
      Treatment (7)* 79.1 ± 17.4 0.75 8.7  71.3 ± 23.1 0.79 10.6 
      Communication I (3) 77.1 ± 24.4 0.77 11.7  81.2 ± 29.3 0.88 10.2 
      Communication II (3) 66.7 ± 33.7 0.85 13.1  66.4 ± 31.8 0.92   9.0 
          
Generic QOL total scores 76.8 ± 17.0 0.92 4.8  70.5 ± 20.8 0.94   5.1 
Subscales (Number of items)          
      Physical (8) 77.0 ± 20.1 0.87 7.2  69.2 ± 25.1 0.90   7.9 
      Emotional (5)   78.0 ± 20.7 0.78 9.7  75.9 ± 22.7 0.83   9.4 
      Social (5) 83.8 ± 20.0 0.84 8.0  79.6 ± 23.0 0.80 10.3 
      School (5)* 68.4 ± 22.8 0.80 10.2  57.8 ± 28.0 0.84 11.2 





Clinically Important Difference represents SEM which indicates Standard Error of Measurement and was derived by multiplying the standard 
deviation of the sample mean by the square root of 1-alpha. MCID scores represent the transformed value of 1 SEM (for instance, a change in 












Table 10 Quality of Life Scores Stratified by Ethnicity 





























 (n = 14) (n = 14) (n = 13) (n = 14) 
        
Disease-specific quality of life         
Total scale 75.9±16.5 61.6±18.9 0.06 14.3(10.5-18.1) 66.4±16.7 56.7±24.1 0.28 9.7  (5.0-14.4) 
Subscale (Number of items)         
Pain and Hurt (9)
 
80.2±20.9 67.3±26.6 0.21 12.9  (7.7-18.1) 73.1±25.3 65.3±26.9 0.41 7.8  (1.9-13.7) 
Pain Impact (10) 64.1±27.6 51.1±24.0 0.20 13.0  (7.4-18.6) 57.1±26.1 43.8±29.6 0.22 13.3  (7.0-19.6) 
Pain Management & Control (2) 61.6±30.8 51.8±36.6 0.46 9.8  (2.5-17.1) 65.4±31.9 51.8±37.3 0.36 13.6  (5.8-21.4) 
Worry I (Pain, ER, Hosp.) (5) 71.8±26.3 62.5±25.9 0.31 9.3  (3.7-14.9) 41.9±36.3 45.0±27.5 0.59 3.1 (-4.1-10.3) 
Worry II (Stroke, chest crisis) (2) 67.0±28.8 83.9±18.0 0.09 16.9(11.7-22.1) 41.3±42.2 73.2±30.6 0.04 31.9(23.6-40.2) 
Emotions (2) 84.8±26.9 46.4±34.8 0.002 38.4(31.7-45.1) 76.9±36.0 46.4±37.8 0.04 30.5(22.2-38.8) 
Treatment (7) 85.7±15.7 72.4±17.0 0.04 13.3  (9.8-16.8) 80.2±15.4 63.0±26.4 0.06 17.2(12.4-22.0) 
Communication I (about pain) (3) 84.5±19.0 69.6±27.5 0.09 14.9  (9.8-20.0) 80.1±29.4 82.1±30.3 0.88 2.0 (-4.7 - 8.7) 
Communication II (about sickle 
cell disease) (3) 
86.9±17.8 46.4±34.1 0.004 40.5(34.6-46.4) 82.1±15.9 51.8±36.3 0.02 30.3(24.0-36.6) 
         
Generic  quality of life        
Total scale 81.5±13.0 72.1±19.5 0.20 9.4  (9.4-16.6) 75.9±15.3 65.4±24.3 0.22 10.5  (5.9-15.1) 
Subscale (Number of items)         
Physical (8) 79.0±17.4 74.9±23.0 0.66 4.1 (-0.3 - 8.5) 70.4±20.9 68.1±29.3 0.92 2.3 (-3.4 - 8.0) 
Emotional (5) 83.9±16.7 72.1±23.3 0.20 11.8  (7.4-16.2) 80.8±14.8 71.4±28.0 0.51 9.4  (4.4-14.4) 
Social (5) 89.3±15.9 78.2±22.7 0.12 11.1  (6.9-15.3) 87.3±14.7 72.5±27.2 0.16 14.8  (9.9-19.7) 
School (5) 75.4±20.5 61.4±23.6 0.10 14.0  (9.2-18.8) 68.5±24.4 47.9±28.3 0.06 20.6(14.7-26.5) 
Notes. 
a
The absolute difference is the mean QOL score in Latinos minus the mean QOL score in Non-Latinos; 
b
Mann-Whitney U tests; Scores are 
on 0-100 scale where higher scores indicate better QOL; ER = Emergency room visits; Hosp = Hospitalizations 






Similar to Latino youth, Latino parents reported higher subscale scores for Emotions (Latino parents had 
less anger about their child having sickle cell disease and/or pain; 76.9 ± 36 versus 46.4 ± 37.8, p = 0.04), 
and Communication II (Latino parents had less difficulty regarding others not understanding about sickle 
cell disease and/or pain; less difficulty telling others that their child has sickle cell disease; 82.1 ± 15.9 
versus 51.8 ± 36.3, p = 0.02) compared to non-Latino parents. Similar to youth, there were no significant 
differences in either total generic QOL or its subscales between Latino and non-Latino parents.  
The absolute differences between Latino versus non-Latino parents QOL scores are shown in 
Table 10. All exceeded or was equal to (Emotional subscale) its respective MCID except Worry I 
subscale, Communication I subscale, and Physical subscale.  
Specific Aim 3 
Specific Aim 3: To explore the relationship between disease-specific quality of life as it relates to 
systemic- (sickle cell disease life burden) and individual-level contextual factors (poorer health) in youth 
with sickle cell disease aged 10-18 years and their parents who participated in the HABIT study.  
Hypothesis 3.1: Youth and parents having greater sickle cell disease life burden (other family members 
in the home have sickle cell disease, greater medication barriers to hydroxyurea, greater discordance 
between youth and parents regarding sickle cell disease responsibility) will have lower disease-specific 
quality of life.  
Life Burden and Disease-specific Quality of Life 
Hypothesis 3.1 was partially supported. Table 11 provides details regarding the results of 
regression analyses for youth and parents. Having additional family members with sickle cell disease and 
medication barriers did not predict youth or parent perception of disease-specific QOL as hypothesized. 
Therefore, further testing by adding Latino ethnicity to the model was not conducted.  
While greater discordance between youth and parents regarding sickle cell family responsibility 
did not predict youth disease-specific QOL, in the parent model there was an inverse association between 
youth-parent discordance and parent perception of disease-specific QOL. For each unit increase in youth-
parent discordance, parent perception of disease-specific QOL decreased by approximately 3 points (β = 
-3.07; p = 0.04). In this model, 12.5% of the variation in parent perception of disease-specific QOL can be 
explained by discordance between parent-youth perception of sickle cell responsibility and management.
 
 
Table 11 Prediction Model of Life Burden and Disease-specific Quality of Life in Youth and Parents 
  Youth Parents  
  Unstandardized Coefficient Collinearity 
Statistics 










Beta SE P-value  Tol. VIF 
              
Others in Home have Sickle Cell Disease 
Step 1 (Constant)  67.00 4.19     58.51 4.75    
 Others with sickle 
cell disease 
 8.78 8.88  -- --  12.03 9.90  -- -- 
 Model  -.001   0.33   .019   0.24   
Step 2 Not conducted       Not conducted 
 
Greater Barriers to Hydroxyurea 
Step 1 (Constant)  88.18 13.88     92.52 16.82    
 Greater barriers  -0.41 0.28  -- --   -0.72   0.38  -- -- 
 Model  .039   0.16   .092   0.07   
Step 2 Not conducted       Not conducted 
 
Youth-Parent Discordance 
Step 1 (Constant)  77.75 7.87     77.76 8.44    
 Discordance   -1.71 1.33  -- --  -3.07 1.41 0.04 -- -- 
 Model  .023   0.21   .125   0.04   
              
Step 2 (Constant) Not conducted  73.57 10.50    
 Discordance        -2.78 1.49 0.07 0.92 1.09 
 Latino         5.47 8.00 0.50 0.92 1.09 









SE = Standard error; 
c
Tol. = Tolerance; Tolerance was considered to be an issue if tolerance was <0.2 and the 








Variation in parent perception of disease-specific QOL decreased from 12.5% to 10.9% once 
ethnicity was added to the model. When ethnicity was added to the model, the model did not retain 
significance (p = 0.10). Collinearity was not an issue for Aim 3.1. 
Hypothesis 3.2: Youth with poorer health and their parents will have lower perception of disease-specific 
QOL compared to those with better health. 
Poorer Health and Disease-specific Quality of Life 
Two variables representing poorer health (number of emergency room visits within the past year 
and number of hospitalizations within the past year due to sickle cell disease) were tested as predictors of 
youth and parent perception of disease-specific QOL. Hypothesis 3.2 was supported. Table 12 provides 
details regarding the results of multivariate regression analyses for youth and parents. Collinearity was 
not an issue for Aim 3.2. 
Emergency Room Visits  
Youth 
Using self-reported emergency room visits for sickle cell disease during the past year, there was 
an inverse association between number of emergency room visits and youth perception of disease-
specific QOL. For each unit increase in the number of emergency room visits due to sickle cell disease, 
youth perception of disease-specific QOL decreased by 2.9 points (β = -2.89; p = 0.005). After controlling 
for ethnicity, the multivariate linear model retained significance (p = 0.008). In the multivariate model,, for 
every unit increase in the number of emergency room visits, youth perception of disease-specific QOL 
decreased by 2.5 points. Twenty eight percent of the variance in youth perception of disease-specific 
QOL can be explained by this model.  
Using electronic medical record documentation of emergency room visits, for each unit increase 
in emergency room visits for sickle cell disease, youth perception of disease-specific QOL decreased by 
5.1 points (β = -5.07; p = 0.002). After controlling for ethnicity, the multivariate linear model retained 
significance (p = 0.001). Controlling for ethnicity, for every increase in the number of emergency room 
visits for sickle cell disease youth perception of disease-specific QOL decreased by 4.7 points. Thirty six 
percent of the variance in disease-specific QOL in youth can be explained by this model. 
  
 
Table 12 Prediction Models of Poorer Health and Disease-specific Quality of Life in Youth and Parents 
  Youth Parents  
  Unstandardized Coefficient Collinearity 
Statistics 
Unstandardized Coefficient Collinearity 
Statistics 
 Variable  R
2a 




VIF      R
2 
Beta SE P-value  Tol. VIF 
              
Emergency Room (ER) visits during past year 
Self-reported  
Step 1 (Constant)  74.03 3.69     67.08 4.04    
 ER visits   -2.89 0.93 0.005 -- --   -3.41 0.99 0.002 -- -- 
 Model  .258   0.005   .309   0.002   
Step 2 (Constant)  69.02 5.16     66.84 5.71    
 ER visits   -2.48 0.96   0.02 0.90 1.11   -3.39 1.07 0.004 0.91 1.10 
 Latino    9.06 6.63   0.19 0.90 1.11    0.46 7.48 0.95 0.91 1.10 
 Model  .284    0.008   .278   0.01   
 
Electronic Medical Record  
Step 1 (Constant) . 72.89 3.27     67.27 3.25    
 ER visits  -5.07 1.50 0.002    -6.93 1.46 <0.001 -- -- 
 Model  .279   0.002   .451   <0.001   
Step 2 (Constant)  66.63 4.31     63.91 4.44    
 ER visits  -4.70 1.42 0.003 0.99 1.02  -6.75 1.47 <0.001 0.99 1.01 
 Latino  11.93 5.74 0.048 0.99 1.02    6.66 6.02    0.28 0.99 1.01 
 Model  .361   0.001   .456   <0.001   
 
Hospitalizations during Past Year 
Self-reported  
Step 1 (Constant)  78.53 3.29     70.02 3.72    
 Hospitalizations  -5.72 1.10 <0.001 -- --  -6.48 1.22 <0.001 -- -- 
 Model  .541   <0.001   .565   <0.001   
Step 2 (Constant)  72.51 4.72     67.10 5.48    
 Hospitalizations  -5.14 1.11 <0.001 0.91 1.10   -6.21 1.29 <0.001 0.92 1.09 
 Latino   9.94 5.81     0.10 0.91 1.10    5.01 6.85 0.47 0.92 1.09 
 Model  .580   <0.001   .555   <0.001   
              
Electronic Medical Record 
Step 1 (Constant)  72.24 3.68     65.77 4.12    
 Hospitalizations  -7.56 3.39 0.03 -- --  -9.16 3.73 0.02 -- -- 
 Model  .129   0.03   .162   0.02   






  Youth Parents  
  Unstandardized Coefficient Collinearity 
Statistics 
Unstandardized Coefficient Collinearity 
Statistics 
 Variable  R
2a 




VIF      R
2 
Beta SE P-value  Tol. VIF 
              
Step 2 (Constant)  65.95 5.15     62.72 5.89    
 Hospitalizations  -6.11 3.39 0.08 0.94 1.07   -8.47 3.88 0.04 0.94 1.06 
 Latino  11.23 6.64 0.10 0.94 1.07    5.64 7.72 0.47 0.94 1.06 









SE = Standard error; 
c
Tol. = Tolerance; Tolerance was considered to be an issue if tolerance was <0.2 and the 







Using self-reported emergency room visits, there was an inverse association between number of 
emergency room visits and parent perception of their youth’s disease-specific QOL.  For each unit 
increase in the number of emergency room visits due to sickle cell disease, parent perception of their 
youth’s disease-specific QOL decreased by 3.4 points (β = -3.41; p = 0.002). When ethnicity was added 
to the model, the model retained statistical significance (p = 0.01). Twenty eight percent of the variance 
in parent perception of disease-specific QOL can be explained by this model. Using electronic medical 
record documentation of emergency room visits, there was an inverse association between number of 
emergency room visits and parent perception of their youth’s disease-specific QOL. For each unit 
increase in the number of emergency room visits due to sickle cell disease, parent perception of disease-
specific QOL decreased by 6.9 points (β = -6.93; p < 0.001). After controlling for ethnicity, the 
multivariate linear model retained significance (p < 0.001). Forty six percent of the variance in parent 
perception of their youth’s disease-specific QOL can be explained by this model. 
Hospitalizations 
Youth 
Using self-reported hospitalizations, there was an inverse association between number of 
hospitalizations in the past year and perception of disease-specific QOL. For each unit increase in the 
number of hospitalizations in the past year for sickle cell disease, disease-specific QOL in youth 
decreased by 5.7 points (β = -5.72; p < 0.001). After controlling for ethnicity, the multivariate linear model 
retained significance (p < 0.001). Controlling for ethnicity, for every increase in the number of 
hospitalizations during the past year due to sickle cell disease youth perception of disease-specific QOL 
decreased by 5.1 points. Fifty eight percent of the variance in youths’ perception of disease-specific QOL 
can be explained by this model.  
Using electronic medical records documentation, for each unit increase in hospitalizations for 
sickle cell disease, disease-specific QOL decreased by 7.6 points (β = -7.56; p = 0.03). After controlling 
for ethnicity, the multivariate linear model retained significance (p = 0.029). Nineteen percent of the 




Using self-reported hospitalizations, there was an inverse association between self-reported 
number of hospitalizations in the past year and parent perception of youth’s disease-specific QOL. For 
each unit increase in the number of hospitalizations due to sickle cell disease, parent perception of their 
youth’s disease-specific QOL decreased by 6.5 points (β = -6.48; p < 0.001). When ethnicity was added 
to the model, the model retained statistical significance (p < 0.001). Fifty six percent of the variance in 
parent perception of disease-specific QOL in youth can be explained by this model.  
Using electronic medical record documentation, there was an inverse association between 
number of hospitalizations and parent perception of their youth’s disease-specific QOL. For each unit 
increase in the number of hospitalizations due to sickle cell disease, parent perception of disease-
specific QOL decreased by 9.2 points (β = -9.16; p = 0.02). After controlling for ethnicity, the multivariate 
linear model no longer retained significance (p = 0.057).
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Chapter V: Discussion 
 In this exploratory mixed methods study, we adapted the Conceptual Model of Health-related 
QOL (Ashing-Giwa, 2005) for use in youth with sickle cell disease to guide our study. In the adapted 
model, the construct sickle cell disease life burden was operationalized in 3 ways: other family members 
in the home have sickle cell disease, greater medication barriers to hydroxyurea, and greater discordance 
regarding sickle cell family responsibility. The construct poorer health was operationalized as greater 
number of emergency room visits and/or hospitalizations within the past year. 
Summary of Study 
Generic QOL in youth with sickle cell disease has been studied over the past several years but a 
disease-specific instrument was lacking. In 2013 a valid and reliable disease-specific measure, the 
PedsQL Sickle Cell Disease Module, was developed by Panepinto et al. (2013) but was only available for 
use with subjects with English language fluency. For use with Spanish speaking subjects enrolled in the 
hydroxyurea Adherence for Personal Best in Sickle Cell Disease (HABIT) feasibility trial (R21 NR013745), 
the PedsQL Sickle Cell Disease Module had undergone a forward and backward Spanish language 
translation to produce a Spanish language version. As a first step of this dissertation research, the final 
phase of the process of linguistic validation was conducted using a sample of Spanish speaking youth 
age 9-17 years with sickle cell disease and their parent (10 youth, 10 parents). Completion of this process 
produced a validated equivalent Spanish language version of the PedsQL Sickle Cell Disease Module for 
age 8-12 and 13-18. The Spanish language version is now available by request from the MAPI Institute 
(Mapi Research Trust, 2015). 
This is one of the first studies to examine disease-specific and generic QOL in Latino youth with 
sickle cell disease. Youth and parent proxy-report of baseline disease-specific and generic QOL of 
subjects who participated in the HABIT feasibility trial was used to compare perception of disease-specific 
and generic QOL by ethnicity; half of the sample was Latino. All youth were treated with hydroxyurea but 
did not adhere to the medication regimen. We explored the relationship between conceptually relevant 
factors such as Latino ethnicity, life burden, and poorer health to examine their contribution to perception 
of QOL.  
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Interpretation of Quality of Life Scores in the Sample 
Disease-specific Quality of Life. Disease-specific QOL scores on the PedsQL Sickle Cell 
Disease Module provide researchers and healthcare providers a guide in assessment of QOL in the 
sickle cell disease population. In prior research (Beverung, Varni, & Panepinto, 2015), Pain and Hurt and 
Pain Impact subscale scores of ≤ 60 were associated with poor QOL, while scores of ≥ 81 were 
associated with good QOL in youth with sickle cell disease. In the sample of youth who participated in the 
HABIT study, Pain and Hurt subscale scores reflected QOL that was between poor and good (73.7 ± 
24.4), while Pain Impact scores (57.6 ± 26.2) on average, reflected poor QOL. Our results are similar to 
those reported in Panepinto et al. (2013) where youth with sickle cell disease also reported Pain and Hurt 
subscale scores that can be associated with poor to good QOL (66.7 ± 20.9) and Pain Impact subscale 
score that can be associated with poor QOL (54.0 ± 24.8). In this study, the mean disease-specific QOL 
scores for each subscale were similar to those reported by Panepinto et al. (2013) with the exception of 
the Treatment and Communication II subscales. Specifically, youth in our study reported higher 
Treatment subscale scores compared to youth who participated in the Panepinto study (79.1 ± 17.4 
versus 64.3 ± 21.9), which means that youth in the current study perceived sickle cell disease-related 
treatment impact such as remembering to take sickle cell disease medication, not liking the taste, and 
worrying about the therapeutic effect of sickle cell disease medication, as having less of a negative effect 
on their QOL compared to the sample in Panepinto et al. (2013).  
Youth versus Parent Quality of Life. Hypothesis 2.1, that youth would report higher disease-
specific and generic QOL than parents was partially supported for total disease-specific but not for total 
generic QOL. Youth scores were significantly higher (p = 0.02) than parent proxy scores for disease-
specific QOL total score and 6 points higher, though not statistically significantly higher, than parent proxy 
for generic QOL total score. As others have reported, there is imperfect agreement between youth self-
report and parent proxy-report of QOL in youth with chronic illnesses (Garetz et al., 2015; Hilliard et al., 
2013; Lins, Tassitano, Brandt, de Castro Antunes, & da Silva, 2015). Parents may overestimate the 
impact of chronic illness on youth’s QOL. Eiser and Morse (2001) conducted a review of 14 studies that 
examined QOL in youth with a range of chronic conditions to examine the extent of concordance between 
youth self-report and parent/caregiver proxy-report. The researchers reported that concordance was 
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commonly found between youth and parent for Physical, Functioning, and Symptoms subscales but not 
Social or Emotional subscales. Eiser and Morse (2001) concluded that additional research is needed to 
provide conclusive evidence to determine if youth self-report of QOL is more reliable than parent proxy-
report.  
Latino versus Non-Latino Quality of Life. Based on the literature review reported in Chapter 2, 
I hypothesized that the perception of disease-specific and generic QOL in Latino youth and parents would 
be lower compared to non-Latino youth and parents. This was not the case.  Compared to non-Latino, 
Latino youth reported higher QOL scores for all subscales except for one, the disease-specific Worry II 
subscale. Latino parents reported higher QOL scores than non-Latino parents for all disease-specific 
subscales except for three: Worry I, Worry II, and Communication I subscales. The hypothesis was based 
on results of 4 studies (Ashing-Giwa et al., 2007; Brice et al. 2011; Lim et al., 2009; Scott et al., 2008) in 
the integrative literature review of cultural factors that compared perception of QOL of Latino participants 
with non-Latino participants. One possible reason for this hypothesis not being fully supported is that in 
this study non-Latino parents reported a higher number of hospitalizations during the past year compared 
to Latino parents (on average, 11 versus 5). As this study and others (Gonzalez-Gil, Jenaro, Gómez-Vela, 
& Flores, 2008; Hegarty, Macdonald, J., Watter, P., & Wilson, 2008; Kullowatz, Kanniess, Dahme, 
Magnussen, & Ritz, 2007) have reported, increased hospitalizations are associated with poorer QOL. 
While there were no significant differences in mean total disease-specific QOL and for the 
majority of subscale scores between ethnicities in our study, Latino youth reported significantly higher 
scores for Emotions (Latino youth reported feeling less mad about having sickle cell disease or when 
he/she has pain), Treatment (Latino youth reported less problems with treatment), and Communication II 
(Latino youth had less difficulty regarding others not understanding about sickle cell disease and/or pain; 
less difficulty telling others that he/she has sickle cell disease) subscales.  
Latino parents reported significantly lower disease-specific QOL scores for Worry II (Latino 
parents worried more than non-Latino parents that their child might have a stroke or a chest crisis). Latino 
parents reported significantly higher disease-specific QOL scores for Emotions (Latino parents reported 
feeling less mad about their child having sickle cell disease or when he/she has pain), and 
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Communication II (Latino parents had less difficulty regarding others not understanding about sickle cell 
disease and/or pain; less difficulty telling others that their child has sickle cell disease). 
The differences in Emotions subscale scores may possibly be explained by the concept of 
familism. Sabogal, Marin, Otero-Sabogal, VanOss Marin, & Perez-Stable (1987) described familism (or 
familismo) as having a high regard for family relationships with close family ties, interconnectedness, and 
prioritizing of family before self, and is a central feature of Latino culture. Familism has been found to 
promote health and appears to be generally beneficial to those who view familism as ideal (Corona, 
Campos, & Chen, 2017).  
Considering that pain is a hallmark of sickle cell disease, it is possible that non-Latino youth and 
parents reported significantly lower QOL for the aforementioned subscales because of a difference in 
treatment regimen prescribed by their physician. In a study of disagreement in pain perception between 
adult patients and their physicians in primary care, Staton et al. (2007) reported that almost 50% of the 
time, physicians underestimated pain levels in African American patients with chronic pain by 2 or more 
points on an 11-point numeric pain rating, compared to 33.5% of the time for non-African Americans with 
chronic pain. Moreover, when pain level was overestimated, physicians were more likely to overestimate 
pain levels in non-African Americans 18.9% compared to 9.5% in African Americans (Staton et al., 2007).  
Our study findings showed that Latino youth and parents reported significantly higher scores on 
Communication II subscale (Latinos had less difficulty regarding others not understanding about sickle 
cell disease and/or pain; less difficulty telling others that he/she has sickle cell disease) compared to non-
Latino youth and parents. To better understand results obtained in our study, additional studies with 
Latino and non-Latino youth with sickle cell disease need to be conducted.  
Not all studies examining QOL in youth with sickle cell disease report the ethnicity of participants 
(Graves, Hodge, & Jacob, 2016; McClellan et al., 2009). Some researchers in studies of sickle cell 
disease have described the ethnicity of participants in their samples but did not examine QOL scores by 
ethnicity because the number of Latino participants was small (Newland, 2008; Panepinto et al., 2010; 
Panepinto et al., 2013). The incidence of sickle cell disease is greatest in African Americans, with 
incidence in Latinos coming in a distant second (Wang et al., 2013). In earlier research, sickle cell 
disease study samples consisted mainly of African Americans and of those who are proficient in English 
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and few if any Latinos were included. While sickle cell disease is less prevalent among Latinos, every 
state in the U.S. has varying percentages of people living with sickle cell disease, ranging from <1 case 
per 1,000 births in Montana to 34.1 cases per 1,000 births in Mississippi (Ojodu, Hulihan, Pope, & Grant, 
2014); therefore, when possible, race/ethnicity should be considered when examining the influence of 
QOL in youth with sickle cell disease. 
While limited, research comparing the perception of QOL by race/ethnicity is accumulating. Using 
the PedsQL Generic Core Scale, McManus and colleagues compared parent proxy perception of health-
related QOL by race/ethnicity in a longitudinal sample of 660 very-low-birth-weight infants age 2 and 3 
years with and without asthma (McManus, Robert, Albanese, Sadek-Badawi, & Palta, 2012). Quality of 
life was similar, on average, for non-Hispanic White and Hispanic children but significantly lower for non-
Hispanic Black infants. Using the 36-item Short Form Health Survey, McLaughlin et al. (2016) examined 
the relationship between race, adherence, chronic pain, and generic QOL in a sample of 80 adolescents 
and young adults with hemophilia. In this sample, 61 participants were White (12% Hispanic and 88% 
non-Hispanic) and 19 participants were non-White (14% Hispanic and 86% non-Hispanic). Quality of life 
scores of non-White subjects were significantly lower compared to Whites for Physical health (63.4 vs 
78.0; p = 0.02) and 3 of its subscales: Bodily Pain (60.6 vs 74.8; p = 0.02), Physical Function (63.7 vs 
79.8; p = 0.03), and Role Limitations (61.8 vs 79.5; p = 0.01). McLaughlin et al. (2016) reported that racial 
differences in perception of chronic pain accounted for statistically different QOL scores. 
Minimal Clinically Important Difference. Minimal clinically important difference (MCID) values 
enable interpretation of changes in QOL scores over time or differences between QOL scores in different 
subject groups. A change in score that exceeds its MCID may be interpreted as a clinically meaningful 
change. In this sample the absolute differences between Latino and non-Latino subjects for disease-
specific and generic QOL total and subscale scores exceeded their respective MCID values. This 
occurred for all disease-specific subscales except Worry I (both youth and parent proxy report), and 
Communication I (parent proxy report). For the generic QOL measure, scores exceeded MCIDs for all but 
the physical subscale. In some cases, the differences in QOL scores were not statistically significant and 
may have lacked statistical power due to our modest sample size. Nonetheless, these absolute 
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differences across both QOL measures provide preliminary insight into differences in perception of QOL 
by Latino and non-Latino youth with sickle cell disease and require validation in future studies.  
Minimal clinically important difference has been previously reported for other pediatric diseases or 
conditions such as asthma (Wyrwich, Tierney, & Wolinsky, 2002), dermatologic disorders (Basra, Salek, 
Camileri, Sturkey, & Finlay, 2015), diabetes (Hilliard et al., 2013), and epilepsy (Junger et al., 2015). 
Minimal clinically important differences were more recently applied to sickle cell disease by Panepinto et 
al. (2017). Minimal clinically important differences calculated using disease-specific scores from our study 
sample were comparable to those reported by Panepinto et al. (2017) in their study 1 week post hospital 
discharge. A 6.5 point change in the Pain and Hurt subscale in our study for example, was considered 
clinically meaningful compared to a 7.4 point change at 1 week post discharge in the Panepinto et al. 
study; while changes had to exceed 14.6 points for Worrying II (worrying about a stroke or chest crisis) in 
our study compared to 14.6 at 1 week post discharge in the Panepinto (2017) sample to be perceived as 
clinically important. 
Poorer Health  
In this study emergency room and hospitalizations were measured in 2 ways: by parent self-
report and by electronic medical records. While data provided by self- or proxy-report may be inaccurate 
due to self-report bias (De Vriendt, Huybrechts, Ottevaere, Van Trimpont, & De Henauw, 2009; Kee et al., 
2017), data retrieved from electronic medical records are not without challenges such as information not 
accurately entered electronically (Cowie et al., 2017). However, when used together as in our study, they 
provide a strong support for accuracy of study results. 
Painful vaso-occlusive sickle cell crisis is the most common cause of emergency room and/or 
hospitalization of patients with sickle cell disease. In our sample, multivariate analyses showed that there 
was an inverse association between number of emergency room visits and/or hospitalization and 
perception of disease-specific QOL. Our findings are consistent with the findings of Panepinto et al. 
(2017), who reported that youth with sickle cell disease who had acute painful vaso-occlusive crises 
reported significantly lower QOL scores while hospitalized compared to higher QOL scores 1 week post 
discharge. Jackson, Lemanek, Clough-Paabo, and Rhodes (2014) reported that a greater number of 
emergency room visits or hospitalizations were significantly associated with poorer physical QOL in their 
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study of 87 adolescents and young adults with sickle cell disease. Jackson et al. (2014) also stated that 
greater emergency room visits or greater hospitalizations indicated greater physical impact of the 
disease.  
Strengths and Limitations 
Strengths 
This study was 1 of only a few to examine QOL in Latino and non-Latino youth using disease-
specific and generic QOL instruments. Furthermore, few studies examining QOL in youth are stratified 
based on youths’ ethnicity. While the study sample was modest, Latinos in our study represent a subset 
of individuals largely overlooked in research of QOL in those with sickle cell disease. Our study used 
report of emergency room visits and hospitalizations from 2 perspectives: self-report and objective 
electronic medical record review. Results from both perspectives pointed in the same direction: greater 
number of emergency room visits and/or hospitalizations resulted in poorer QOL.  
Limitations  
This study has several limitations. The sample size was small and did not allow for statistical 
control of demographic variables like age and gender. This study used secondary data that was not 
designed to study cultural factors and was therefore confined to the type of data that were captured in the 
primary study. We were unable to measure factors such as acculturation, familism, patient-provider 
relationship, and religiosity/spirituality, which were identified as important factors of QOL in participants in 
previous studies. Measuring the relationship between disease-specific and generic QOL in youth with 
sickle cell disease and cultural factors would have provided a broader understanding of QOL in this 
sample. Furthermore, this study was unable to examine some of the variables that might be associated 
with variations in QOL, such as mental health (depression), cognitive issues, immigration status, and 
family instability. 
The sample for Aims 2 and 3 was derived from the HABIT study and included Latino and non-
Latino youth with sickle cell disease from Columbia University Medical Center and from Albert 
Einstein/Montefiore Medical Center who had not successfully integrated a daily hydroxyurea adherence 
routine and self-management into a standard health habit. This study design limits generalizability to 
other Latinos and non-Latinos with sickle cell disease who have successfully integrated their daily 
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hydroxyurea adherence routine and self-management into a standard health habit, because our findings 
would only represent those who had a history of not successfully incorporating their daily hydroxyurea 
adherence routine and self-management into a healthy practice. Additionally, because our sample of 
Latinos were either born in the Dominican Republic or their parents were born in the Dominican Republic, 
study findings may not pertain to other Latinos from other Spanish-speaking countries.  
 This study found significant associations between emergency room visits in the past year and 
disease-specific QOL, and hospitalizations within the past year and disease-specific QOL. These results 
however, are correlational in nature and as a result, a causal relationship cannot be established. It is 
possible that visiting the emergency room and/or being hospitalized leads to poor disease-specific QOL in 
youth with sickle cell disease and parents, but it is also possible that disease-specific QOL may have an 
influence on the number of emergency room visits and/or hospitalizations. Experiencing chronic pain and 
hurt, for example, may result in increased emergency room visits and/or hospitalizations. Moreover, the 
self-reported nature of some of this data collection relied on participants’ recollection of past events such 
as barriers to medication adherence and sickle cell family responsibility and may have presented an 
element of recall bias over that period.  
Implications for Practice 
This exploratory study emphasizes the relevance of understanding the relationship between 
poorer health and QOL in youth with sickle cell disease. Greater number of hospitalizations was related to 
poorer QOL in youth with sickle cell disease. Routine QOL screening with a disease-specific QOL 
instrument like the PedsQL Sickle Cell Disease Module during regular office visits for youth with sickle cell 
disease may lead to better management of sickle cell disease and to less emergency utilization of 
healthcare resources. Routine screening has the potential of identifying youth with poor QOL. Routine 
screenings can potentially supplement clinical findings by using MCIDs to identify meaningful changes in 
QOL scores. 
Recommendations for Policy 
A goal of Health People 2020 is to “Improve health-related QOL and well-being for all individuals” 
(Office of Disease Prevention and Health Promotion [ODPHP], 2017). The importance of this goal was 
underscored by its inclusion as one of Healthy People’s (HP) 2020 overarching goal of “promoting quality 
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of life, healthy development, and health behaviors across all life stages” (ODPHP, 2017). To improve 
QOL and well-being for Latinos on how sickle cell disease impacts their life, we recommend that health 
care staff be educated regarding the importance of having valid and reliable questionnaires that are 
culturally and linguistically sound in the language that the patient is most comfortable with.  
Conclusion 
In conclusion, this exploratory study of Latino and non-Latino examined disease-specific and 
generic QOL in youth aged 8-18 years with sickle cell disease. Moreover, we completed the translation 
and linguistic validation of a sickle cell disease-specific QOL instrument for use among Spanish-speaking 
sickle cell disease population. This study highlighted the importance of having QOL questionnaires 
available in the preferred language of participants, so that the influence of sickle cell disease on their 
sense of well-being can be assessed, and to offer a useful addition to more objective clinical measures. 
The findings of this study emphasized the relationship between QOL and greater number of emergency 
room visits and/or hospitalizations among youth with sickle cell disease and could serve as a call to action 
for clinicians and researchers to find ways of improving the lives of those affected with this disease by 
preventing painful vaso-occlusive crises. Furthermore, the results of this study may help to increase 
understanding and utility of measurement of QOL in clinical settings in patients with sickle cell and other 
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Name: _________________________                  Date:  ___________  
  
INSTRUCTIONS:  Please complete the following questions by indicating an X next to your answer. Your 
information will be kept strictly confidential.  
  
1. How old are you? _______________ years 
  
2. What is your gender?    Male ____ Female ____  
  
3. Are you Latino or Hispanic?   Yes ____ No ____  
  
4. Do you have sickle cell disease?   Yes____ No ____  
  
5. Were you born in the United States?    Yes ____ No ____  
 







Subject ID _________            Parent Demographic Questionnaire               Date _____________                     
 
Name: ______________________________                                             
Address: _______________________________  
Home Phone number:  _____________________   
Personal cell phone number: _____________  
Date of birth: ________________________             
Do you consider yourself Latino/Hispanic?  
        Yes  
        No  
        Prefer not to respond  
What is your race?  
       White     
       Black/African American  
       Asian  
       Native Hawaiian/Pacific Islander             
 (Please specify: _________________)  
       American Indian/Alaskan Native  
        Multiracial  
       Other: ______________________  
       Prefer not to respond.  
How long have you lived in the United States?     
       Less than one year    
       1 to 3 years                   
       4 to 5 years                 
       6 to 10 years       
       More than 10 years  




      
Subject ID _________            Parent Demographic Questionnaire               Date _____________                     
What is your highest level of education?  
      Elementary school          
      Some high school          
       High school graduate      
      Some college                  
      College graduate           
        Graduate school           
  
Are you the person who takes care of your child most of the time?         YES      NO  
Employment:  
      Full time (35 hours per week or more)   
      Part time (less than 35 hours per week)  
      Laid off   
      Unemployed or currently looking for work   
      Disabled/retired   
      Attending school  
  
Marital status:    
      Married, living with spouse   
      Married, living separately   
      Single   
      Separated from spouse   
      Divorced  
  
Number of children in household: ________________  
Number of people living in the home of child with sickle cell: ________________  
Do you have sickle cell disease?    Yes      No  
Do other people in the home have sickle cell disease?   




Subject ID _________            Parent Demographic Questionnaire              Date _____________                     
  
Information about your child 
 Child’s name: ______________________________                                             
  
Address: _______________________________  
Home Phone number:  _______________Child’s personal cell phone number: __________  
 
Child’s date of birth: ________________________       
  
Is your child Latino/Hispanic?  
       Yes  
        No  
        Prefer not to respond.  
What is your child’s race?  
        White  
         Black/African American  
         Asian  
        Native Hawaiian/Pacific Islander              
     (Please specify: _________________)  
        American Indian/Alaskan Native  
        Multiracial  
        Other: ______________________  
        Prefer not to respond.  
 
Does your child live in the same house as you? Yes □    No □  
How long has your child lived in the United States?       
      Less than one year    
        1 to 3 years                    
      4 to 5 years                  
      6 to 10 years      
       More than 10 years   
      Born in the United States  
   
What is your child’s grade level in school? __________________   
127 
 
 Subject ID _________            Parent Demographic Questionnaire              Date _____________                     
 
Who is the person who takes care of the child most of the time?   
      Mother  
       Father   
      Grandmother or Grandparent   
      Foster parent   
      Someone else __________  
  
List information about your child’s medications:   
Name  Dose (mg) Times per day Date started (more than 6 months 
ago; less than 6 months ago) 
Hydroxyurea     
Penicillin     
Folic acid    
Exjade     
Tylenol     
Ibuprofen     
    
    
    
 




In the past year, has your child been treated in the emergency room?   Yes □    No □  
If yes, how many times? __________   
Did you go to the emergency room for treatment of sickle cell disease?   Yes □    No □  
 Are you the one who usually takes your child to his or her appointments/takes your child to the 
ER when needed?             Yes □    No □  
 In the past year, has your child been hospitalized?        Yes □    No □  
  If yes, how many times? __________  




Report of Translation Process for PedsQL Sickle Cell Disease Module 
A total of 10 Latino parent-child dyads participated in the cognitive interview component of the 
translation process of the PedsQL Sickle Cell Disease Module Child Report (ages 8-12), the PedsQL 
Sickle Cell Disease Module Parent Report for Children (ages 8-12), the PedsQL Sickle Cell Disease 
Module Teen Report (ages 13-18), and the PedsQL Sickle Cell Disease Module Parent Report for Teens 
(ages 13-18). All subjects currently receive care at New York Presbyterian/Columbia University Medical 
Center. All interviews were conducted at the location requested by the parent. The majority of interviews 
were conducted in participants’ homes except for two which were conducted either at New York 
Presbyterian/Columbia University Medical Center Transplant Center or at Columbia’s Pediatric sickle cell 
disease Clinic. 
Child Demographics  
Overall, youth ranged in age from 9-17 years (average 13.4 years). 
8-12 years. Children ranged in age from 9-12 years (average 10.8 years). Four out of five 
children were male. Children in this age group all reported being born in the United States. PedsQL Sickle 
Cell Disease Module completion time ranged from 8-15 minutes (average 10.4 minutes). One parent 
reported having sickle cell disease.  
Table A provides a summary of the demographic characteristics of the children who participated in the 
linguistic validation process for the PedsQL Sickle Cell Disease Module Child Report (ages 8-12). While 
all youth were born in the United States, all were fluent in Spanish. 
 
 
Table A Children in 8-12 Age Group 
Age (years) Gender Ethnicity Born in U.S. Module 
Completion 
(minutes) 
9 Male Latino Yes 15 
11 Male Latino Yes 9 
11 Male Latino Yes 8 
11 Female Latino Yes 8 




13-18 years. Children ranged in age from 15-17 years (average 16 years). Four out of five 
children were male. Only 2 children (age 15 and 17 years) reported Dominican Republic as their country 
of birth while the remaining majority reported being born in the United States. PedsQL Sickle Cell Disease 
Module completion time ranged from 7-12 minutes (average 9 minutes). Table B provides a summary of 
children demographics for the 13-18 age group.  
 
Table B Youth in 13-18 Age Group 
Age in 
years 
Gender Ethnicity Born in the 
U.S. 




15 Male Latino Yes 
 
9 
15 Male Latino No Dominican Rep. 8 
16 Male Latino Yes 
 
12 
17 Male Latino Yes 
 
7 
17   Female Latino No Dominican Rep. 8 
 
Parent Demographics 
Overall, parents ranged in age from 29-48 years (average 36.9 years). The entire sample of 
parents reported Dominican Republic as their country of birth.  
Parents of 8-12 year olds. Parents ranged in age from 30-47 years (average 35.2 years). 
PedsQL Sickle Cell Disease Module completion time ranged from 6-12 minutes (average 9.4 minutes). All 
parents were female. Table C summarizes demographics of parents of children in the 8-12 year olds. 
 
Table C Parents of Children in 8-12 Age Group 
Age in 
years 





If no, country Completion 
time in 
minutes 
30 Female Latino No No Dominican Republic 8 
30 Female Latino Yes No Dominican Republic 11 
34 Female Latino No No Dominican Republic 6 
35 Female Latino No No Dominican Republic 10 
47 Female Latino No No Dominican Republic 12 
 
Parents of 13-18 year olds. Parents ranged in age from 29-48 years (average 38.6 years). 
Completion time ranged from 7-12 years (average 8.6 minutes). All parents were female except for one 





Table D Parents of Children in 13-18 Age Group 
Age in 
years 





If no, country Completion 
time in 
minutes 
29 Female Latino No No Dominican Republic 7 
35 Female Latino No No Dominican Republic 8 
35 Female Latino No No Dominican Republic 8 
46  Male Latino No No Dominican Republic 12 
48 Female Latino No No Dominican Republic 8 
 
Cognitive Interview  
 After the completion of the PedsQL Sickle Cell Disease Module, individual face to face interviews 
were conducted in Spanish by a bilingual research assistant with children for the age appropriate child 
self-report questionnaires and with parents for the corresponding parent proxy-report questionnaires. 
Youth and parent interviews were conducted separately. Item-by-item analyses were conducted where 
participants were asked whether the PedsQL Sickle Cell Disease Module directions and questions were 
clear, response choices were appropriate, they understood each item, questions were relevant for youths 
with sickle cell disease, and were questions too difficult to answer. Participants reported that there was no 
difficulty understanding and completing questionnaires. Participants stated that directions and questions 
were clear and easy to understand, response choices were appropriate, and questions were relevant to 
youths with sickle cell disease. 
 Only one participant had a suggestion regarding solutions for enhancing wording of a 
questionnaire item. The participant, aged 16 years, stated that the questions were “clear except for one: 
when they asked me if I was able to sleep in the night and did not ask if I normally have pain” (About MY 
Pain Impact, #9: I wake up at night when I have pain). In order to make the question clearer, she 
suggested that the questionnaire should “ask if it is hard to sleep during the night when you have pain, or 
if you wake up many times.”  
 
